{
  "meta": {
    "title": "55_Mission_Neet_Pg-Inicet_Grand_Test-24_-_28-02-2025",
    "url": "https://brainandscalpel.vercel.app/55-mission-neet-pg-inicet-grand-test-24-28-02-2025-4303389f.html",
    "scrapedAt": "2025-11-29T17:23:57.069Z"
  },
  "questions": [
    {
      "id": 72089,
      "choices": [
        {
          "id": 287357,
          "text": "<p><span style=\"font-size:14.0pt;\">1-D, 2-B, 3-A, 4-C</span></p>"
        },
        {
          "id": 287358,
          "text": "<p><span style=\"font-size:14.0pt;\">1-C, 2-D, 3-B, 4-A</span></p>"
        },
        {
          "id": 287359,
          "text": "<p><span style=\"font-size:14.0pt;\">1-D, 2-B, 3-C, 4-A</span></p>"
        },
        {
          "id": 287360,
          "text": "<p><span style=\"font-size:14.0pt;\">1-A, 2-C, 3-B, 4-D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the following types of synovial joints with their characteristics:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-19%20181204.jpg\" width=\"1107\" height=\"392\"></span></p>",
      "unique_key": "Q7012610",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) 1-D, 2-B, 3-C, 4-A</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1. Hinge Joints - D. Uniaxial; Flexion, Extension</strong></span></p><ul><li><span style=\"font-size:14.0pt;\"><strong>Movement:</strong> Uniaxial (only Flexion and Extension).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Examples:</strong> Elbow joints, ankle joints, interphalangeal joints.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2. Pivot Joints - B. Uniaxial; Rotation</strong></span></p><ul><li><span style=\"font-size:14.0pt;\"><strong>Movement:</strong> Uniaxial (Rotation).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Examples:</strong> Median atlantoaxial joint, superior and inferior radioulnar joints.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3. Condylar Joints - C. Biaxial; Flexion, Extension, Limited rotation</strong></span></p><ul><li><span style=\"font-size:14.0pt;\"><strong>Movement:</strong> Biaxial (Flexion, Extension, Limited rotation).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Examples:</strong> Knee joints, temporomandibular joints.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4. Ellipsoid Joints - A. Biaxial; Flexion, Extension, Abduction, Adduction, Circumduction</strong></span></p><ul><li><span style=\"font-size:14.0pt;\"><strong>Movement:</strong> Biaxial (Flexion, Extension, Abduction, Adduction, Circumduction).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Examples:</strong> Wrist joint (radiocarpal joint), metacarpophalangeal joint, atlanto-occipital joint (head nodding).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>types of synovial joints</strong> are classified based on their movement and structure:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-19%20181231.jpg\" width=\"1212\" height=\"580\"></span></p>",
      "correct_choice_id": 287359,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72503,
      "choices": [
        {
          "id": 289001,
          "text": "<p><span style=\"font-size:14.0pt;\">Production of carbon dioxide gas&nbsp;</span></p>"
        },
        {
          "id": 289002,
          "text": "<p><span style=\"font-size:14.0pt;\">Citrate utilization as sole carbon source</span></p>"
        },
        {
          "id": 289003,
          "text": "<p><span style=\"font-size:14.0pt;\">Fermentation of multiple sugars&nbsp;</span></p>"
        },
        {
          "id": 289004,
          "text": "<p><span style=\"font-size:14.0pt;\">Production of hydrogen sulfide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A microbiology laboratory receives a stool sample from a 28-year-old man with bloody diarrhea and fever. Initial culture grows gram-negative bacilli on MacConkey agar. To identify the organism, the technologist performs the triple sugar iron (TSI) test, along with several other biochemical tests. Which of the following bacterial properties cannot be determined using the TSI test alone?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7680788",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Citrate utilization as sole carbon source</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The triple sugar iron (TSI) test cannot determine citrate utilization, which requires a separate Simmons citrate test.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">TSI agar is specifically designed to test three key characteristics: fermentation of three sugars (glucose, lactose, and sucrose), gas production (visible as bubbles or cracks in the medium), and hydrogen sulfide production (visible as black precipitate).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Citrate utilization, which indicates an organism's ability to use citrate as its sole carbon source, requires a different medium containing citrate as the only carbon source.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;A. Production of carbon dioxide gas:&nbsp;</strong>TSI can detect gas production through visible bubbles or cracks in the medium, typically produced during glucose fermentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;C. Fermentation of multiple sugars:&nbsp;</strong>TSI contains three sugars (glucose, lactose, and sucrose) and can detect their fermentation through pH indicators that show acid production.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;D. Production of hydrogen sulphide:&nbsp;</strong>TSI contains ferrous sulfate and can detect H₂S production through the formation of black ferrous sulfide precipitate.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Triple sugar iron (TSI) test is designed to detect sugar fermentation, gas production, and H₂S production, but cannot determine citrate utilization, which requires a separate Simmons citrate test.</span></li></ul>",
      "correct_choice_id": 289002,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72067,
      "choices": [
        {
          "id": 287269,
          "text": "<p><span style=\"font-size:14.0pt;\">ACE inhibitors</span></p>"
        },
        {
          "id": 287270,
          "text": "<p><span style=\"font-size:14.0pt;\">Labetalol</span></p>"
        },
        {
          "id": 287271,
          "text": "<p><span style=\"font-size:14.0pt;\">Nifedipine</span></p>"
        },
        {
          "id": 287272,
          "text": "<p><span style=\"font-size:14.0pt;\">Methyldopa</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">What is the antihypertensive drug of choice for chronic hypertension in pregnancy?&nbsp;</span></p>",
      "unique_key": "Q1066617",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Labetalol</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Labetalol is the first-line antihypertensive due to its efficacy and safety profile in pregnancy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>ACE inhibitors:&nbsp;</strong>ACE inhibitors are contraindicated in pregnancy due to teratogenic effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C and D.</strong> <strong>Nifedipine and Methyldopa:&nbsp;</strong>Nifedipine and methyldopa are alternative options but are not the first choice.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Labetalol is the antihypertensive of choice for chronic hypertension and hypertensive emergencies in pregnancy.</span></li></ul>",
      "correct_choice_id": 287270,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72504,
      "choices": [
        {
          "id": 289005,
          "text": "<p><span style=\"font-size:14.0pt;\">Phenol coefficient test&nbsp;</span></p>"
        },
        {
          "id": 289006,
          "text": "<p><span style=\"font-size:14.0pt;\">Modified Kelsey-Sykes capacity test&nbsp;</span></p>"
        },
        {
          "id": 289007,
          "text": "<p><span style=\"font-size:14.0pt;\">Chick Martin test</span></p>"
        },
        {
          "id": 289008,
          "text": "<p><span style=\"font-size:14.0pt;\">In-use test with weekly monitoring</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A hospital infection control team is evaluating a new quaternary ammonium compound for use in the surgical ward. The compound shows excellent activity in initial testing, but after three weeks of use, several surfaces show bacterial contamination. Which of the following testing methods would have best predicted this outcome before implementation?&nbsp;</span></p>",
      "unique_key": "Q4624790",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Modified Kelsey-Sykes capacity test</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The Kelsey-Sykes capacity test is specifically designed to evaluate a disinfectant's ability to maintain its effectiveness under repeated microbial challenges.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This test assesses whether the disinfectant can retain its antimicrobial activity when repeatedly exposed to increasing microbial loads, simulating real-world conditions where disinfectants must maintain efficacy over multiple uses and increasing bacterial contamination.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Phenol coefficient test:&nbsp;</strong>This test only compares the disinfectant's activity to phenol under controlled conditions and cannot predict long-term effectiveness or performance under repeated use.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Chick Martin test:&nbsp;</strong>While this test evaluates performance in the presence of organic matter, it doesn't assess the disinfectant's capacity to maintain effectiveness over repeated microbial challenges.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. In-use test with weekly monitoring:&nbsp;</strong>This is a surveillance method to detect contamination after implementation rather than a predictive test of the disinfectant's capacity to maintain effectiveness.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The Kelsey-Sykes capacity test is essential for predicting a disinfectant's ability to maintain effectiveness under repeated microbial challenges in real-world settings.</span></li></ul>",
      "correct_choice_id": 289006,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72125,
      "choices": [
        {
          "id": 287501,
          "text": "<p><span style=\"font-size:14.0pt;\">1-b, 2-c, 3-d, 4-a</span></p>"
        },
        {
          "id": 287502,
          "text": "<p><span style=\"font-size:14.0pt;\">1-b, 2-d, 3-a, 4-c&nbsp;</span></p>"
        },
        {
          "id": 287503,
          "text": "<p><span style=\"font-size:14.0pt;\">1-d, 2-c, 3-b, 4-a</span></p>"
        },
        {
          "id": 287504,
          "text": "<p><span style=\"font-size:14.0pt;\">1-a, 2-d, 3-c, 4-b</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the Following (Scales in Dermatology):</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column A:</span></p><ol><li><span style=\"font-size:14.0pt;\">Branny/Furfuraceous</span></li><li><span style=\"font-size:14.0pt;\">Mica like</span></li><li><span style=\"font-size:14.0pt;\">Silvery white</span></li><li><span style=\"font-size:14.0pt;\">Fish-like</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column B:&nbsp;</span></p><ol style=\"list-style-type:lower-latin;\"><li><span style=\"font-size:14.0pt;\">Psoriasis</span></li><li><span style=\"font-size:14.0pt;\">Pityriasis versicolor</span></li><li><span style=\"font-size:14.0pt;\">Ichthyosis vulgaris</span></li><li><span style=\"font-size:14.0pt;\">Pityriasis lichenoides chronica</span></li></ol>",
      "unique_key": "Q9082037",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) 1-b, 2-d, 3-a, 4-c</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Branny/Furfuraceous (1-b):</strong> Associated with Pityriasis versicolor, which presents with fine, scaly, branny lesions.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Mica-like (2-d):</strong> Describes the scale pattern seen in Pityriasis lichenoides chronica.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Silvery white (3-a):</strong> Classical of Psoriasis due to the hyperkeratotic scaling.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Fish-like (4-c):</strong> Characteristic of Ichthyosis vulgaris.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"color:black;font-size:14.0pt;\">Branny/Furfuraceous: Pityriasis versicolor</span></li><li><span style=\"color:black;font-size:14.0pt;\">Mica like: Pityriasis lichenoides</span></li><li><span style=\"color:black;font-size:14.0pt;\">Silvery white: Psoriasis chronica</span></li><li><span style=\"color:black;font-size:14.0pt;\">Fish-like: Ichthyosis vulgaris</span></li></ul>",
      "correct_choice_id": 287502,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        18
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72083,
      "choices": [
        {
          "id": 287333,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3 are correct.</span></p>"
        },
        {
          "id": 287334,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3 and 4 are correct.</span></p>"
        },
        {
          "id": 287335,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3 and 4 are correct.</span></p>"
        },
        {
          "id": 287336,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 4 are correct.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 9-month-old infant is being assessed for fine motor development. Which of the following statements regarding developmental milestones are true?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Grasp reflex disappears by 9 months.</span></li><li><span style=\"font-size:14.0pt;\">Immature Pincer grasp develops at 9 months.</span></li><li><span style=\"font-size:14.0pt;\">Transferring objects from one hand to another is possible by 7 months.</span></li><li><span style=\"font-size:14.0pt;\">Mature pincer grasp is achieved by 12 months.</span></li></ol>",
      "unique_key": "Q4006517",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans</strong>. <strong>B) 2, 3 and 4 are correct.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>Immature Pincer grasp develops at 9 months:&nbsp;</strong>Correct<strong>.</strong> The immature pincer grasp is a fine motor milestone that develops around 9 months, allowing infants to pick up small objects with their thumb and index finger and assisted fingers</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>Transferring objects from one hand to another is possible by 7 months:&nbsp;</strong>Correct. By 6-7 months of age, infants can transfer objects from one hand to another, marking the development of coordinated hand movements.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>Mature pincer grasp is achieved by 12 months:&nbsp;</strong>Correct. Mature pincer grasp is also achieved at 12 months, signifying advanced fine motor control.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>Grasp reflex disappears by 9 months:&nbsp;</strong>Incorrect. Grasp reflex disappears earlier, by 3 months of age, as it is a primitive reflex and not present at 9 months.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The immature pincer grasp is a fine motor milestone that develops around 9 months, By 6-7 months of age, infants can transfer objects from one hand to another, Mature pincer grasp is also achieved at 12 months, Grasp reflex disappears earlier, by 3 months of age.</span></p>",
      "correct_choice_id": 287334,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72500,
      "choices": [
        {
          "id": 288989,
          "text": "<p><span style=\"font-size:14.0pt;\">Use of vancomycin, as it is the first-line treatment for MRSA infections</span></p>"
        },
        {
          "id": 288990,
          "text": "<p><span style=\"font-size:14.0pt;\">Use of β-lactam antibiotics, as the presence of the blaZ gene is likely conferring resistance to penicillin</span></p>"
        },
        {
          "id": 288991,
          "text": "<p><span style=\"font-size:14.0pt;\">Use of tetracycline, as the tetM gene would confer protection against the infection</span></p>"
        },
        {
          "id": 288992,
          "text": "<p><span style=\"font-size:14.0pt;\">Use of alternative antibiotics, as the mecA gene indicates methicillin resistance and requires an alternative treatment approach</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old male with a history of chronic obstructive pulmonary disease (COPD) presents to the hospital with a fever and increasing shortness of breath. Blood cultures reveal Methicillin-resistant Staphylococcus aureus (MRSA), and a molecular assay identifies the presence of the mecA gene. Based on the resistance profile of the pathogen, which of the following treatment strategies would be most appropriate for this patient?&nbsp;</span></p>",
      "unique_key": "Q4371012",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A) Use of vancomycin, as it is the first-line treatment for MRSA infections</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Vancomycin remains the first-line treatment for Methicillin-resistant Staphylococcus aureus (MRSA) infections, despite the presence of the mecA gene.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The mecA gene confers resistance to methicillin, but vancomycin is typically still effective against MRSA.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Therefore, vancomycin is the appropriate choice for treating this infection, as it targets the cell wall synthesis of MRSA.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Use of β-lactam antibiotics, as the presence of the blaZ gene is likely conferring resistance to penicillin:</strong> β-lactam antibiotics<strong>&nbsp;</strong>are ineffective for MRSA infections due to the presence of the mecA gene, which confers resistance to methicillin and related antibiotics.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Use of tetracycline, as the tetM gene would confer protection against the infection:&nbsp;</strong>Tetracycline resistance is not relevant to MRSA treatment in this case, as MRSA requires antibiotics specifically effective against its resistance mechanisms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Use of alternative antibiotics, as the mecA gene indicates methicillin resistance and requires an alternative treatment approach:&nbsp;</strong>Although mecA gene confers resistance to methicillin, vancomycin is still an appropriate treatment for MRSA, and no alternative antibiotics are necessarily required unless the infection is resistant to vancomycin.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Vancomycin is the first-line treatment for MRSA infections, even in the presence of the mecA gene, which confers resistance to methicillin.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-21%20181501.jpg\" width=\"897\" height=\"608\"></span></p>",
      "correct_choice_id": 288989,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72211,
      "choices": [
        {
          "id": 287845,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 2</span></p>"
        },
        {
          "id": 287846,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 3</span></p>"
        },
        {
          "id": 287847,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 4</span></p>"
        },
        {
          "id": 287848,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding the effects of estrogen is/are incorrect?&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Estrogen increases sensitivity to oxytocin in the uterus and reduces uterine excitability.</span></li><li><span style=\"font-size:14.0pt;\">Estrogen has no role in stimulation of ductal growth in the breast&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Estrogen has a cardioprotective effect by inhibiting platelet activation and lowering serum cholesterol.</span></li><li><span style=\"font-size:14.0pt;\">Estrogen promotes neuroprotection by preventing apoptosis in the central nervous system.</span></li></ol>",
      "unique_key": "Q7492401",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1 and 2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. Estrogen increases sensitivity to oxytocin in the uterus and reduces uterine excitability:</strong> Incorrect. Estrogen increases both uterine excitability and sensitivity to oxytocin, which aids in uterine contractions during labor.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. Estrogen has no role in stimulation of ductal growth in the breast:</strong> Incorrect. Estrogen stimulates ductal growth in the breast, it directly enhances secondary sexual characteristics and not solely through ductal growth.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. Estrogen has a cardioprotective effect by inhibiting platelet activation and lowering serum cholesterol:</strong> Correct. Estrogen has a dual cardioprotective effect by lowering serum cholesterol levels through its actions on the liver and reducing platelet activation, thereby preventing cardiovascular disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. Estrogen promotes neuroprotection by preventing apoptosis in the central nervous system:</strong> Correct. Estrogen provides neuroprotection by inhibiting neuronal apoptosis, reducing the risk of neurodegenerative diseases.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-21%20143723.jpg\" width=\"981\" height=\"594\"></p>",
      "correct_choice_id": 287845,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72094,
      "choices": [
        {
          "id": 287377,
          "text": "<p><span style=\"font-size:14.0pt;\">Is the widest and most dilatable part</span></p>"
        },
        {
          "id": 287378,
          "text": "<p><span style=\"font-size:14.0pt;\">Presents a concavity posteriorly</span></p>"
        },
        {
          "id": 287379,
          "text": "<p><span style=\"font-size:14.0pt;\">Lies closer to anterior surface of prostate</span></p>"
        },
        {
          "id": 287380,
          "text": "<p><span style=\"font-size:14.0pt;\">Receives prostatic ductules along its posterior wall</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Prostatic urethra is characterized by all of the following features except:<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9607177",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Presents a concavity posteriorly</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The prostatic urethra does not present a posterior concavity. Instead, it has an anterior concavity, which becomes more pronounced in the membranous urethra.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Is the widest and most dilatable part:</strong> The prostatic urethra is indeed the widest and most dilatable part of the urethra. This feature allows for easier passage of instruments like catheters through this segment during medical procedures.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Lies closer to the anterior surface of the prostate:</strong> The prostatic urethra runs more anteriorly through the prostate and is situated closer to its anterior surface. It passes at the junction of the anterior 1/3rd and posterior 2/3rds of the prostate gland.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Receives prostatic ductules along its posterior wall:</strong> Multiple prostatic ductules open into the posterior wall of the prostatic urethra, contributing to the ejaculate during ejaculation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-19%20181935.jpg\" width=\"1007\" height=\"430\"></strong></span></p>",
      "correct_choice_id": 287378,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72462,
      "choices": [
        {
          "id": 288837,
          "text": "<p><span style=\"font-size:14.0pt;\">PTHrP</span></p>"
        },
        {
          "id": 288838,
          "text": "<p><span style=\"font-size:14.0pt;\">CEA</span></p>"
        },
        {
          "id": 288839,
          "text": "<p><span style=\"font-size:14.0pt;\">INSM-1</span></p>"
        },
        {
          "id": 288840,
          "text": "<p><span style=\"font-size:14.0pt;\">Calretinin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old male with a 40-pack-year smoking history presents with a centrally located lung mass. Biopsy of the tumor shows cells with high mitotic activity and the presence of dense-core neurosecretory granules on electron microscopy. Immunohistochemistry reveals chromogranin, synaptophysin, and CD56 positivity. Which of the following markers is most likely to be elevated in this patient?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3549663",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) INSM-1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Clinical clues:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">65-year-old male</span></li><li><span style=\"font-size:14.0pt;\">40 pack-year smoking history</span></li><li><span style=\"font-size:14.0pt;\">Centrally located lung mass</span></li><li><span style=\"font-size:14.0pt;\">High mitotic activity</span></li><li><span style=\"font-size:14.0pt;\">Dense-core neurosecretory granules (EM)</span></li><li><span style=\"font-size:14.0pt;\">Chromogranin+, Synaptophysin+, CD56+ (IHC)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">These findings are <strong>classic for Small Cell Lung Carcinoma (SCLC)</strong>, a <strong>neuroendocrine tumor</strong> of the lung.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">INSM-1 is an intra-nuclear marker for the diagnosis of small cell lung carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. PTHrP:</strong> Seen in <strong>squamous cell carcinoma</strong>, which is also centrally located but <strong>not neuroendocrine</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. CEA:</strong> Marker for <strong>adenocarcinomas</strong>, not neuroendocrine tumors.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Calretinin:</strong> Marker for <strong>mesothelioma</strong> and <strong>mesothelial cells</strong>, not relevant here.</span></p>",
      "correct_choice_id": 288839,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72551,
      "choices": [
        {
          "id": 289193,
          "text": "<p><span style=\"font-size:14.0pt;\">The substrate and the modifiers (activator and inhibitor) bind to the same site on the enzyme.</span></p>"
        },
        {
          "id": 289194,
          "text": "<p><span style=\"font-size:14.0pt;\">The substrate and the modifiers are structural analogues of each other.</span></p>"
        },
        {
          "id": 289195,
          "text": "<p><span style=\"font-size:14.0pt;\">The enzyme exhibits cooperative binding, indicative of allosteric modulation.</span></p>"
        },
        {
          "id": 289196,
          "text": "<p><span style=\"font-size:14.0pt;\">The enzyme regulation depicted involves changes in the quantity of enzyme molecules.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Refer to the provided diagram displaying an enzyme with distinct sites for substrate, an allosteric activator, and an allosteric inhibitor. Given this arrangement, which statement accurately describes the behavior exhibited by the enzyme?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-24%20122050.jpg\" width=\"923\" height=\"594\"></span></p>",
      "unique_key": "Q8551968",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;C) The enzyme exhibits cooperative binding, indicative of allosteric modulation</strong>.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The diagram illustrates an enzyme where allosteric sites (activator and inhibitor sites) distinct from the substrate-binding site influence the enzyme's activity.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This configuration supports cooperative binding, a hallmark of allosteric modulation, where the binding of one molecule (activator or inhibitor) alters the enzyme's affinity for the substrate or additional regulatory molecules.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This mechanism enhances or diminishes the enzyme's activity by inducing conformational changes that either favor or disfavor the substrate's optimal binding.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>The substrate and the modifiers (activator and inhibitor) bind to the same site on the enzyme:</strong> <strong>Incorrect.</strong> The substrate and modifiers bind to different sites, as clearly indicated by separate allosteric activator and inhibitor sites in the diagram.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>The substrate and the modifiers are structural analogues of each other:</strong> <strong>Incorrect.</strong> There is no indication that the substrate and modifiers are structural analogues; they affect the enzyme through different mechanisms at distinct sites.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>The enzyme regulation depicted involves changes in the quantity of enzyme molecules: Incorrect.</strong> The regulation shown pertains to the activity of the enzyme through conformational changes, not the quantity of enzyme molecules.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Understand the principles of allosteric regulation in enzymes, particularly how cooperative binding at allosteric sites can significantly influence enzyme activity, enhancing or inhibiting the enzyme's function based on the presence of regulatory molecules.</span></li></ul>",
      "correct_choice_id": 289195,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72496,
      "choices": [
        {
          "id": 288973,
          "text": "<p><span style=\"font-size:14.0pt;\">Increase dose and extend dosing interval</span></p>"
        },
        {
          "id": 288974,
          "text": "<p><span style=\"font-size:14.0pt;\">Reduce dose and maintain standard dosing interval</span></p>"
        },
        {
          "id": 288975,
          "text": "<p><span style=\"font-size:14.0pt;\">Maintain dose and reduce dosing interval</span></p>"
        },
        {
          "id": 288976,
          "text": "<p><span style=\"font-size:14.0pt;\">Reduce dose and extend dosing interval</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In managing a complicated urinary tract infection in an 80-year-old man with declining renal function (creatinine clearance of 20 mL/min), how would the Vancomycin nomogram suggest adjusting the dosing strategy to maintain effective plasma concentrations without exacerbating renal impairment?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9515581",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>D) Reduce dose and extend dosing interval</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">For elderly patients with significantly reduced creatinine clearance, the Vancomycin nomogram typically recommends reducing the dose and extending the dosing interval.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This strategy helps maintain effective drug levels while reducing the risk of accumulating toxic levels due to impaired renal clearance.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Adjust vancomycin dosing in elderly patients with severe renal impairment to achieve therapeutic drug levels safely.</span></li></ul>",
      "correct_choice_id": 288976,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72148,
      "choices": [
        {
          "id": 287593,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 4 only</span></p>"
        },
        {
          "id": 287594,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3 and 4 only</span></p>"
        },
        {
          "id": 287595,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 4 only</span></p>"
        },
        {
          "id": 287596,
          "text": "<p><span style=\"font-size:14.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old woman presents with recurrent oral and genital ulcers, erythema nodosum, and uveitis. Which of the following statements about her condition are true?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">It is associated with a multisystem inflammatory disorder.</span></li><li><span style=\"font-size:14.0pt;\">The diagnosis is made clinically based on characteristic findings.</span></li><li><span style=\"font-size:14.0pt;\">It is more common in men than women.</span></li><li><span style=\"font-size:14.0pt;\">Arthritis is a common feature.</span></li></ol>",
      "unique_key": "Q8542476",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) 1, 2 and 4 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1.</strong> <strong>It is associated with a multisystem inflammatory disorder: True.</strong> Behçet syndrome is a multisystem inflammatory disorder involving mucocutaneous, ocular, and articular systems.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2.</strong> <strong>The diagnosis is made clinically based on characteristic findings: True.</strong> Diagnosis is based on clinical findings, including recurrent oral/genital ulcers and uveitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4.</strong> <strong>Arthritis is a common feature: True.</strong> Arthritis is a recognized feature of Behçet syndrome.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3.</strong> <strong>It is more common in men than women: False.</strong> Behçet syndrome is more common in women than men.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Behçet syndrome is a multisystem disorder diagnosed clinically by recurrent oral/genital ulcers, uveitis, and associated arthritis.</span></li></ul>",
      "correct_choice_id": 287593,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72513,
      "choices": [
        {
          "id": 289041,
          "text": "<p><span style=\"font-size:14.0pt;\">Improvement in left ventricular ejection fraction (LVEF).</span></p>"
        },
        {
          "id": 289042,
          "text": "<p><span style=\"font-size:14.0pt;\">Reduction in the frequency of anginal attacks.</span></p>"
        },
        {
          "id": 289043,
          "text": "<p><span style=\"font-size:14.0pt;\">Changes in myocardial fatty acid uptake on PET scans.</span></p>"
        },
        {
          "id": 289044,
          "text": "<p><span style=\"font-size:14.0pt;\">Decrease in overall patient mortality.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In a clinical trial assessing the efficacy of Trimetazidine in patients with ischemic heart disease, researchers are examining the secondary outcomes related to its metabolic effects. Considering its mechanism of action, which of the following would be an important secondary outcome to monitor in this trial?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1950149",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Changes in myocardial fatty acid uptake on PET scans</strong>.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Given that Trimetazidine modulates myocardial energy metabolism by reducing fatty acid oxidation and increasing glucose utilization, monitoring changes in myocardial fatty acid uptake using PET scans provides direct insight into the biochemical efficacy of the drug.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This outcome would help validate the metabolic shift hypothesized to underlie the clinical benefits observed in patients with ischemic heart disease.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Improvement in left ventricular ejection fraction (LVEF):</strong> Incorrect because Trimetazidine does not directly improve cardiac contractility or LVEF.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Reduction in the frequency of anginal attacks:</strong> Relevant but does not directly measure the metabolic effect.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Decrease in overall patient mortality:</strong> While important, mortality is a broader outcome that may not directly reflect the metabolic effects of the drug.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Analyze the specific metabolic effects of Trimetazidine in clinical research, particularly how it alters myocardial substrate utilization, to understand its mechanism of action in ischemic heart disease.</span></li></ul>",
      "correct_choice_id": 289043,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72473,
      "choices": [
        {
          "id": 288881,
          "text": "<p><span style=\"font-size:14.0pt;\">Takayama test</span></p>"
        },
        {
          "id": 288882,
          "text": "<p><span style=\"font-size:14.0pt;\">Teichmann test</span></p>"
        },
        {
          "id": 288883,
          "text": "<p><span style=\"font-size:14.0pt;\">Barbario’s test</span></p>"
        },
        {
          "id": 288884,
          "text": "<p><span style=\"font-size:14.0pt;\">Xanthoproteic test</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old male is found dead in his home under suspicious circumstances. The authorities suspect foul play and request an autopsy. During the procedure, the forensic expert notices a small stain on the victim's clothing. To confirm its nature, &nbsp;he performs a test and observes pink feathery crystals under the microscope after heating the sample. Which test was most likely performed?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-21%20174111.jpg\" width=\"520\" height=\"356\"></span></p>",
      "unique_key": "Q4725346",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Takayama test</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The Takayama test, also known as the hemochromogen test, is a confirmatory test for blood.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The reagent used in this test includes sodium hydroxide (NaOH), pyridine, and glucose.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">When a blood sample is mixed with this reagent and heated, it forms pink feathery crystals of hemochromogen (reduced alkaline hematin).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This test can be performed on small quantities of blood stains, is effective on aged stains, and is generally more dependable.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Teichmann test:</strong> The Teichmann test, also known as the hemin test, uses sodium chloride (NaCl) and acetic acid as reagents. It produces brownish-black rhombic crystals of hematin chloride. However, this test often yields negative results on old stains or those that have been washed or treated with chemicals.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-21%20174148.jpg\" width=\"667\" height=\"465\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Barbario’s test:</strong> Barbario’s test is used to detect the presence of semen, specifically spermine secreted from the prostate gland. The reagent used is picric acid, which forms yellow needle-shaped crystals of spermine picrate. This test is not related to blood detection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-21%20174223.jpg\" width=\"609\" height=\"455\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Xanthoproteic test:</strong> The xanthoproteic reaction detects the presence of proteins soluble in a solution, using concentrated nitric acid. It gives a positive result for amino acids with aromatic groups (phenylalanine, tyrosine, and tryptophan), forming a yellow-colored product known as xantho protein. This test is unrelated to blood detection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Microchemical tests for Blood: Teichmann’s and Takayama test (Both are confirmatory tests)</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Teichmann’s - Brownish-black rhombic crystals of hematin chloride</span></li><li><span style=\"font-size:14.0pt;\">Takayama test - Pink feathery crystals of hemochromogen (reduced alkaline hematin)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Microchemical tests for Semen: Florence and Barberio test (Both are presumptive tests)</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Florence test—For choline (dark brown rhombic crystals)</span></li><li><span style=\"font-size:14.0pt;\">Barberio test— detects spermine (yellow needle-shaped rhombic crystals)</span></li></ul>",
      "correct_choice_id": 288881,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        10
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72454,
      "choices": [
        {
          "id": 288805,
          "text": "<p><span style=\"font-size:14.0pt;\">Both the assertion and reasoning are correct, and the reasoning is the correct explanation of the assertion.</span></p>"
        },
        {
          "id": 288806,
          "text": "<p><span style=\"font-size:14.0pt;\">Both the assertion and reasoning are correct, but the reasoning is not the correct explanation of the assertion.</span></p>"
        },
        {
          "id": 288807,
          "text": "<p><span style=\"font-size:14.0pt;\">The assertion is correct, but the reasoning is incorrect.</span></p>"
        },
        {
          "id": 288808,
          "text": "<p><span style=\"font-size:14.0pt;\">Both the assertion and reasoning are incorrect.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Assertion: Luminal A breast cancer is characterized by hormone receptor positivity (ER+, PR+) and a low Ki67 index, indicating a more favorable prognosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Reasoning: The low Ki67 index suggests that the tumor has low proliferative activity, which contributes to the slower growth and expression of hormone receptors would have better response to hormonal therapies.</span></p>",
      "unique_key": "Q8915445",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) Both the assertion and reasoning are correct, and the reasoning is the correct explanation of the assertion.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Luminal A breast cancer is characterized by ER+ and PR+ with a low Ki67 index, reflecting low proliferative activity.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The low Ki67 index indicates slower tumor growth, contributing to the favorable prognosis of Luminal A. This tumor has expression of ER and PR and so has better response to anti-hormonal therapies.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Luminal A breast cancer is marked by ER+, PR+, and low Ki67, indicating lower proliferation rates and a more favorable prognosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Breast cancers are classified into <strong>molecular subtypes</strong> based on the expression of receptors and proliferation markers:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_GBddEsr.png\" width=\"715\" height=\"348\"></span></p>",
      "correct_choice_id": 288805,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72472,
      "choices": [
        {
          "id": 288877,
          "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_8BSI4PY.png\" width=\"171\" height=\"395\"></p>"
        },
        {
          "id": 288878,
          "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_RFcFAyo.png\" width=\"156\" height=\"396\"></p>"
        },
        {
          "id": 288879,
          "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_N9h1LUy.png\" width=\"148\" height=\"273\"></p>"
        },
        {
          "id": 288880,
          "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_TydDUgn.png\" width=\"152\" height=\"299\"></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old researcher is working in a laboratory to evaluate the environmental conditions affecting the thermal comfort of workers exposed to radiant heat. To measure the mean radiant temperature (MRT), the researcher uses an instrument that accounts for the radiation absorbed by its surface. Which of the following instruments is most appropriate for this purpose?&nbsp;</span></p>",
      "unique_key": "Q2884317",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Image C</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Globe thermometer</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The Globe thermometer is specifically designed to measure the mean radiant temperature (MRT) by capturing the heat absorbed by a black surface.</span></li><li><span style=\"font-size:14.0pt;\">It is widely used in environmental studies to assess the effect of radiant heat on individuals in a specific setting.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The globe surface mimics the radiation absorbed by the human body, making it ideal for measuring MRT and thermal comfort.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option Image A.</strong> The wet and dry bulb thermometer measures the humidity and air temperature but does not assess radiant heat.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option Image B.</strong> Six’s maximum and minimum thermometer is used for measuring maximum and minimum air temperatures over time and is not designed for measuring mean radiant temperature.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option Image D.</strong> The Kata thermometer is used to measure temperature but does not account for radiation, making it inappropriate for MRT measurement.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Instruments:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ODmmoML.png\" width=\"1085\" height=\"583\"></strong></span></p>",
      "correct_choice_id": 288879,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72517,
      "choices": [
        {
          "id": 289057,
          "text": "<p><span style=\"font-size:14.0pt;\">Fosfomycin</span></p>"
        },
        {
          "id": 289058,
          "text": "<p><span style=\"font-size:14.0pt;\">Bacitracin</span></p>"
        },
        {
          "id": 289059,
          "text": "<p><span style=\"font-size:14.0pt;\">Vancomycin</span></p>"
        },
        {
          "id": 289060,
          "text": "<p><span style=\"font-size:14.0pt;\">Beta-lactams</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old woman presents to the clinic with symptoms of a urinary tract infection (UTI). She is allergic to penicillin. Given the biochemical pathways shown in the diagram, which antibiotic would be most appropriate to prescribe, considering its mechanism involves inhibition of step 1?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_6kiOmGt.png\" width=\"655\" height=\"525\"></strong></span></p>",
      "unique_key": "Q5705025",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) Fosfomycin</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Fosfomycin targets step 1 of the bacterial cell wall synthesis pathway, where it inhibits the enzyme enolpyruvate transferase, preventing the formation of N-acetylmuramic acid (NAM), a critical precursor in peptidoglycan synthesis.</span></li><li><span style=\"font-size:14.0pt;\">&nbsp;Its mechanism makes it an effective choice for treating UTIs, particularly in patients who have allergies to beta-lactams.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Bacitracin:</strong> Incorrect because Bacitracin acts at step 2 and is not typically used for UTIs.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Vancomycin:</strong> Incorrect as Vancomycin targets step 3 and is generally reserved for more severe infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Beta-lactams:</strong> Incorrect because Beta-lactams, which act at step 4, are avoided due to her penicillin allergy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Fosfomycin inhibits enolpyruvate transferase, blocking N-acetylmuramic acid (NAM) synthesis in bacterial cell walls. It is effective for UTIs, especially in beta-lactam-allergic patients.</span></p>",
      "correct_choice_id": 289057,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72512,
      "choices": [
        {
          "id": 289037,
          "text": "<p><span style=\"font-size:14.0pt;\">Activates secondary messengers to increase gene transcription.</span></p>"
        },
        {
          "id": 289038,
          "text": "<p><span style=\"font-size:14.0pt;\">Binds directly to DNA at hormone response elements to initiate gene transcription.</span></p>"
        },
        {
          "id": 289039,
          "text": "<p><span style=\"font-size:14.0pt;\">Triggers degradation of transcription inhibitors to enhance gene expression.</span></p>"
        },
        {
          "id": 289040,
          "text": "<p><span style=\"font-size:14.0pt;\">Causes phosphorylation of transcription factors that act on specific genes.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 43-year-old female with newly diagnosed hypothyroidism is prescribed levothyroxine. Given that levothyroxine mimics natural thyroid hormone, which action does it primarily perform at the genomic level when bound to its nuclear receptor?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2405177",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Binds directly to DNA at hormone response elements to initiate gene transcription.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Thyroid hormones, including levothyroxine, exert their effects by entering cells, binding to thyroid hormone receptors in the nucleus, and directly interacting with hormone response elements (HREs) on DNA.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This direct interaction promotes the transcription of genes involved in metabolic processes, growth, and development.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This mechanism highlights the role of thyroid hormone therapy in managing hypothyroidism by compensating for the body’s insufficient hormone production.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Activates secondary messengers to increase gene transcription:</strong> Incorrect, as thyroid hormones do not primarily function through secondary messenger pathways for gene transcription.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Triggers degradation of transcription inhibitors to enhance gene expression:</strong> Incorrect, thyroid hormones do not promote proteosomal degradation of transcription inhibitors.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Causes phosphorylation of transcription factors that act on specific genes:</strong> Incorrect, direct phosphorylation of transcription factors is not the primary mechanism by which thyroid hormones operate at the genomic level.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Thyroid hormone receptors are intracellular and intranuclear receptors.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">They primarily function as transcription factors and directly interact with the genomic DNA to regulate gene expression.</span></li><li><span style=\"font-size:14.0pt;\">Other examples of intranuclear receptors include Vitamin A and Vitamin D receptors.</span></li></ul>",
      "correct_choice_id": 289038,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72526,
      "choices": [
        {
          "id": 289093,
          "text": "<p><span style=\"font-size:14.0pt;\">HRZE (Isoniazid, Rifampin, Pyrazinamide, Ethambutol)</span></p>"
        },
        {
          "id": 289094,
          "text": "<p><span style=\"font-size:14.0pt;\">Ceftriaxone + Vancomycin</span></p>"
        },
        {
          "id": 289095,
          "text": "<p><span style=\"font-size:14.0pt;\">Cefepime + Vancomycin + Ampicillin</span></p>"
        },
        {
          "id": 289096,
          "text": "<p><span style=\"font-size:14.0pt;\">Liposomal Amphotericin B + Flucytosine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old man from Kolkata presents with persistent headache, photophobia, and neck stiffness for the past month. He also reports low-grade fever and weight loss over the same period. Neurological examination reveals a positive Kernig’s and Brudzinski sign.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A lumbar puncture (CSF analysis) reveals:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Mononuclear pleocytosis (lymphocyte predominance)</span></li><li><span style=\"font-size:14.0pt;\">Low glucose (hypoglycorrhachia)</span></li><li><span style=\"font-size:14.0pt;\">High protein</span></li><li><span style=\"font-size:14.0pt;\">Cobweb-like coagulum formation on standing</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">MRI brain is shown below. What is the therapy of choice for this patient?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-24%20121526.jpg\" width=\"435\" height=\"515\"></strong></span></p>",
      "unique_key": "Q4752642",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) HRZE (Isoniazid, Rifampin, Pyrazinamide, Ethambutol)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>chronic presentation of headache, photophobia, and neck stiffness</strong>, combined with <strong>CSF findings of mononuclear pleocytosis, low glucose, and cobweb coagulum formation</strong>, is highly suggestive of <strong>tuberculous meningitis (TBM)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>MRI findings of basal exudates with meningeal enhancement</strong> further support the diagnosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>First-line treatment for TB meningitis includes:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Antitubercular therapy (ATT)</strong> with <strong>HRZE</strong> for <strong>2 months</strong>, followed by continuation of <strong>Isoniazid and Rifampin for at least 9–12 months</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Adjunctive corticosteroids (Dexamethasone or Prednisolone)</strong> to reduce inflammation and intracranial pressure (ICP), improving outcomes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ceftriaxone + Vancomycin:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This combination is used for <strong>bacterial (pyogenic) meningitis</strong>, especially for <strong>Streptococcus pneumoniae and Neisseria meningitidis</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>TBM has a more chronic course</strong> and presents with <strong>lymphocytic pleocytosis and low glucose</strong>, unlike the <strong>polymorphonuclear (neutrophilic) predominance</strong> seen in bacterial meningitis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Cefepime + Vancomycin + Ampicillin:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This regimen is used in <strong>empirical treatment of bacterial meningitis</strong> when <strong>Listeria monocytogenes is suspected</strong> (e.g., elderly, immunocompromised patients).</span></li><li><span style=\"font-size:14.0pt;\"><strong>TBM does not respond to standard antibiotics</strong> and requires prolonged antitubercular therapy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Liposomal Amphotericin B + Flucytosine:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is the treatment for <strong>cryptococcal meningitis</strong>, commonly seen in <strong>HIV/AIDS and immunocompromised patients</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Cryptococcal meningitis presents with <strong>very high CSF opening pressure and India ink-positive encapsulated yeast</strong>, which were <strong>not described in this case</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Tuberculous meningitis should be suspected in a patient with chronic headache, photophobia, and neck stiffness, along with CSF findings of lymphocytic pleocytosis, low glucose, and cobweb-like coagulum.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The treatment of choice is antitubercular therapy (HRZE) along with corticosteroids to reduce inflammation.</span></li></ul>",
      "correct_choice_id": 289093,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72459,
      "choices": [
        {
          "id": 288825,
          "text": "<p><span style=\"font-size:14.0pt;\">Red-top tube</span></p>"
        },
        {
          "id": 288826,
          "text": "<p><span style=\"font-size:14.0pt;\">Light-blue top tube</span></p>"
        },
        {
          "id": 288827,
          "text": "<p><span style=\"font-size:14.0pt;\">Lavender -top tube</span></p>"
        },
        {
          "id": 288828,
          "text": "<p><span style=\"font-size:14.0pt;\">Grey top tube</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old male is undergoing routine blood work for diabetes management. The phlebotomist uses different vacutainer tubes to collect blood samples for various tests. Which of the following tubes contains an anticoagulant and is commonly used for a complete blood count?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4035016",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Lavender -top tube</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>lavender (purple)-top tube</strong> is the standard tube for <strong>Complete Blood Count (CBC)</strong> because it contains <strong>ethylenediaminetetraacetic acid (EDTA)</strong> as an anticoagulant.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>EDTA binds calcium</strong>, preventing clotting and preserving blood cell morphology for hematological analysis, including <strong>red blood cells, white blood cells, and platelets</strong>. It is also used for <strong>peripheral blood smears</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Red-top tube</strong>: Incorrect. This tube <strong>contains no anticoagulant</strong> and is used for <strong>serum collection</strong> (e.g., chemistry tests, serology).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Light-blue top tube</strong>: Incorrect. This tube contains <strong>sodium citrate</strong> and is used for <strong>coagulation studies</strong> (e.g., PT, PTT).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Grey-top tube</strong>: Incorrect. This tube contains <strong>sodium fluoride and potassium oxalate</strong>, which is used for <strong>blood glucose estimation</strong> and not CBC.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Lavender (purple)-top tubes</strong> contain <strong>EDTA</strong>, an anticoagulant that prevents blood clotting and preserves blood cells for <strong>CBC and peripheral blood smears</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Red-top tubes</strong> are for <strong>serum collection</strong>, <strong>light-blue tubes</strong> are for <strong>coagulation studies</strong>, and <strong>grey-top tubes</strong> are used for <strong>glucose testing</strong>.</span></li></ul>",
      "correct_choice_id": 288827,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72074,
      "choices": [
        {
          "id": 287297,
          "text": "<p><span style=\"font-size:14.0pt;\">Both A and R are true, and R is the correct explanation of A</span></p>"
        },
        {
          "id": 287298,
          "text": "<p><span style=\"font-size:14.0pt;\">Both A and R are true, but R is not the correct explanation of A</span></p>"
        },
        {
          "id": 287299,
          "text": "<p><span style=\"font-size:14.0pt;\">A is true, but R is false</span></p>"
        },
        {
          "id": 287300,
          "text": "<p><span style=\"font-size:14.0pt;\">A is false, and R is true</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Assertion (A): Magnesium sulfate is the drug of choice for eclampsia.</span></p><p><br><span style=\"font-size:14.0pt;\">Reason (R): Magnesium sulfate reduces blood pressure effectively in eclampsia.&nbsp;</span></p>",
      "unique_key": "Q6005929",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;C) A is true, but R is false</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Magnesium sulfate is the drug of choice for eclampsia due to its anticonvulsant properties, not its ability to lower blood pressure.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Magnesium sulfate is used for seizure prevention in eclampsia, not as an antihypertensive agent.</span></li></ul>",
      "correct_choice_id": 287299,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72468,
      "choices": [
        {
          "id": 288861,
          "text": "<p><span style=\"font-size:14.0pt;\">BRAF mutations leading to excessive activation of the MAPK pathway</span></p>"
        },
        {
          "id": 288862,
          "text": "<p><span style=\"font-size:14.0pt;\">Autoimmune destruction of the endothelial cells lining blood vessels</span></p>"
        },
        {
          "id": 288863,
          "text": "<p><span style=\"font-size:14.0pt;\">T-cell mediated lymphocyte infiltration and cytokine release</span></p>"
        },
        {
          "id": 288864,
          "text": "<p><span style=\"font-size:14.0pt;\">Abnormal activation of histiocytes and macrophages leading to granuloma formation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 5-year-old male with a history of failure to thrive, exophthalmos, and seborrheic dermatitis is diagnosed with Letterer-Siwe Disease. What is the pathophysiological mechanism responsible for the systemic manifestations seen in this disease?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8583612",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) BRAF mutations leading to excessive activation of the MAPK pathway&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Letterer-Siwe Disease</strong> results from <strong>Langerhans cell proliferation</strong> due to mutations in the <strong>BRAF gene</strong>, which leads to abnormal activation of the <strong>MAPK pathway</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This causes <strong>granuloma formation</strong> in various organs, including the <strong>bones</strong>, <strong>liver</strong>, and <strong>skin</strong>, leading to <strong>hepatosplenomegaly</strong>, <strong>seborrheic dermatitis</strong>, and <strong>bony lytic lesions</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The granulomas contribute to the systemic manifestations of the disease, including <strong>failure to thrive</strong> and <strong>exophthalmos</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other&nbsp;Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B</strong>.<strong> Autoimmune destruction of the endothelial cells lining blood vessels:</strong> <strong>T-cell mediated mechanisms</strong> are more commonly associated with diseases like <strong>autoimmune disorders</strong> or <strong>lymphomas</strong>, not <strong>Langerhans cell proliferation</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. T-cell mediated lymphocyte infiltration and cytokine release:</strong> <strong>Histopathology</strong> in <strong>Letterer-Siwe Disease</strong> shows <strong>granuloma formation</strong> due to <strong>macrophage and histiocyte activation</strong>, not <strong>T-cell mediated destruction</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D</strong>. <strong>Abnormal activation of histiocytes and macrophages leading to granuloma formation:</strong> Although LCH involves <strong>Langerhans cells (specialized dendritic cells)</strong>, it does <strong>not</strong> form true granulomas like <strong>tuberculosis or sarcoidosis</strong>. Instead, LCH is characterized by <strong>clonal proliferation</strong>, eosinophilic infiltration, and <strong>Birbeck granules</strong> on electron microscopy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Letterer-Siwe Disease</strong> is caused by <strong>Langerhans cell proliferation</strong> due to <strong>BRAF mutations</strong>, leading to <strong>granuloma formation</strong> and systemic manifestations like <strong>bony lytic lesions</strong> and <strong>hepatosplenomegaly</strong>.</span></li></ul>",
      "correct_choice_id": 288861,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72523,
      "choices": [
        {
          "id": 289081,
          "text": "<p><span style=\"font-size:14.0pt;\">Anterior wall</span></p>"
        },
        {
          "id": 289082,
          "text": "<p><span style=\"font-size:14.0pt;\">Inferior wall</span></p>"
        },
        {
          "id": 289083,
          "text": "<p><span style=\"font-size:14.0pt;\">Lateral wall</span></p>"
        },
        {
          "id": 289084,
          "text": "<p><span style=\"font-size:14.0pt;\">Posterior wall</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old man, Mr. Ravi from Mumbai, presents to the emergency department with severe chest pain radiating to his jaw and left arm. His blood pressure is 110/70 mmHg, heart rate is 88/min. ECG is shown below. What is the most likely site of ischemia?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-24%20121120.jpg\" width=\"919\" height=\"410\"></span></p>",
      "unique_key": "Q6385548",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>D) Posterior wall</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Posterior wall myocardial infarction (MI) is often identified by reciprocal changes on the standard 12-lead ECG, as the posterior wall isn’t directly visualized.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">ST depressions in leads V1–V3 with tall R waves and upright T waves are characteristic. A posterior ECG (with leads V7–V9) can confirm ST elevations.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Anterior wall:</strong> Typically presents with ST elevations in leads V1–V6, not isolated ST depressions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Inferior wall:</strong> Involves ST elevations in leads II, III, and aVF, reflecting right coronary artery ischemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Lateral wall:</strong> Shows ST elevations in leads I, aVL, V5, and V6.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Posterior wall MI presents with reciprocal changes on the ECG—ST depressions in V1–V3 with tall R waves.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Recognizing these patterns is crucial as posterior infarctions can be easily missed on a standard ECG.</span></li></ul>",
      "correct_choice_id": 289084,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72098,
      "choices": [
        {
          "id": 287393,
          "text": "<p><span style=\"font-size:14.0pt;\">Rathke's pouch</span></p>"
        },
        {
          "id": 287394,
          "text": "<p><span style=\"font-size:14.0pt;\">Neural tube</span></p>"
        },
        {
          "id": 287395,
          "text": "<p><span style=\"font-size:14.0pt;\">Adenohypophysis</span></p>"
        },
        {
          "id": 287396,
          "text": "<p><span style=\"font-size:14.0pt;\">Mesodermal layer</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old male presents with headaches, vision changes, and hormonal imbalances. Imaging finding is shown below. The lesion is likely originating from which of the following embryonic structures?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-20%20132604.jpg\" width=\"512\" height=\"441\"></span></p>",
      "unique_key": "Q9486145",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Rathke's pouch</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The lesion described is most likely a craniopharyngioma, which arises from Rathke’s pouch.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is a cystic lesion commonly located in the suprasellar region with calcification, and it extends near the pituitary stalk.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Rathke's pouch is an embryological remnant that gives rise to the anterior pituitary.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Neural tube</strong>: The neural tube gives rise to the central nervous system structures, not craniopharyngiomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Adenohypophysis</strong>: This is the anterior part of the pituitary gland, but craniopharyngiomas are not derived from this structure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Mesodermal layer</strong>: This layer does not give rise to the structures seen in craniopharyngiomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Craniopharyngiomas arise from Rathke’s pouch and are characterized by cystic formation and calcifications on imaging.</span></li></ul>",
      "correct_choice_id": 287393,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        17
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72485,
      "choices": [
        {
          "id": 288929,
          "text": "<p><span style=\"font-size:14.0pt;\">0.8</span></p>"
        },
        {
          "id": 288930,
          "text": "<p><span style=\"font-size:14.0pt;\">0.9</span></p>"
        },
        {
          "id": 288931,
          "text": "<p><span style=\"font-size:14.0pt;\">1.2</span></p>"
        },
        {
          "id": 288932,
          "text": "<p><span style=\"font-size:14.0pt;\">1.6</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">During a population health assessment, a survey identifies an adult female who is a construction worker. The researcher needs to compute the energy requirements for this individual. Which Consumption Unit Coefficient (CUC) should be applied for this calculation?&nbsp;</span></p><p>&nbsp;</p>",
      "unique_key": "Q2624433",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 1.2</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">An adult female performing heavy work has a CUC of 1.2 according to the table. This reflects higher energy expenditure due to the intensity of the physical activity.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Consumption Unit Coefficients (CUC)&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_muVUxjX.png\" width=\"956\" height=\"668\"></span></p>",
      "correct_choice_id": 288931,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72482,
      "choices": [
        {
          "id": 288917,
          "text": "<p><span style=\"font-size:14.0pt;\">Actinomycetoma&nbsp;</span></p>"
        },
        {
          "id": 288918,
          "text": "<p><span style=\"font-size:14.0pt;\">Eumycetoma</span></p>"
        },
        {
          "id": 288919,
          "text": "<p><span style=\"font-size:14.0pt;\">Tuberculosis</span></p>"
        },
        {
          "id": 288920,
          "text": "<p><span style=\"font-size:14.0pt;\">Leprosy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 40-year-old male presents with a chronic infection in the foot. The lesion has been present for several months and contains a yellowish purulent discharge. Upon examination, the lesion has a raised inflamed opening and is accompanied by osteolytic lesions. Based on the presentation, which of the following is the most likely diagnosis?&nbsp;</span></p>",
      "unique_key": "Q4004882",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Actinomycetoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Mycetoma is a chronic granulomatous infection involving the skin, subcutaneous tissues, and bones, often presenting with swelling, draining sinuses, and granules in the discharge.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">It can be classified into <strong>Actinomycetoma</strong> and <strong>Eumycetoma</strong>, based on the causative organism.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Actinomycetoma</strong> is caused by <strong>bacterial species</strong> like Nocardia, Actinomyces, and Streptomyces.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Eumycetoma</strong> is caused by <strong>fungi</strong> such as Madurella and Exophiala.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The given clinical case describes a <strong>chronic foot infection</strong> with a <strong>yellowish purulent discharge, inflamed opening, and osteolytic lesions</strong>, which strongly suggests <strong>Actinomycetoma</strong>. Actinomycetoma tends to have more <strong>rapid progression</strong>, bone involvement, and produces <strong>yellow-white granules</strong> in the purulent discharge. In contrast, <strong>Eumycetoma</strong> progresses more slowly and is associated with <strong>black or white granules</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Eumycetoma</strong>: Though it presents with similar chronic swelling and sinus tracts, eumycetoma is <strong>less aggressive</strong> than actinomycetoma and typically involves <strong>black or white granules</strong> in the discharge. In Bone Osteosclerotic lesions is seen.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Tuberculosis</strong>: Tuberculosis affecting the foot (tuberculous osteomyelitis) can cause <strong>chronic osteolytic lesions</strong> but does not usually present with <strong>discharging sinuses containing granules</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Leprosy</strong>: Leprosy mainly causes <strong>nerve involvement, skin patches, and sensory loss</strong>. It does not typically present with chronic purulent discharge or bone destruction in this manner.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Actinomycetoma is a <strong>chronic bacterial infection</strong> characterized by <strong>swelling, draining sinuses, purulent discharge containing yellow granules, and osteolytic lesions</strong>. It progresses more rapidly than <strong>Eumycetoma</strong>, which is fungal in origin and presents with <strong>black or white granules</strong>.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-03-03%20193143.jpg\" width=\"787\" height=\"477\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-03-03%20193154.jpg\" width=\"792\" height=\"572\"></span></p>",
      "correct_choice_id": 288917,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72548,
      "choices": [
        {
          "id": 289181,
          "text": "<p><span style=\"font-size:14.0pt;\">Colorimetry</span></p>"
        },
        {
          "id": 289182,
          "text": "<p><span style=\"font-size:14.0pt;\">Spectrophotometry</span></p>"
        },
        {
          "id": 289183,
          "text": "<p><span style=\"font-size:14.0pt;\">X-ray Crystallography</span></p>"
        },
        {
          "id": 289184,
          "text": "<p><span style=\"font-size:14.0pt;\">Mass Spectrometry</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old male presents with an undiagnosed protein disorder. His physician orders a detailed analysis of the protein's molecular mass and amino acid sequence to identify possible mutations or modifications. Which of the following techniques would be the most effective for this purpose?</span></p>",
      "unique_key": "Q9474374",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Mass Spectrometry</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Mass spectrometry (MS) is the gold standard for determining molecular mass and the primary amino acid sequence</strong> of peptides and proteins.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Advanced techniques like <strong>tandem MS (MS/MS)</strong> allow precise protein sequencing and post-translational modification analysis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Colorimetry: Incorrect</strong>. Colorimetry measures the <strong>concentration</strong> of a substance based on color intensity but <strong>cannot determine molecular mass or amino acid sequence</strong>. It is often used for <strong>protein estimation methods</strong> like the Biuret, Lowry, or Bradford assays.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Spectrophotometry: Incorrect.&nbsp;</strong>Spectrophotometry assesses <strong>protein concentration</strong> by measuring <strong>absorbance at specific wavelengths</strong> (e.g., 280 nm for aromatic amino acids). However, it does <strong>not provide molecular mass or sequence information</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. X-ray Crystallography: Incorrect.</strong> X-ray crystallography is used to determine the <strong>3D structure of proteins</strong> at atomic resolution but <strong>does not provide molecular mass or amino acid sequence information</strong>. It requires high-quality crystals, which can be difficult to obtain.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Mass spectrometry is the most powerful technique for determining molecular mass and primary amino acid sequence</strong>, making it essential for proteomics research and clinical diagnostics.</span></li></ul>",
      "correct_choice_id": 289184,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72550,
      "choices": [
        {
          "id": 289189,
          "text": "<p><span style=\"font-size:14.0pt;\">UAA → CAA</span></p>"
        },
        {
          "id": 289190,
          "text": "<p><span style=\"font-size:14.0pt;\">UAA → UAG</span></p>"
        },
        {
          "id": 289191,
          "text": "<p><span style=\"font-size:14.0pt;\">CGA → UGA</span></p>"
        },
        {
          "id": 289192,
          "text": "<p><span style=\"font-size:14.0pt;\">GAU → GAC</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 20-year-old male presents with anemia and is found to have an abnormal form of the β-globin chain, which is 168 amino acids long instead of the normal 123. Genetic analysis reveals a point mutation affecting the stop codon, leading to an abnormally elongated protein. Which of the following point mutations is most likely responsible for this abnormality?</span></p>",
      "unique_key": "Q4160961",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) UAA → CAA</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>UAA is a stop codon</strong> (one of the three stop codons: UAA, UAG, UGA).</span></li><li><span style=\"font-size:14.0pt;\">A mutation from <strong>UAA (stop) to CAA (glutamine)</strong> removes the normal termination signal, causing the ribosome to <strong>continue translating past the normal stop site</strong>, <strong>elongating the β-globin chain</strong> to <strong>168 amino acids instead of 123</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This is an example of a <strong>stop codon loss&nbsp;</strong>leading to an <strong>abnormally long β-globin chain</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. UAA → UAG: Incorrect.</strong>&nbsp;</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Both <strong>UAA and UAG</strong> are <strong>stop codons</strong>, so this mutation would <strong>not affect protein length</strong>. The translation would still terminate at the same point, producing a normal-length protein.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. CGA → UGA: Incorrect.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>CGA codes for arginine</strong>, and changing it to <strong>UGA creates a premature stop codon</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This would <strong>shorten</strong> the β-globin chain rather than <strong>elongating it</strong>. This is an example of a <strong>nonsense mutation</strong>, which leads to a <strong>truncated, nonfunctional protein</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. GAU → GAC: Incorrect.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Both <strong>GAU and GAC</strong> code for <strong>aspartic acid</strong>, meaning this is a <strong>silent mutation</strong> that does not change the protein structure.</span></li><li><span style=\"font-size:14.0pt;\">This mutation would <strong>not cause elongation of the β-globin chain</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>stop codon mutation (UAA → CAA) causes loss of the normal stop signal</strong>, leading to an <strong>elongated β-globin chain</strong>. This <strong>stop codon loss</strong> can lead to <strong>unstable hemoglobin</strong>, which may contribute to anemia.</span></li></ul>",
      "correct_choice_id": 289189,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72069,
      "choices": [
        {
          "id": 287277,
          "text": "<p><span style=\"font-size:14.0pt;\">Decreased sex hormone-binding globulin (SHBG)</span></p>"
        },
        {
          "id": 287278,
          "text": "<p><span style=\"font-size:14.0pt;\">Decreased plasma testosterone levels</span></p>"
        },
        {
          "id": 287279,
          "text": "<p><span style=\"font-size:14.0pt;\">Elevated FSH levels relative to LH</span></p>"
        },
        {
          "id": 287280,
          "text": "<p><span style=\"font-size:14.0pt;\">Normal insulin sensitivity</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is a biochemical feature of Stein-Leventhal syndrome?</span></p>",
      "unique_key": "Q6298382",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A) Decreased sex hormone-binding globulin (SHBG)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In PCOS, SHBG levels decrease due to hyperinsulinemia, which increases free testosterone and exacerbates hyperandrogenic features.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Decreased plasma testosterone levels:&nbsp;</strong>Plasma testosterone is elevated in PCOS, contributing to hirsutism and acne.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Elevated FSH levels relative to LH:&nbsp;</strong>PCOS is characterized by elevated LH relative to FSH, not vice versa.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Normal insulin sensitivity:&nbsp;</strong>Insulin resistance is a hallmark of PCOS and contributes to hyperinsulinemia and metabolic abnormalities.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">PCOS is associated with decreased SHBG, hyperandrogenism, insulin resistance, and an elevated LH: FSH ratio.</span></li></ul>",
      "correct_choice_id": 287277,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72062,
      "choices": [
        {
          "id": 287249,
          "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-A, 3-D, 4-C</span></p>"
        },
        {
          "id": 287250,
          "text": "<p><span style=\"font-size:14.0pt;\">1-D, 2-B, 3-C, 4-A</span></p>"
        },
        {
          "id": 287251,
          "text": "<p><span style=\"font-size:14.0pt;\">1-A, 2-B, 3-D, 4-C</span></p>"
        },
        {
          "id": 287252,
          "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-D, 3-A, 4-C&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the following hormones with their primary functions or characteristics during the menstrual cycle.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column A:</span></p><ol><li><span style=\"font-size:14.0pt;\">LH Surge</span></li><li><span style=\"font-size:14.0pt;\">Estrogen</span></li><li><span style=\"font-size:14.0pt;\">Progesterone</span></li><li><span style=\"font-size:14.0pt;\">FSH</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column B:</span></p><ol style=\"list-style-type:upper-latin;\"><li><span style=\"font-size:14.0pt;\">Supports the corpus luteum during the luteal phase</span></li><li><span style=\"font-size:14.0pt;\">Stimulates ovulation and release of the oocyte</span></li><li><span style=\"font-size:14.0pt;\">Stimulates follicular growth in the ovary</span></li><li><span style=\"font-size:14.0pt;\">Peaks before ovulation to support endometrial proliferation</span></li></ol>",
      "unique_key": "Q7191416",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;D) 1-B, 2-D, 3-A, 4-C</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>LH Surge (1-B):</strong> Triggers ovulation and oocyte release from the dominant follicle.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Estrogen (2-D):</strong> Peaks before ovulation, supporting endometrial proliferation.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Progesterone (3-A):</strong> Dominates the luteal phase and supports the corpus luteum.</span></li><li><span style=\"font-size:14.0pt;\"><strong>FSH (4-C):</strong> Promotes follicular growth in the ovary.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">LH Surge : Triggers ovulation and oocyte release from the dominant follicle.</span></li><li><span style=\"font-size:14.0pt;\">Estrogen : Peaks before ovulation, supporting endometrial proliferation.</span></li><li><span style=\"font-size:14.0pt;\">Progesterone : Dominates the luteal phase and supports the corpus luteum.</span></li><li><span style=\"font-size:14.0pt;\">FSH : Promotes follicular growth in the ovary.</span></li></ul>",
      "correct_choice_id": 287252,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72509,
      "choices": [
        {
          "id": 289025,
          "text": "<p><span style=\"font-size:14.0pt;\">The risk of severe hypoglycemia.</span></p>"
        },
        {
          "id": 289026,
          "text": "<p><span style=\"font-size:14.0pt;\">The potential for weight gain.</span></p>"
        },
        {
          "id": 289027,
          "text": "<p><span style=\"font-size:14.0pt;\">The development of diabetic ketoacidosis (DKA).</span></p>"
        },
        {
          "id": 289028,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased risk of myocardial infarction.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old woman with type 1 diabetes is interested in adding an SGLT-2 inhibitor to her regimen after reading about its benefits in controlling blood glucose and aiding in weight loss. Given the pharmacodynamics of SGLT-2 inhibitors and her diabetes type, what is the most critical risk to discuss with her before initiating therapy?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1786342",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) The development of diabetic ketoacidosis (DKA).</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">For patients with type 1 diabetes, the use of SGLT-2 inhibitors can lead to euglycemic DKA, a serious condition where despite normal or near-normal blood sugars, high levels of ketones are produced because of insufficient insulin activity.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This risk needs to be carefully managed by continuing insulin therapy and monitoring for symptoms of DKA.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>The risk of severe hypoglycaemia:</strong> Incorrect because SGLT-2 inhibitors typically do not cause hypoglycemia unless combined with other glucose-lowering drugs.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>The potential for weight gain:</strong> Incorrect as these drugs generally promote weight loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Increased risk of myocardial infarction:</strong> Incorrect because there is no direct increase in the risk of myocardial infarction with SGLT-2 inhibitors; in fact, they offer cardiovascular benefits.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Recognize the risk of euglycemic DKA in patients with type 1 diabetes treated with SGLT-2 inhibitors and the importance of continued insulin use.</span></li></ul>",
      "correct_choice_id": 289027,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72071,
      "choices": [
        {
          "id": 287285,
          "text": "<p><span style=\"font-size:14.0pt;\">a, b, c</span></p>"
        },
        {
          "id": 287286,
          "text": "<p><span style=\"font-size:14.0pt;\">b, c, d</span></p>"
        },
        {
          "id": 287287,
          "text": "<p><span style=\"font-size:14.0pt;\">c, d, e</span></p>"
        },
        {
          "id": 287288,
          "text": "<p><span style=\"font-size:14.0pt;\">a, b, c, d</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements about placenta accreta is true?</span></p><p>&nbsp;</p><ol style=\"list-style-type:lower-latin;\"><li><span style=\"font-size:14.0pt;\">The incidence is about 1 in 2500 pregnancies</span></li><li><span style=\"font-size:14.0pt;\">The incidence has increased in the last decade</span></li><li><span style=\"font-size:14.0pt;\">It is caused by the absence of decidua basalis</span></li><li><span style=\"font-size:14.0pt;\">The fibrinoid layer is deficient</span></li><li><span style=\"font-size:14.0pt;\">It is more common in primigravida</span></li></ol>",
      "unique_key": "Q6045504",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) b, c, d</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>b. The incidence has increased in the last decade:&nbsp;</strong>The incidence of placenta accreta has increased significantly over the last decade, largely due to the rise in cesarean sections, which predispose women to abnormal placental adherence in subsequent pregnancies.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>c. It is caused by the absence of decidua basalis:&nbsp;</strong>Placenta accreta occurs when the decidua basalis is absent, allowing the placental villi to attach directly to the myometrium.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>d. The fibrinoid layer is deficient:&nbsp;</strong>The absence or poor development of Nitabuch’s fibrinoid layer further contributes to abnormal adherence of the placenta to the uterine wall.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>a. The incidence is about 1 in 2500 pregnancies:&nbsp;</strong>This is false. While earlier estimates suggested an incidence of 1 in 2500, recent data show the incidence is closer to <strong>1 in 550 deliveries</strong> due to the increasing rates of cesarean sections.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>e. It is more common in primigravida:&nbsp;</strong>This is false. Placenta accreta is more common in women with <strong>multiple pregnancies</strong>, especially those with a history of placenta previa or prior cesarean deliveries.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Placenta accreta is associated with the absence of the decidua basalis and a deficient fibrinoid layer, and its incidence has increased with rising cesarean delivery rates.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is more common in women with a history of cesarean sections and placenta previa, not in primigravida.</span></li></ul>",
      "correct_choice_id": 287286,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72529,
      "choices": [
        {
          "id": 289105,
          "text": "<p><span style=\"font-size:14.0pt;\">Urgent IV Thrombolysis</span></p>"
        },
        {
          "id": 289106,
          "text": "<p><span style=\"font-size:14.0pt;\">Urgent Trans-Esophageal Echocardiogram</span></p>"
        },
        {
          "id": 289107,
          "text": "<p><span style=\"font-size:14.0pt;\">Rapid initiation of LMWH</span></p>"
        },
        {
          "id": 289108,
          "text": "<p><span style=\"font-size:14.0pt;\">Urgent CT Pulmonary Angiogram</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 31-year-old man presents to the emergency department with a 3-day history of worsening left-sided pleuritic chest pain and shortness of breath. On examination:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Blood pressure: 78/46 mmHg</span></li><li><span style=\"font-size:14.0pt;\">SpO₂: 81% on 8 L/min oxygen via face mask</span></li><li><span style=\"font-size:14.0pt;\">Heart rate: 147 bpm</span></li><li><span style=\"font-size:14.0pt;\">Temperature: 37.3°C</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Lung auscultation is normal, and ECG shows sinus tachycardia. The patient does not respond to adequate fluid resuscitation. High-flow oxygen is applied. What is the best course of action?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5211697",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) Urgent IV Thrombolysis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient’s <strong>hemodynamic instability</strong> (hypotension, tachycardia) and history are consistent with <strong>massive pulmonary embolism (PE)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Guidelines recommend <strong>thrombolysis</strong> in patients with PE and <strong>SBP &lt; 90 mmHg</strong> who fail to respond to fluid resuscitation.</span></li><li><span style=\"font-size:14.0pt;\">Diagnostic investigations, such as <strong>CT pulmonary angiogram (CTPA)</strong> or echocardiogram, should not delay lifesaving thrombolysis in such cases.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Urgent Trans-Esophageal Echocardiogram:</strong> While echocardiography can detect signs of right heart strain due to PE, it is not definitive and delays treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Rapid initiation of LMWH:</strong> LMWH is standard for <strong>stable PE</strong>, but in <strong>hemodynamic instability</strong>, thrombolysis is required.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Urgent CT Pulmonary Angiogram:</strong> Although CTPA is the diagnostic gold standard for PE, it should not delay thrombolysis in critically unstable patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In suspected or confirmed <strong>massive PE</strong> with <strong>SBP &lt; 90 mmHg</strong>, <strong>thrombolysis should be initiated immediately</strong>, even on clinical grounds, to prevent cardiac arrest.</span></li></ul>",
      "correct_choice_id": 289105,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72215,
      "choices": [
        {
          "id": 287861,
          "text": "<p><span style=\"font-size:14.0pt;\">Stomach</span></p>"
        },
        {
          "id": 287862,
          "text": "<p><span style=\"font-size:14.0pt;\">Duodenum</span></p>"
        },
        {
          "id": 287863,
          "text": "<p><span style=\"font-size:14.0pt;\">Ileum</span></p>"
        },
        {
          "id": 287864,
          "text": "<p><span style=\"font-size:14.0pt;\">&nbsp;Jejunum</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Iron absorption primarily occurs in which part of the gastrointestinal tract?&nbsp;</span></p>",
      "unique_key": "Q4115987",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Duodenum</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Iron is mainly absorbed in the duodenum, where dietary ferric iron (Fe³⁺) is reduced to the ferrous form (Fe²⁺) for absorption through the intestinal mucosa. This process is facilitated by the acidic environment and the presence of reducing agents like vitamin C.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Stomach:&nbsp;</strong>Incorrect. The stomach contributes to iron absorption by providing an acidic environment that helps convert ferric iron (Fe³⁺) into the absorbable ferrous form (Fe²⁺), but no significant absorption occurs here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Ileum:&nbsp;</strong>Incorrect. The ileum is responsible for the absorption of vitamin B12 and bile salts but does not play a major role in iron absorption.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Jejunum:&nbsp;</strong>Incorrect. While the jejunum absorbs various nutrients, including some trace elements, the majority of iron absorption takes place in the duodenum.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The duodenum is the primary site for iron absorption in the gastrointestinal tract.</span></p>",
      "correct_choice_id": 287862,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72506,
      "choices": [
        {
          "id": 289013,
          "text": "<p><span style=\"font-size:14.0pt;\">Activated charcoal administration</span></p>"
        },
        {
          "id": 289014,
          "text": "<p><span style=\"font-size:14.0pt;\">Acetylcysteine infusion</span></p>"
        },
        {
          "id": 289015,
          "text": "<p><span style=\"font-size:14.0pt;\">Urinary alkalinization with sodium bicarbonate</span></p>"
        },
        {
          "id": 289016,
          "text": "<p><span style=\"font-size:14.0pt;\">Intravenous calcium gluconate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old male presents to the emergency department with confusion, hyperventilation, nausea, and ringing in the ears after consuming an unknown quantity of over-the-counter pain relievers. Arterial blood gas shows primary respiratory alkalosis with anion gap metabolic acidosis. Which of the following is the most effective intervention to enhance salicylate elimination and prevent further toxicity progression?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9440173",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Urinary alkalinization with sodium bicarbonate</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Salicylate toxicity causes a mixed <strong>respiratory alkalosis (due to direct stimulation of the respiratory center) and metabolic acidosis</strong> (due to lactate accumulation and uncoupling of oxidative phosphorylation).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>most effective intervention</strong> is <strong>urinary alkalinization with sodium bicarbonate</strong>, which <strong>ionizes salicylates in renal tubules</strong>, preventing reabsorption and enhancing elimination.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This method is preferred unless severe toxicity requires hemodialysis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Activated charcoal administration:</strong> Incorrect. Activated charcoal is <strong>only useful within 1-2 hours of ingestion</strong> before significant systemic absorption. Late-stage salicylate toxicity requires enhanced elimination strategies.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Acetylcysteine infusion:</strong> Incorrect. Acetylcysteine replenishes glutathione for <strong>acetaminophen overdose</strong>, but it has no role in <strong>salicylate poisoning</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Intravenous calcium gluconate:</strong> Incorrect. Calcium gluconate is used in <strong>hyperkalemia and calcium channel blocker toxicity</strong>, but it does not alter <strong>salicylate metabolism or excretion</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Salicylate poisoning causes <strong>respiratory alkalosis transitioning to anion gap metabolic acidosis</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Urinary alkalinization with sodium bicarbonate enhances excretion by trapping ionized salicylates in renal tubules.</strong></span></li></ul>",
      "correct_choice_id": 289015,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72065,
      "choices": [
        {
          "id": 287261,
          "text": "<p><span style=\"font-size:14.0pt;\">Stop warfarin and start LMWH</span></p>"
        },
        {
          "id": 287262,
          "text": "<p><span style=\"font-size:14.0pt;\">Stop warfarin and start heparin</span></p>"
        },
        {
          "id": 287263,
          "text": "<p><span style=\"font-size:14.0pt;\">Continue warfarin</span></p>"
        },
        {
          "id": 287264,
          "text": "<p><span style=\"font-size:14.0pt;\">Stop warfarin, start LMWH and aspirin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A pregnant woman at 36 weeks of gestation with a prosthetic valve replacement for mitral stenosis is on warfarin therapy. Her INR is 3. What is the appropriate next step in management?</span></p>",
      "unique_key": "Q4079190",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A) Stop warfarin and start LMWH</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Warfarin is contraindicated in late pregnancy due to its teratogenic effects and potential risks of bleeding complications during delivery.</span></li><li><span style=\"font-size:14.0pt;\">At 36 weeks, warfarin should be stopped, and LMWH (low molecular weight heparin) should be initiated as it is safer and allows better control during delivery.</span></li><li><span style=\"font-size:14.0pt;\">LMWH also has a shorter half-life compared to warfarin, making it easier to discontinue prior to delivery and restart postpartum.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Stop warfarin and start heparin:&nbsp;</strong>While unfractionated heparin (UFH) can be used in pregnancy, LMWH is preferred due to its longer half-life, better bioavailability, and more predictable anticoagulant effects, reducing the need for frequent monitoring.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Continue warfarin:&nbsp;</strong>Continuing warfarin is incorrect at this stage of pregnancy because it poses a high risk of fetal complications (e.g., fetal hemorrhage and warfarin embryopathy) and maternal bleeding during delivery.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Stop warfarin, start LMWH and aspirin:&nbsp;</strong>While LMWH is the preferred option, aspirin is not routinely added unless the patient has a very high risk of thrombosis (e.g., history of recurrent thrombosis or additional prothrombotic disorders). In this case, aspirin is unnecessary.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">At 36 weeks of pregnancy, warfarin therapy should be replaced with LMWH to prevent fetal risks and minimize maternal complications during delivery, ensuring safe anticoagulation management.</span></li></ul>",
      "correct_choice_id": 287261,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72467,
      "choices": [
        {
          "id": 288857,
          "text": "<p><span style=\"font-size:14.0pt;\">Pandemic potential due to global spread</span></p>"
        },
        {
          "id": 288858,
          "text": "<p><span style=\"font-size:14.0pt;\">High morbidity in healthy adults and elderly</span></p>"
        },
        {
          "id": 288859,
          "text": "<p><span style=\"font-size:14.0pt;\">Seasonal endemic outbreaks with peaks in winter</span></p>"
        },
        {
          "id": 288860,
          "text": "<p><span style=\"font-size:14.0pt;\">Nosocomial transmission in healthcare settings</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A community health surveillance team in an urban area reports a sharp rise in respiratory illness among children, with many presenting with fever, wheezing, and mild cough. Upon further investigation, the team identifies a cluster of cases, and HMPV is confirmed as the causative agent. The team also notes a significant increase in hospital admissions for respiratory complications, particularly in immunocompromised individuals. Based on these findings, which of the following is the most likely characteristic of this HMPV outbreak?&nbsp;</span></p>",
      "unique_key": "Q1917780",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Seasonal endemic outbreaks with peaks in winter</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">HMPV is typically associated with seasonal outbreaks, most often in winter months.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These outbreaks tend to occur in localized regions and primarily affect young children and immunocompromised individuals.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">While HMPV can cause severe illness, especially in these vulnerable groups, it does not have pandemic potential.</span></li><li><span style=\"font-size:14.0pt;\">The majority of infections tend to remain localized within regions, with seasonal peaks in respiratory illness.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Pandemic potential due to global spread:&nbsp;</strong>HMPV does not have the same pandemic potential as other viruses like influenza or SARS-CoV-2, and its spread is typically regional.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. High morbidity in healthy adults and elderly:&nbsp;</strong>Healthy adults generally have mild or no symptoms when infected with HMPV, with the highest morbidity observed in children and the elderly.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Nosocomial transmission in healthcare settings:&nbsp;</strong>Nosocomial transmission is a concern for respiratory viruses, but HMPV outbreaks are more common in the community, with children being the primary vector.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Human Metapneumovirus (HMPV) typically causes seasonal outbreaks in winter, with the highest burden on young children and immunocompromised individuals.</span></li></ul>",
      "correct_choice_id": 288859,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72524,
      "choices": [
        {
          "id": 289085,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute myocardial infarction</span></p>"
        },
        {
          "id": 289086,
          "text": "<p><span style=\"font-size:14.0pt;\">Takotsubo syndrome</span></p>"
        },
        {
          "id": 289087,
          "text": "<p><span style=\"font-size:14.0pt;\">Prinzmetal’s angina</span></p>"
        },
        {
          "id": 289088,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute pericarditis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 52-year-old woman presents to the emergency department with sudden onset chest pain and shortness of breath after experiencing a highly emotional event. She denies a history of coronary artery disease. Her ECG is shown below. Coronary angiography reveals no significant coronary artery obstruction. What is the most likely diagnosis?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-24%20124706.jpg\" width=\"952\" height=\"438\"></strong></span></p>",
      "unique_key": "Q9708836",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Takotsubo syndrome</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Takotsubo syndrome, also known as stress cardiomyopathy or \"broken heart syndrome,\" is characterized by transient regional left ventricular dysfunction, typically following a significant emotional or physical stressor.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It mimics acute myocardial infarction with chest pain, ST-segment elevations, and elevated cardiac biomarkers, but coronary angiography reveals no significant obstructive coronary artery disease.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Acute myocardial infarction</strong>: Typically associated with significant coronary artery occlusion, which is absent in Takotsubo syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Prinzmetal’s angina</strong>: Caused by coronary artery spasm, leading to transient ST-segment elevations that resolve with vasodilator therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Acute pericarditis</strong>: Produces diffuse ST-segment elevations and PR-segment depressions, typically without regional wall motion abnormalities.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Takotsubo syndrome mimics acute myocardial infarction but is triggered by stress, shows transient ST elevations, and lacks obstructive coronary disease on angiography.</span></li><li><span style=\"font-size:14.0pt;\">Recognizing this condition is essential to avoid unnecessary interventions.</span></li></ul>",
      "correct_choice_id": 289086,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72210,
      "choices": [
        {
          "id": 287841,
          "text": "<p><span style=\"font-size:14.0pt;\">Both Assertion and Reason are true, and Reason is the correct explanation of Assertion.</span></p>"
        },
        {
          "id": 287842,
          "text": "<p><span style=\"font-size:14.0pt;\">Both Assertion and Reason are true, but Reason is not the correct explanation of Assertion.</span></p>"
        },
        {
          "id": 287843,
          "text": "<p><span style=\"font-size:14.0pt;\">Assertion is true, but Reason is false.</span></p>"
        },
        {
          "id": 287844,
          "text": "<p><span style=\"font-size:14.0pt;\">Both Assertion and Reason are false.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Assertion (A): During Phase 2 (plateau phase) of the ventricular action potential, calcium influx through L-type calcium channels occurs simultaneously with potassium efflux.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Reason (R): The plateau phase ensures prolonged Absolute Refractory period necessary to prevent premature depolarization by other&nbsp;cardiac tissues.</span></p>",
      "unique_key": "Q3750596",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Both Assertion and Reason are true, and Reason is the correct explanation of Assertion.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><p><span style=\"font-size:14.0pt;\"><strong>Assertion:</strong> The plateau phase (Phase 2) is characterized by an equilibrium between potassium efflux and calcium influx through L-type calcium channels, resulting in a steady membrane potential. This phase plays a critical role in cardiac muscle contraction.</span></p><p>&nbsp;</p></li><li><span style=\"font-size:14.0pt;\"><strong>Reason:</strong> The prolonged depolarization during the plateau phase is vital for ventricular contraction (inotropy). It prevents early repolarization and ensures synchronous contraction of the ventricles, thereby maintaining cardiac output.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-21%20143528.jpg\" width=\"983\" height=\"602\"></p>",
      "correct_choice_id": 287841,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72209,
      "choices": [
        {
          "id": 287837,
          "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-A, 3-D, 4-C</span></p>"
        },
        {
          "id": 287838,
          "text": "<p><span style=\"font-size:14.0pt;\">1-A, 2-B, 3-C, 4-D</span></p>"
        },
        {
          "id": 287839,
          "text": "<p><span style=\"font-size:14.0pt;\">1-C, 2-D, 3-A, 4-B</span></p>"
        },
        {
          "id": 287840,
          "text": "<p><span style=\"font-size:14.0pt;\">1-A, 2-C, 3-D, 4-B</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the components of pulmonary surfactant with their respective roles:&nbsp;</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-21%20143318.jpg\" width=\"855\" height=\"287\"></p>",
      "unique_key": "Q9833404",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) 1-A, 2-B, 3-C, 4-D</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>1-A:</strong> Lecithin (DPPC) is the major surfactant lipid, reducing alveolar surface tension and preventing collapse.</span></li><li><span style=\"font-size:14.0pt;\"><strong>2-B:</strong> Sphingomyelin is a minor component of surfactant but is crucial in fetal lung assessment through the L/S ratio.</span></li><li><span style=\"font-size:14.0pt;\"><strong>3-C:</strong> Surfactant proteins SP-B and SP-C are critical for spreading and stabilizing the surfactant layer.</span></li><li><span style=\"font-size:14.0pt;\"><strong>4-D:</strong> L/S ratio (Lecithin/Sphingomyelin ratio) is used to assess fetal lung maturity, with a ratio ≥2 indicating sufficient maturity.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-21%20143357.jpg\" width=\"854\" height=\"399\"></p>",
      "correct_choice_id": 287838,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72155,
      "choices": [
        {
          "id": 287621,
          "text": "<p><span style=\"font-size:14.0pt;\">Serum calcium levels are normal</span></p>"
        },
        {
          "id": 287622,
          "text": "<p><span style=\"font-size:14.0pt;\">Serum vitamin D levels are normal</span></p>"
        },
        {
          "id": 287623,
          "text": "<p><span style=\"font-size:14.0pt;\">Growth plate healing becomes normal</span></p>"
        },
        {
          "id": 287624,
          "text": "<p><span style=\"font-size:14.0pt;\">Serum ALP becomes normal</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 2-year-old child with rickets is on calcium supplements and has a foot deformity. The child will be referred to a surgeon for the correction of the deformity when:</span></p><p>&nbsp;</p>",
      "unique_key": "Q9041744",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Growth plate healing becomes normal&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>FOOT DEFORMITY IN RICKETS</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Corrective osteotomy in rickets should only be done once radiological healing has taken place otherwise the osteotomy will not unite due to defective mineralization.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Serum calcium levels are normal.</strong> Serum calcium levels are important for bone health, but correcting a foot deformity for 2-year-olds with rickets has more to do with normalizing growth plate healing than serum calcium levels.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Serum vitamin D levels are normal.</strong> While normalizing serum vitamin D is essential for the treatment of rickets, it does not directly address the healing of the growth plate. Correcting the foot deformity has more to do with restoring normal growth plate function.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Serum ALP becomes normal.&nbsp;</strong>ALP is an enzyme involved in the mineralization of bone. Elevated ALP levels are commonly seen in rickets due to an increase in bone turnover.&nbsp;However, ALP normalization alone may not be enough to determine the right time for surgical correction of your foot deformity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The appropriate timing for surgical intervention based on the normalization of growth plate healing rather than relying solely on normal serum calcium, vitamin D levels, or alkaline phosphatase levels.</span></li></ul>",
      "correct_choice_id": 287623,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72539,
      "choices": [
        {
          "id": 289145,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute Myeloid Leukemia (AML)</span></p>"
        },
        {
          "id": 289146,
          "text": "<p><span style=\"font-size:14.0pt;\">Chronic Myeloid Leukemia (CML)</span></p>"
        },
        {
          "id": 289147,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute Lymphoblastic Leukemia (ALL)</span></p>"
        },
        {
          "id": 289148,
          "text": "<p><span style=\"font-size:14.0pt;\">Chronic Lymphocytic Leukemia (CLL)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Mr. Ramesh, a 60-year-old gentleman from Hyderabad, presents with progressive fatigue, loss of appetite, and a feeling of heaviness in the left upper abdomen for three months. He reports early satiety but denies fever, night sweats, or weight loss. Examination reveals pallor and massive splenomegaly extending below the umbilicus. Laboratory findings show leukocytosis (1.65 lakh/µL) with peripheral smear revealing myeloblasts (45%), promyelocytes (30%), metamyelocytes (15%), along with basophils and eosinophils. Karyotyping image is shown below. What is the most likely diagnosis?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-24%20121817.jpg\" width=\"725\" height=\"539\"></strong></span></p>",
      "unique_key": "Q2542343",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Chronic Myeloid Leukemia (CML)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">CML typically presents with marked leukocytosis, splenomegaly, and a left shift in the myeloid lineage, as seen in Mr. Ramesh's peripheral smear showing myeloblasts, promyelocytes, and metamyelocytes.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The presence of basophilia and eosinophilia is characteristic of CML. The disease often presents insidiously with symptoms like fatigue, early satiety due to splenomegaly, and weight loss.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Acute Myeloid Leukemia (AML):</strong> Usually presents with rapid onset symptoms and &gt;20% myeloblasts without the marked left shift seen in CML.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Acute Lymphoblastic Leukemia (ALL):</strong> Primarily a disease of children, with lymphoblast predominance rather than myeloid precursors.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Chronic Lymphocytic Leukemia (CLL):</strong> Characterized by lymphocytosis and smudge cells, without significant myeloid precursor proliferation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Chronic Myeloid Leukemia is marked by leukocytosis with a left-shifted myeloid lineage, basophilia, eosinophilia, and splenomegaly.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The Philadelphia chromosome (BCR-ABL fusion gene) confirms the diagnosis and guides targeted therapy with tyrosine kinase inhibitors.</span></li></ul>",
      "correct_choice_id": 289146,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72070,
      "choices": [
        {
          "id": 287281,
          "text": "<p><span style=\"font-size:14.0pt;\">Insignificant</span></p>"
        },
        {
          "id": 287282,
          "text": "<p><span style=\"font-size:14.0pt;\">Occurs in 10% of newborns</span></p>"
        },
        {
          "id": 287283,
          "text": "<p><span style=\"font-size:14.0pt;\">An indicator of considerably increased incidence of major malformations of the fetus</span></p>"
        },
        {
          "id": 287284,
          "text": "<p><span style=\"font-size:14.0pt;\">Equally common in newborns of diabetic and nondiabetic mothers</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">During the examination of the umbilical cord after delivery, a single umbilical artery is identified instead of the usual two arteries and one vein. What does the presence of a single umbilical artery indicate?</span></p>",
      "unique_key": "Q3333304",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) An indicator of considerably increased incidence of major malformations of the fetus</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The presence of a <strong>single umbilical artery (SUA)</strong> is associated with an increased risk of fetal congenital malformations, particularly involving the <strong>cardiovascular and genitourinary systems</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is found in <strong>20–25% of cases</strong> with major fetal anomalies. SUA is also linked to an increased risk of <strong>abortion, intrauterine growth restriction (IUGR), prematurity, and perinatal mortality</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Insignificant:&nbsp;</strong>This is incorrect as SUA is a significant finding due to its association with fetal malformations and adverse pregnancy outcomes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Occurs in 10% of newborns:&nbsp;</strong>This is incorrect. SUA occurs in <strong>0.7–0.8% of single pregnancies</strong> and about <strong>5% of twin pregnancies</strong>, not in 10% of all newborns.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Equally common in newborns of diabetic and nondiabetic mothers: </strong>This is incorrect. SUA is <strong>more common in diabetic patients</strong> and in black populations.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The presence of a <strong>single umbilical artery</strong> is an important clinical finding associated with a <strong>considerably increased risk of major fetal malformations</strong>, particularly of the cardiovascular and genitourinary systems, as well as adverse pregnancy outcomes like IUGR and prematurity.</span></li></ul>",
      "correct_choice_id": 287283,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72088,
      "choices": [
        {
          "id": 287353,
          "text": "<p><span style=\"font-size:14.0pt;\">Protects from neonatal jaundice</span></p>"
        },
        {
          "id": 287354,
          "text": "<p><span style=\"font-size:14.0pt;\">Protects from hypothermia</span></p>"
        },
        {
          "id": 287355,
          "text": "<p><span style=\"font-size:14.0pt;\">Decreases duration of hospital stay</span></p>"
        },
        {
          "id": 287356,
          "text": "<p><span style=\"font-size:14.0pt;\">Promotes exclusive breastfeeding</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A preterm neonate weighing 1.8 kg is receiving the care technique shown in the image below. Which of the following is not a benefit of this care?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-19%20180402.jpg\" width=\"452\" height=\"342\"></span></p>",
      "unique_key": "Q3251414",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans</strong>. <strong>A) Protects from neonatal jaundice</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Kangaroo Mother Care (KMC) does not directly prevent neonatal jaundice, which requires phototherapy or other treatments to reduce bilirubin levels.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Protects from hypothermia:</strong> KMC helps maintain body temperature by skin-to-skin contact, reducing the risk of hypothermia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Decreases duration of hospital stay:</strong> Studies show KMC is associated with faster weight gain and improved outcomes, reducing hospital stay.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Promotes exclusive breastfeeding:</strong> KMC facilitates bonding and improves breastfeeding rates, supporting exclusive breastfeeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Kangaroo Mother Care (KMC) provides thermal regulation, promotes exclusive breastfeeding, and reduces hospital stay, but it does not prevent neonatal jaundice.</span></li></ul>",
      "correct_choice_id": 287353,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72487,
      "choices": [
        {
          "id": 288937,
          "text": "<p><span style=\"font-size:14.0pt;\">Single-dose Rifampicin for prophylaxis</span></p>"
        },
        {
          "id": 288938,
          "text": "<p><span style=\"font-size:14.0pt;\">6-month course of Dapsone</span></p>"
        },
        {
          "id": 288939,
          "text": "<p><span style=\"font-size:14.0pt;\">Daily Rifampicin for 12 weeks</span></p>"
        },
        {
          "id": 288940,
          "text": "<p><span style=\"font-size:14.0pt;\">Immediate initiation of multidrug therapy (MDT)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 40-year-old healthcare worker who has been in contact with several leprosy patients in a high-risk setting, visits the clinic for a check-up. The individual has not yet developed any symptoms but has had significant exposure (around 50 hours per week for 4 months) to multiple known cases. Based on the exposure and the individual’s eligibility for post-exposure prophylaxis, which of the following is the recommended intervention?&nbsp;</span></p>",
      "unique_key": "Q7596917",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans</strong>. <strong>A)</strong> <strong>Single-dose Rifampicin</strong> <strong>for prophylaxis</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">For individuals who have been identified as high-risk contacts of leprosy patients (with exposure of more than 20 hours per week for over 3 months), single-dose Rifampicin is the recommended post-exposure prophylaxis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This strategy has been shown to be highly effective in preventing the development of leprosy in these individuals, provided they have not yet shown symptoms.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. 6-month course of Dapsone:</strong> Is used in the treatment of active leprosy, not for prophylaxis.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option C. Daily Rifampicin for 12 weeks</strong>: Is not a recommended regimen for PEP, as Rifampicin is given as a single dose for prophylaxis.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Immediate initiation of multidrug therapy (MDT)</strong>: Would be indicated for individuals diagnosed with leprosy, not for high-risk contacts without symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Post-exposure prophylaxis for leprosy is given as chemoprophylaxis, where Rifampicin single dose is given</span></li><li><span style=\"font-size:14.0pt;\">Inclusion Criteria for PEP Leprosy:</span><ul><li><span style=\"font-size:14.0pt;\">Being identified as a contact, i.e. a person who has been in close contact with the index case for 20 hours or more per week for more than 3 months</span></li><li><span style=\"font-size:14.0pt;\">Age: more than 2 years; if younger than 2 years, the child can be given SDR at the age of 2, in follow up visits of contacts (if meeting all other inclusion criteria)</span></li></ul></li></ul>",
      "correct_choice_id": 288937,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72465,
      "choices": [
        {
          "id": 288849,
          "text": "<p><span style=\"font-size:14.0pt;\">Decrease total dissolved solids (TDS) and increase pH</span></p>"
        },
        {
          "id": 288850,
          "text": "<p><span style=\"font-size:14.0pt;\">Increase calcium concentration and decrease pH</span></p>"
        },
        {
          "id": 288851,
          "text": "<p><span style=\"font-size:14.0pt;\">Increase calcium concentration and alkalinity</span></p>"
        },
        {
          "id": 288852,
          "text": "<p><span style=\"font-size:14.0pt;\">Decrease calcium concentration and increase temperature</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A researcher at a water quality control lab is assessing the water supply for a manufacturing plant. The water has an LSI value of -0.5, indicating corrosive potential. To mitigate this issue, the researcher considers adjusting the water's characteristics. Which combination of adjustments would most likely help reduce corrosion and bring the LSI to a positive value?</span></p>",
      "unique_key": "Q7738697",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Increase calcium concentration</strong> <strong>and alkalinity</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">An LSI negative indicates that the water is undersaturated with respect to calcium carbonate, leading to corrosion.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">To make the water less corrosive and bring the LSI to a positive value, the researcher should increase the calcium concentration (hardness) and increase the alkalinity.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These adjustments will help saturate the water with calcium carbonate and reduce corrosion, shifting the LSI to positive, indicating a tendency for scaling rather than corrosion.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Decrease</strong> <strong>total dissolved solids (TDS)</strong> <strong>and increase</strong> <strong>pH:</strong> Decreasing TDS and increasing pH alone may not address the need for calcium saturation, which is crucial to prevent corrosion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Increase</strong> <strong>calcium concentration</strong> <strong>and decrease</strong> <strong>pH:</strong> Decreasing pH increases acidity, worsening corrosion instead of mitigating it.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Decrease</strong> <strong>calcium concentration</strong> <strong>and increase</strong> <strong>temperature:</strong> Decreasing calcium concentration would only worsen the undersaturation with calcium carbonate, increasing corrosion potential.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Langlier’s Saturation Index (LSI)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">LSI provides an indicator of the degree of saturation of water with respect to calcium carbonate.</span></li><li><span style=\"font-size:14.0pt;\">LSI is based on estimating Hardness (calcium concentration), Total dissolved solids (TDS), Alkalinity, pH and Temperature.</span></li><li><span style=\"font-size:14.0pt;\">LSI Positive indicates Scaling, LSI negative indicates corrosion.</span></li></ul>",
      "correct_choice_id": 288851,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72546,
      "choices": [
        {
          "id": 289173,
          "text": "<p><span style=\"font-size:14.0pt;\">Impaired ATP production due to decreased NADH generation</span></p>"
        },
        {
          "id": 289174,
          "text": "<p><span style=\"font-size:14.0pt;\">Disrupted nucleic acid synthesis due to reduced ribose-5-phosphate availability</span></p>"
        },
        {
          "id": 289175,
          "text": "<p><span style=\"font-size:14.0pt;\">Accumulation of glucose-6-phosphate, leading to increased glycolysis</span></p>"
        },
        {
          "id": 289176,
          "text": "<p><span style=\"font-size:14.0pt;\">Reduced acetyl-CoA production, impairing the citric acid cycle</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A genetic mutation in the enzyme transketolase leads to inefficient carbon transfer in the pentose phosphate pathway, despite adequate thiamine intake. Which of the following is the most likely outcome of this defect, considering the role of thiamine pyrophosphate (TPP) in the reaction?&nbsp;</span></p>",
      "unique_key": "Q6397776",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Disrupted nucleic acid synthesis due to reduced ribose-5-phosphate availability</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Transketolase is an enzyme in the non-oxidative phase of the pentose phosphate pathway, which helps convert sugar phosphates into ribose-5-phosphate (a precursor for nucleotide and nucleic acid synthesis).</span></li><li><span style=\"font-size:14.0pt;\">A mutation in transketolase, even with sufficient thiamine (TPP is its coenzyme), would impair the enzyme’s function, leading to reduced ribose-5-phosphate formation.</span></li><li><span style=\"font-size:14.0pt;\">This directly impacts nucleic acid (DNA and RNA) synthesis, making this the most likely outcome.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Impaired ATP production due to decreased NADH generation: Incorrect:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The pentose phosphate pathway (PPP) generates NADPH, not NADH.</span></li><li><span style=\"font-size:14.0pt;\">NADPH is primarily involved in reductive biosynthesis and antioxidant defense, while NADH is produced mainly in glycolysis, the TCA cycle, and oxidative phosphorylation.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, a transketolase defect would not directly affect ATP production through NADH generation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Accumulation of glucose-6-phosphate, leading to increased glycolysis: Incorrect:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A transketolase defect occurs in the non-oxidative phase, while glucose-6-phosphate is involved in the oxidative phase of the PPP.</span></li><li><span style=\"font-size:14.0pt;\">Glucose-6-phosphate could accumulate if glucose-6-phosphate dehydrogenase (G6PD) was defective, not transketolase.</span></li><li><span style=\"font-size:14.0pt;\">This mutation would not directly lead to increased glycolysis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Reduced acetyl-CoA production, impairing the citric acid cycle: Incorrect:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Acetyl-CoA is produced primarily from pyruvate via pyruvate dehydrogenase, fatty acid oxidation, or amino acid metabolism.</span></li><li><span style=\"font-size:14.0pt;\">The pentose phosphate pathway does not produce or regulate acetyl-CoA directly, and a defect in transketolase would not impair the citric acid cycle.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A mutation in transketolase affects the non-oxidative phase of the pentose phosphate pathway, leading to a deficiency of ribose-5-phosphate, which is essential for nucleic acid synthesis. Thus, the correct answer is B. Disrupted nucleic acid synthesis due to reduced ribose-5-phosphate availability.</span></li></ul>",
      "correct_choice_id": 289174,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72525,
      "choices": [
        {
          "id": 289089,
          "text": "<p><span style=\"font-size:14.0pt;\">Anti-voltage-gated calcium channel antibodies</span></p>"
        },
        {
          "id": 289090,
          "text": "<p><span style=\"font-size:14.0pt;\">Anti-LRP4 antibodies</span></p>"
        },
        {
          "id": 289091,
          "text": "<p><span style=\"font-size:14.0pt;\">Anti-GM1 antibodies</span></p>"
        },
        {
          "id": 289092,
          "text": "<p><span style=\"font-size:14.0pt;\">Anti-dsDNA antibodies</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Mr. Rajesh, a 52-year-old man from Chennai, presents with progressive muscle weakness over the past six months, worsening as the day progresses. He reports intermittent double vision, difficulty chewing and swallowing, and nasal regurgitation of liquids, especially after prolonged meals. &nbsp;Examination reveals fatigable weakness in proximal muscles, with normal reflexes and sensation and the findings shown in the provided images:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-24%20121453.jpg\" width=\"484\" height=\"243\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">After application of ice pack:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-24%20121504.jpg\" width=\"488\" height=\"247\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The edrophonium test improves his symptoms. Given the likely diagnosis, which of the following antibodies will be tested positive in this patient?</span></p>",
      "unique_key": "Q1432785",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Anti-LRP4 antibodies</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Myasthenia Gravis (MG) is an autoimmune disorder primarily associated with antibodies against acetylcholine receptors, but a subset of patients, particularly those who are seronegative for AChR antibodies, may have antibodies against low-density lipoprotein receptor-related protein 4 (LRP4).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">LRP4 antibodies interfere with neuromuscular junction signaling, leading to fluctuating muscle weakness, especially involving ocular and bulbar muscles.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The edrophonium test and improvement with an ice pack are supportive diagnostic tools.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Anti-voltage-gated calcium channel antibodies:</strong> Seen in Lambert-Eaton Myasthenic Syndrome, which presents with proximal weakness improving with activity and autonomic symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Anti-GM1 antibodies:</strong> Associated with acute motor axonal neuropathy, a variant of Guillain-Barré Syndrome, presenting with ascending weakness.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Anti-dsDNA antibodies:</strong> Specific for systemic lupus erythematosus (SLE), which presents with multi-system involvement, not isolated muscle weakness.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Myasthenia Gravis can be caused by antibodies against acetylcholine receptors or, in some cases, anti-LRP4 antibodies.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Both forms result in fluctuating muscle weakness, often starting with ocular symptoms.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Diagnosis involves antibody testing and bedside assessments like the edrophonium and ice pack tests.</span></li></ul>",
      "correct_choice_id": 289090,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72206,
      "choices": [
        {
          "id": 287825,
          "text": "<p><span style=\"font-size:14.0pt;\">Horse-shoe kidney: USG KUB&nbsp;</span></p>"
        },
        {
          "id": 287826,
          "text": "<p><span style=\"font-size:14.0pt;\">Renal cell carcinoma: Whittaker test&nbsp;</span></p>"
        },
        {
          "id": 287827,
          "text": "<p><span style=\"font-size:14.0pt;\">Renal TB: Early morning urinary analysis</span></p>"
        },
        {
          "id": 287828,
          "text": "<p><span style=\"font-size:14.0pt;\">Renal Cysts: CECT abdomen&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Identify the mismatched disease and its diagnostic test:&nbsp;</span></p>",
      "unique_key": "Q6797880",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Renal cell carcinoma: Whittaker test</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Pressure measurement in the pelvicalyceal system is conducted using the Whittaker test, which involves catheterization of the renal pelvis and measurement of pressures to determine the significance of urinary tract obstruction.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is not used in renal malignancies, where imaging is diagnostic.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Horse-shoe kidney: USG KUB</strong>: Horse shoe kidney is diagnosed on imaging studies like USG.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>C. Renal TB: Early morning urinary analysis:</strong> Urine analysis in renal TB shows sterile pyuria. Urine may be subjected to CBNAAT for isolation of organism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Renal Cysts: CECT abdomen</strong>: Renal cysts or polycystic kidneys are seen on imaging like USG or CECT abdomen.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The Whittaker test is used for direct pressure measurement in the pelvicalyceal system, particularly to assess for the presence and significance of an obstruction in the upper urinary tract.</span></li></ul>",
      "correct_choice_id": 287826,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72095,
      "choices": [
        {
          "id": 287381,
          "text": "<p><span style=\"font-size:14.0pt;\">A</span></p>"
        },
        {
          "id": 287382,
          "text": "<p><span style=\"font-size:14.0pt;\">B</span></p>"
        },
        {
          "id": 287383,
          "text": "<p><span style=\"font-size:14.0pt;\">C</span></p>"
        },
        {
          "id": 287384,
          "text": "<p><span style=\"font-size:14.0pt;\">D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In this cut section through the ischioanal fossa, correctly identify the pelvic diaphragm.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-19%20182004.jpg\" width=\"622\" height=\"399\"></span></p>",
      "unique_key": "Q9873076",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) B</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The pelvic diaphragm is indicated as <strong>B</strong> in the diagram.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is primarily composed of the <strong>levator ani</strong> and <strong>coccygeus muscles</strong>, which form a muscular partition separating the pelvic cavity from the perineal region.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-19%20182029.jpg\" width=\"813\" height=\"486\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Components of the Pelvic Diaphragm:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>Levator Ani Muscle:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Includes three parts:</span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:14.0pt;\"><strong>Pubococcygeus</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Iliococcygeus</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Puborectalis</strong></span></li><li><span style=\"font-size:14.0pt;\">Functions: Provides support to pelvic organs and plays a role in maintaining continence.</span></li></ul></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Coccygeus Muscle:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Originates from the ischial spine and inserts onto the lower sacrum and coccyx.</span></li><li><span style=\"font-size:14.0pt;\">Provides additional support to the pelvic floor.</span></li></ul></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Boundaries of Ischioanal Fossa</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>Lateral Boundary:</strong> Fascia covering the obturator internus muscle and the ischial tuberosity.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Medial Boundary:</strong> Fascia covering the levator ani and external anal sphincter.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Posterior Boundary:</strong> Sacrotuberous ligament, overlain by gluteus maximus.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Anterior Boundary:</strong> Posterior border of the perineal membrane.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Floor:</strong> Perineal skin.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Roof:</strong> Fascia meeting point between the obturator internus and the inferior fascia of the pelvic diaphragm.</span></li></ol>",
      "correct_choice_id": 287382,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72520,
      "choices": [
        {
          "id": 289069,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer both medications simultaneously to maximize their absorption.</span></p>"
        },
        {
          "id": 289070,
          "text": "<p><span style=\"font-size:14.0pt;\">Take phenytoin 2 hours before sucralfate to avoid absorption interference.</span></p>"
        },
        {
          "id": 289071,
          "text": "<p><span style=\"font-size:14.0pt;\">Take sucralfate 2 hours before phenytoin to prioritize ulcer healing.</span></p>"
        },
        {
          "id": 289072,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer phenytoin immediately after sucralfate to promote drug binding.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">For a patient taking both phenytoin and sucralfate, what timing strategy should be implemented to prevent reduced drug efficacy due to interaction?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3799163",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Take phenytoin 2 hours before sucralfate to avoid absorption interference.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Administering phenytoin at least 2 hours before sucralfate allows for adequate absorption of phenytoin before the sucralfate forms a barrier in the stomach.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This management strategy helps maintain effective plasma levels of phenytoin, crucial for controlling seizures.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>A.</strong> <strong>Administer both medications simultaneously to maximize their absorption:</strong> Incorrect as simultaneous administration may lead to reduced absorption of phenytoin.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Take sucralfate 2 hours before phenytoin to prioritize ulcer healing:</strong> Incorrect because taking sucralfate first may impair phenytoin absorption.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Administer phenytoin immediately after sucralfate to promote drug binding:</strong> Incorrect as administering phenytoin after sucralfate does not promote effective drug binding and can still result in impaired absorption.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Learn to appropriately time the administration of sucralfate and phenytoin to optimize the pharmacokinetic profiles and therapeutic efficacy of both medications.</span></li></ul>",
      "correct_choice_id": 289070,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72212,
      "choices": [
        {
          "id": 287849,
          "text": "<p><span style=\"font-size:14.0pt;\">Juxtaglomerular cells</span></p>"
        },
        {
          "id": 287850,
          "text": "<p><span style=\"font-size:14.0pt;\">Macula densa cells</span></p>"
        },
        {
          "id": 287851,
          "text": "<p><span style=\"font-size:14.0pt;\">Mesangial cells</span></p>"
        },
        {
          "id": 287852,
          "text": "<p><span style=\"font-size:14.0pt;\">Podocytes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following cells in the kidney are responsible for releasing adenosine in response to an increase in glomerular filtration rate (GFR)?&nbsp;</span></p>",
      "unique_key": "Q9628904",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Macula densa cells</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Macula densa cells</strong> are specialized cells located in the thick ascending loop of Henle, near the juxtaglomerular apparatus. These cells sense changes in the sodium chloride (NaCl) concentration in the tubular fluid, which indirectly reflects the glomerular filtration rate (GFR).</span></li><li><span style=\"font-size:14.0pt;\">When there is an increase in GFR, the macula densa detects a higher NaCl concentration in the tubular fluid. In response, the macula densa releases <strong>adenosine</strong>, which acts locally to constrict the afferent arteriole, thereby reducing GFR as part of the <strong>tubuloglomerular feedback mechanism</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Juxtaglomerular cells:&nbsp;</strong>Juxtaglomerular cells are responsible for the secretion of renin in response to a decrease in blood pressure or sympathetic stimulation. They do not release adenosine.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Mesangial cells:&nbsp;</strong>Mesangial cells provide structural support to the glomerulus and help in modulating the filtration surface area by contracting or relaxing. They do not release adenosine.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Podocytes:&nbsp;</strong>Podocytes are specialized cells of the visceral layer of Bowman's capsule that help maintain the filtration barrier in the glomerulus. They do not release adenosine.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Macula densa cells in the kidney release adenosine in response to an increase in glomerular filtration rate (GFR) as part of the tubuloglomerular feedback mechanism, which helps regulate GFR by constricting the afferent arteriole.</span></p>",
      "correct_choice_id": 287850,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72192,
      "choices": [
        {
          "id": 287769,
          "text": "<p><span style=\"font-size:14.0pt;\">Open appendectomy</span></p>"
        },
        {
          "id": 287770,
          "text": "<p><span style=\"font-size:14.0pt;\">Right hemicolectomy</span></p>"
        },
        {
          "id": 287771,
          "text": "<p><span style=\"font-size:14.0pt;\">Percutaneous drainage and antibiotics</span></p>"
        },
        {
          "id": 287772,
          "text": "<p><span style=\"font-size:14.0pt;\">Follow-up with serial imaging</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old female presents with chronic right lower quadrant pain and a history of intermittent fever. CT shows a 3.5 cm cystic mass at the appendix tip with calcifications, suspicious of malignancy. What is the most appropriate management?</span></p>",
      "unique_key": "Q5082368",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Right hemicolectomy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><p><span style=\"font-size:14.0pt;\">Appendiceal neoplasms &gt;2 cm (especially mucinous tumors) require right hemicolectomy due to the risk of malignancy and lymphatic spread.</span></p><p>&nbsp;</p></li></ul><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Open appendectomy</strong>: Open appendectomy is insufficient for neoplasms &gt;2 cm.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Percutaneous drainage and antibiotics</strong>: Percutaneous drainage is for abscesses, not neoplasms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Follow-up with serial imaging</strong>: Observation risks progression of malignancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Mucinous appendiceal neoplasms &gt;2 cm require right hemicolectomy to ensure complete removal and minimize malignancy risks.</span></li></ul>",
      "correct_choice_id": 287770,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72516,
      "choices": [
        {
          "id": 289053,
          "text": "<p><span style=\"font-size:14.0pt;\">Rapid-acting insulin.</span></p>"
        },
        {
          "id": 289054,
          "text": "<p><span style=\"font-size:14.0pt;\">Vaccine adjuvants.</span></p>"
        },
        {
          "id": 289055,
          "text": "<p><span style=\"font-size:14.0pt;\">Iron dextran.</span></p>"
        },
        {
          "id": 289056,
          "text": "<p><span style=\"font-size:14.0pt;\">Heparin.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A healthcare provider is instructing a nursing student on the administration of intramuscular injections using the Z track technique. Which of the following medications is most appropriately administered using this technique due to its potential for causing severe local reactions?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5145643",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Iron dextran</strong>.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Iron dextran, used for treating iron deficiency anemia, is known for its potential to cause staining and irritation when injected.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The Z track method is particularly useful for such medications as it prevents the medication from tracking back to the surface, thereby minimizing staining and local irritation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This technique ensures that the injection remains deep within the muscle, reducing the likelihood of leakage.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Rapid-acting insulin:</strong> Incorrect as insulin is typically administered subcutaneously and does not usually cause severe local reactions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Vaccine adjuvants:</strong> Incorrect because vaccines are generally not administered using the Z track technique unless specifically indicated due to their content.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Heparin:</strong> Incorrect as heparin is typically given subcutaneously and does not require Z track technique for its administration.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Recognize the application of the Z track technique for medications like iron dextran that are prone to causing local discoloration and irritation.</span></li></ul>",
      "correct_choice_id": 289055,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72464,
      "choices": [
        {
          "id": 288845,
          "text": "<p><span style=\"font-size:14.0pt;\">Category A&nbsp;</span></p>"
        },
        {
          "id": 288846,
          "text": "<p><span style=\"font-size:14.0pt;\">Category B&nbsp;</span></p>"
        },
        {
          "id": 288847,
          "text": "<p><span style=\"font-size:14.0pt;\">Category C&nbsp;</span></p>"
        },
        {
          "id": 288848,
          "text": "<p><span style=\"font-size:14.0pt;\">Category D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old woman in an urban area is brought to the hospital with symptoms of fever, chills, and unilateral swelling on her arm. She mentions that she recently visited a rural area where there was a suspected bioterrorism event involving an infected animal. On examination, the patient has buboes in her axilla and the diagnostic test confirms the presence of Yersinia pestis. Given the potential of this pathogen for large-scale dissemination, which bioterrorism agent classification best fits this agent?&nbsp;</span></p><p>&nbsp;</p>",
      "unique_key": "Q7757087",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Category A&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Yersinia pestis, the causative agent of plague, is classified as a Category A bioterrorism agent due to its high mortality, ease of dissemination (especially via aerosolized transmission), and its ability to cause significant public panic.</span></li><li><span style=\"font-size:14.0pt;\">Plague can lead to bubonic, septic, or pneumonic forms, and the buboes seen in this patient’s axilla are a classic sign of bubonic plague.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Given its potential for widespread impact, plague is a serious concern for bioterrorism preparedness.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B</strong>. <strong>Category B:</strong> Category B agents, such as salmonella, cause moderate morbidity but low mortality, and do not match the high fatality seen with plague.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C</strong>. <strong>Category C:</strong> Category C agents like Nipah virus are emerging pathogens but do not have the same historical precedent or immediate threat as plague for bioterrorism.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Category D:&nbsp;</strong>Category D does not exist in the classification system for bioterrorism agents.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:14.0pt;\"><strong>&nbsp;</strong></span></p><ul><li><span style=\"font-size:14.0pt;\">Category A bioterrorism agents can be easily disseminated, have high mortality rates and lead to public panic &amp; disruption. Agents include Botulism, Tularaemia, Anthrax, Small pox, Plague, Viral haemorrhagic fevers</span></li><li><span style=\"font-size:14.0pt;\">Category B bioterrorism agents are moderately easy to disseminate, cause moderate morbidity with low mortality, require enhanced diagnostic capacity with enhanced surveillance</span></li><li><span style=\"font-size:14.0pt;\">Category C bioterrorism agents are new emerging pathogens that are available, have ease of production and exhibit high morbidity and mortality</span></li></ul>",
      "correct_choice_id": 288845,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72471,
      "choices": [
        {
          "id": 288873,
          "text": "<p><span style=\"font-size:14.0pt;\">AFP</span></p>"
        },
        {
          "id": 288874,
          "text": "<p><span style=\"font-size:14.0pt;\">Inhibin B</span></p>"
        },
        {
          "id": 288875,
          "text": "<p><span style=\"font-size:14.0pt;\">HCG</span></p>"
        },
        {
          "id": 288876,
          "text": "<p><span style=\"font-size:14.0pt;\">CA-125</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 42-year-old female with menstrual irregularities, obesity, and infertility presents with an ovarian mass. Imaging reveals a solid tumor with fluid-filled cystic areas. Histopathology shows coffee bean nuclei and Call Exner bodies. Which of the following markers would be most helpful in confirming the diagnosis?&nbsp;</span></p>",
      "unique_key": "Q7681953",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Inhibin B</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The presence of <strong>coffee bean nuclei</strong> and <strong>Call Exner bodies</strong> on histopathology is characteristic of <strong>Granulosa cell tumors</strong>, which are commonly seen in elderly females.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>inhibin B</strong> marker is specific for these tumors, as they secrete <strong>inhibin B</strong>, which is involved in regulating the gonadotropin levels.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other&nbsp;Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. AFP</strong>: <strong>AFP</strong> is a marker for <strong>Yolk Sac tumor</strong>, not <strong>Granulosa cell tumor</strong>.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. HCG:&nbsp;</strong>HCG<strong>&nbsp;</strong>is elevated in gestational trophoblastic disease or choriocarcinoma, not Granulosa cell tumors.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. CA-125:</strong> <strong>CA-125</strong> is not specific for <strong>Granulosa cell tumors</strong> and is used for other ovarian malignancies.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Granulosa cell tumors</strong> are associated with <strong>inhibin B</strong> production and are characterized by <strong>Call Exner bodies</strong> and <strong>coffee bean nuclei</strong> on histology.</span></li></ul>",
      "correct_choice_id": 288874,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72541,
      "choices": [
        {
          "id": 289153,
          "text": "<p><span style=\"font-size:14.0pt;\">Arterial embolism</span></p>"
        },
        {
          "id": 289154,
          "text": "<p><span style=\"font-size:14.0pt;\">Clostridium difficile colitis</span></p>"
        },
        {
          "id": 289155,
          "text": "<p><span style=\"font-size:14.0pt;\">Inflammatory bowel disease</span></p>"
        },
        {
          "id": 289156,
          "text": "<p><span style=\"font-size:14.0pt;\">Nonocclusive mesenteric ischemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 63-year-old man with a history of diabetes and myocardial infarction (MI) was admitted to the ICU one day ago for sepsis due to pneumococcal pneumonia with bacteremia. He was started on antibiotics, fluids, and noradrenaline to stabilize his blood pressure. Over the past 2 hours, he has developed worsening abdominal pain, distension, and bloody stools. His vital signs include:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Blood pressure: 100/50 mmHg</span></li><li><span style=\"font-size:14.0pt;\">Heart rate: 100/min</span></li><li><span style=\"font-size:14.0pt;\">Respiratory rate: 22/min</span></li><li><span style=\"font-size:14.0pt;\">SpO₂: 93% on high-flow nasal oxygen (HFNO)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">On examination, his abdomen is diffusely tender with no audible bowel sounds. An CT image showed air fluid levels. &nbsp;What is the most likely diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2897323",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;D) Nonocclusive mesenteric ischemia</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient’s presentation is most consistent with <strong>nonocclusive mesenteric ischemia (NOMI)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">NOMI is a form of intestinal ischemia caused by decreased mesenteric perfusion in the absence of arterial occlusion.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Contributing factors in this patient include:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Sepsis and shock requiring noradrenaline, which reduces splanchnic perfusion.</span></li><li><span style=\"font-size:14.0pt;\">Bloody stools, abdominal pain, and radiographic findings of bowel air-fluid levels are typical for intestinal ischemia.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Arterial embolism</strong>: This typically presents with sudden-onset severe abdominal pain and is often associated with embolic risk factors (e.g., atrial fibrillation). However, this patient’s symptoms developed in the setting of systemic hypoperfusion, favoring NOMI.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Clostridium difficile colitis</strong>: While this can cause abdominal pain and bloody stools, it is less likely in this setting, as there is no history of recent antibiotic use beyond sepsis treatment, and radiographs would show colonic thickening, not small bowel air-fluid levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Inflammatory bowel disease (IBD)</strong>: IBD is unlikely in an older patient with no prior history of chronic diarrhea or inflammatory symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Nonocclusive mesenteric ischemia is a common cause of intestinal ischemia in critically ill patients with systemic hypoperfusion.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It should be suspected in patients with risk factors like sepsis, vasopressor use, and abdominal pain.</span></li></ul>",
      "correct_choice_id": 289156,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72528,
      "choices": [
        {
          "id": 289101,
          "text": "<p><span style=\"font-size:14.0pt;\">Allergic bronchopulmonary aspergillosis&nbsp;</span></p>"
        },
        {
          "id": 289102,
          "text": "<p><span style=\"font-size:14.0pt;\">Idiopathic pulmonary fibrosis</span></p>"
        },
        {
          "id": 289103,
          "text": "<p><span style=\"font-size:14.0pt;\">Goodpasture syndrome</span></p>"
        },
        {
          "id": 289104,
          "text": "<p><span style=\"font-size:14.0pt;\">Cryptogenic organising Pneumonia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 43-year-old man presents with a 5-week history of progressive dyspnea and intermittent fever. Blood tests show the following:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Total leukocyte count (TLC): 18,000/µL</span></li><li><span style=\"font-size:14.0pt;\">Elevated CRP and ESR</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A chest X-ray reveals bilateral areas of consolidation. Empirical antibiotics are started, but the patient shows no improvement. A CT chest image is shown below. What is the most likely diagnosis?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-24%20121558.jpg\" width=\"429\" height=\"430\"></strong></span></p>",
      "unique_key": "Q9885834",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>D) Cryptogenic organising Pneumonia</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This case represents the classic presentation of<strong> cryptogenic organizing pneumonia</strong> <strong>(COP),</strong> where patients initially appear to have <strong>community-acquired pneumonia</strong> (CAP) but fail to respond to multiple courses of antibiotics.</span></li><li><span style=\"font-size:14.0pt;\">A <strong>lung biopsy</strong> is the definitive diagnostic test, revealing organizing pneumonia without organisms or positive cultures.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Allergic bronchopulmonary aspergillosis (ABPA):</strong> Requires a background of <strong>asthma</strong> or <strong>wheezing</strong>, which this patient lacks. Additionally, ABPA typically presents with bronchiectasis rather than consolidations.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Idiopathic Pulmonary Fibrosis:</strong> Presents with <strong>progressive dyspnea</strong> and dry cough over <strong>months to years</strong>, with chest X-ray findings of interstitial reticulonodular patterns, not new consolidations.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Goodpasture Syndrome:</strong> Involves <strong>pulmonary-renal syndrome</strong> with hemoptysis and renal dysfunction (hematuria, proteinuria). This patient lacks renal involvement and hemoptysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">When a patient with suspected pneumonia fails to improve with antibiotics and develops new consolidations, <strong>COP</strong> should be suspected, confirmed by lung biopsy.</span></p>",
      "correct_choice_id": 289104,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72486,
      "choices": [
        {
          "id": 288933,
          "text": "<p><span style=\"font-size:14.0pt;\">Low hunger levels, indicating effective measures for food security and nutritional health.</span></p>"
        },
        {
          "id": 288934,
          "text": "<p><span style=\"font-size:14.0pt;\">Moderate hunger levels, suggesting the country faces some challenges but manageable food insecurity.</span></p>"
        },
        {
          "id": 288935,
          "text": "<p><span style=\"font-size:14.0pt;\">Alarming hunger levels, requiring immediate intervention due to widespread food insecurity and malnutrition.</span></p>"
        },
        {
          "id": 288936,
          "text": "<p><span style=\"font-size:14.0pt;\">Extremely alarming hunger levels, indicating a severe food crisis requiring urgent global intervention.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A researcher studying global hunger indicators analyzes data on the Global Hunger Index (GHI) for a country with a reported GHI score of 42.3. The score places the country in a critical range. Based on the GHI classification system, how would the hunger situation in this country be described?&nbsp;</span></p>",
      "unique_key": "Q9909007",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Alarming hunger levels, requiring immediate intervention due to widespread food insecurity and malnutrition.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A GHI score of 35-49.9 is classified as Alarming, indicating that food insecurity is a pressing concern.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Immediate measures are needed to address the growing malnutrition and the increasing risk of hunger crises in the country.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Global Hunger Index (GHI)</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The Global Hunger Index is a tool designed to comprehensively measure and track hunger at the global, regional, and country levels.</span></li><li><span style=\"font-size:14.0pt;\">The International Food Policy Research Institute (IFPRI) calculates GHI scores each year to assess progress, or the lack thereof, in combating hunger.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">GHI Classification and Interpretation:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_tfOc7EN.png\" width=\"1157\" height=\"301\"></span></p>",
      "correct_choice_id": 288935,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72150,
      "choices": [
        {
          "id": 287601,
          "text": "<p><span style=\"font-size:14.0pt;\">Start Anti-osteoporotic treatment</span></p>"
        },
        {
          "id": 287602,
          "text": "<p><span style=\"font-size:14.0pt;\">Do MRI scan</span></p>"
        },
        {
          "id": 287603,
          "text": "<p><span style=\"font-size:14.0pt;\">Go for screw fixation of L1 vertebra</span></p>"
        },
        {
          "id": 287604,
          "text": "<p><span style=\"font-size:14.0pt;\">To take Dexamethasone&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 70-year-old lady got compression fracture of L1 vertebra. There is no neurological deficit to this patient. What advise will you give for this patient?&nbsp;</span></p>",
      "unique_key": "Q6672187",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A) Start Anti-osteoporotic treatment</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Osteoporotic compression fractures are common in elderly patients, particularly in postmenopausal women.</span></li><li><span style=\"font-size:14.0pt;\">Osteoporosis weakens bones, making them more prone to fractures, especially in the spine.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In the absence of neurological deficit, the primary treatment is to address osteoporosis itself to prevent further fractures.</span></li><li><span style=\"font-size:14.0pt;\">Anti-osteoporotic treatment typically includes medications like bisphosphonates (e.g., alendronate), denosumab, or selective estrogen receptor modulators (SERMs) to improve bone density and reduce the risk of future fractures.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The patient may also be advised to take calcium and vitamin D supplements.</span></li><li><span style=\"font-size:14.0pt;\">This approach focuses on improving bone health to prevent more fractures in the future, which is crucial for older patients.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Do MRI scan: </strong>An MRI scan is typically used to evaluate soft tissues or identify spinal cord involvement or other structural abnormalities. However, in this patient, there is no neurological deficit, so an MRI is not immediately necessary for assessing the compression fracture. MRI could be considered if there were signs of neurological involvement, or if there was concern about a more complex pathology (e.g., malignancy or infection), but in the absence of these symptoms, this option is not needed.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Go for screw fixation of L1 vertebra:&nbsp;</strong>Screw fixation or surgical intervention is typically reserved for cases with significant neurological deficit, severe deformity, or instability. Since the patient has no neurological symptoms and the compression fracture is likely osteoporotic, surgery is generally not required. Most compression fractures in elderly patients are managed conservatively with pain management, bracing, and osteoporosis treatment. Surgical intervention may be necessary if the fracture is unstable, causing significant pain, or if there is a risk of further collapse.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. To take Dexamethasone:&nbsp;</strong>Dexamethasone is a corticosteroid used for reducing inflammation and swelling. It is typically used in cases of severe inflammation, conditions like spinal cord compression with inflammation, or other inflammatory diseases. If there is no evidence of inflammation, and corticosteroids this would not be appropriate. In fact, long-term use of corticosteroids can increase the risk of osteoporosis and further fractures, so it would not be advisable for the patient. The focus should be on anti-osteoporotic treatment rather than steroids.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The most appropriate action is to start anti-osteoporotic treatment to address the underlying bone weakness that led to the compression fracture.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This will help in preventing further fractures and managing the patient's bone health.</span></li></ul>",
      "correct_choice_id": 287601,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72489,
      "choices": [
        {
          "id": 288945,
          "text": "<p><span style=\"font-size:14.0pt;\">Painless beefy-red ulcer</span></p>"
        },
        {
          "id": 288946,
          "text": "<p><span style=\"font-size:14.0pt;\">Painful, soft ulcers with marked swelling</span></p>"
        },
        {
          "id": 288947,
          "text": "<p><span style=\"font-size:14.0pt;\">Multiple, painful, vesicular lesions</span></p>"
        },
        {
          "id": 288948,
          "text": "<p><span style=\"font-size:14.0pt;\">Single, indurated, painless ulcer</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following features is characteristic of donovanosis?</span></p>",
      "unique_key": "Q3891831",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A)</strong> <strong>Painless beefy-red ulcer</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Donovanosis</strong>, caused by <strong>Klebsiella granulomatis</strong>, presents with a <strong>painless, beefy-red ulcer</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is characterized by <strong>progressive ulceration</strong> and <strong>granulomatous inflammation</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The lesion often has a <strong>red, moist appearance</strong> and may develop <strong>fleshy granulomatous tissue</strong> around it.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Painful, soft ulcers with marked swelling:&nbsp; </strong>Painful, soft ulcers with marked swelling <strong>with marked swelling</strong> are more typical of <strong>chancroid</strong>.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Multiple, painful, vesicular lesions: Herpes Simplex Virus (HSV)</strong> typically causes <strong>painful, vesicular lesions</strong> that rapidly ulcerate.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Single, indurated, painless ulcer: Syphilis</strong> usually presents with a <strong>single, painless indurated ulcer</strong> (chancre), not the beefy-red appearance of <strong>donovanosis</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Differential diagnoses&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-21%20180721.jpg\" width=\"1116\" height=\"561\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-21%20180749.jpg\" width=\"1060\" height=\"513\"></span></p>",
      "correct_choice_id": 288945,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72542,
      "choices": [
        {
          "id": 289157,
          "text": "<p><span style=\"font-size:14.0pt;\">Tay-Sachs Disease</span></p>"
        },
        {
          "id": 289158,
          "text": "<p><span style=\"font-size:14.0pt;\">Farber's Disease</span></p>"
        },
        {
          "id": 289159,
          "text": "<p><span style=\"font-size:14.0pt;\">Fabry's Disease</span></p>"
        },
        {
          "id": 289160,
          "text": "<p><span style=\"font-size:14.0pt;\">Gaucher's Disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient presents with joint deformities and pain reminiscent of rheumatoid arthritis, as shown in the image below. Which of the following conditions is most likely responsible for these findings?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-24%20122018.jpg\" width=\"648\" height=\"446\"></span></p>",
      "unique_key": "Q1828589",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Farber's Disease</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Farber’s disease, a rare lysosomal storage disorder caused by a deficiency in acid ceramidase, characteristically presents with joint swelling and deformities, subcutaneous nodules, and progressive arthritis that may mimic rheumatoid arthritis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These symptoms are due to the accumulation of ceramide in the lysosomes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Tay-Sachs Disease:</strong> Incorrect, as it primarily affects the central nervous system in infants, leading to neurodegeneration, not joint deformities.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Fabry's Disease:</strong> Incorrect, while it involves lysosomal storage, its main symptoms include pain, kidney failure, and heart issues, not arthritis-like joint deformities.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Gaucher's Disease:</strong> Incorrect, primarily involves hepatosplenomegaly, bone pain, and marrow infiltration, but does not typically present with joint deformities that mimic rheumatoid arthritis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Identify and differentiate between lysosomal storage disorders based on symptomatology, focusing on Farber's disease and its unique presentation with arthritis-like symptoms.</span></li></ul>",
      "correct_choice_id": 289158,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72090,
      "choices": [
        {
          "id": 287361,
          "text": "<p><span style=\"font-size:14.0pt;\">A</span></p>"
        },
        {
          "id": 287362,
          "text": "<p><span style=\"font-size:14.0pt;\">B</span></p>"
        },
        {
          "id": 287363,
          "text": "<p><span style=\"font-size:14.0pt;\">C</span></p>"
        },
        {
          "id": 287364,
          "text": "<p><span style=\"font-size:14.0pt;\">D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient presented with weakness of 4th and 5th distal interphalangeal joint and was not able to hold a piece of paper between his fingers. The nerve likely to be injured lies in relation to which part of the bone as shown below?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Anatomy%20Image%201.jpg\" width=\"478\" height=\"1265\"></p>",
      "unique_key": "Q5879046",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) D</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The ulnar nerve passes posterior to the medial epicondyle (marked D) of the humerus. This is the most common site of injury leading to weakness in the 4th and 5th fingers, as described.</span></li><li><span style=\"font-size:14.0pt;\">Ulnar nerve injury affects the medial half of the flexor digitorum profundus and medial lumbricals, resulting in a claw hand. The inability to hold a piece of paper (Froment’s sign) occurs due to weakened adductor pollicis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. A:</strong> Refers to the humeral head. This part is not related to ulnar nerve injury but may involve axillary nerve injury in shoulder dislocations.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>B: </strong>Refers to the humeral shaft. The radial nerve lies in the spiral groove here, and its injury causes wrist drop, not claw hand.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. C:</strong> Refers to the lateral epicondyle. It is related to the origin of the extensor muscles and does not involve the ulnar nerve.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-19%20181439.jpg\" width=\"1029\" height=\"424\"></strong></span></p>",
      "correct_choice_id": 287364,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72519,
      "choices": [
        {
          "id": 289065,
          "text": "<p><span style=\"font-size:14.0pt;\">Infliximab</span></p>"
        },
        {
          "id": 289066,
          "text": "<p><span style=\"font-size:14.0pt;\">Trastuzumab</span></p>"
        },
        {
          "id": 289067,
          "text": "<p><span style=\"font-size:14.0pt;\">Ipilimumab</span></p>"
        },
        {
          "id": 289068,
          "text": "<p><span style=\"font-size:14.0pt;\">Denosumab</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient with metastatic melanoma has progressed despite initial therapy with targeted agents. Which immune checkpoint inhibitor, known for its effectiveness in melanoma, should be considered next in the management of this patient?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9144201",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Ipilimumab</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Ipilimumab is another immune checkpoint inhibitor like Nivolumab but targets CTLA-4, another regulatory protein on T cells.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is particularly known for its use in melanoma, often in combination with PD-1 inhibitors like Nivolumab, to enhance immune response against advanced stages of the disease.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Infliximab:</strong> Infliximab is a TNF-alpha inhibitor, primarily used for inflammatory conditions like rheumatoid arthritis and Crohn's disease. It is <strong>not</strong> an immune checkpoint inhibitor and is not used in the treatment of melanoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Trastuzumab:</strong> Trastuzumab is a monoclonal antibody that targets the HER2 protein, primarily used in HER2-positive breast cancer and some gastric cancers. It is <strong>not</strong> an immune checkpoint inhibitor and is not used in the treatment of melanoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>D. Denosumab:</strong> Denosumab is a monoclonal antibody that targets RANKL (receptor activator of nuclear factor-kappa B ligand). It is primarily used to prevent skeletal-related events in patients with bone metastases from various cancers and to treat osteoporosis. It is <strong>not</strong> an immune checkpoint inhibitor and is not used as a primary systemic treatment for melanoma itself.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Ipilimumab, a CTLA-4 inhibitor, enhances T-cell activation and is effective in metastatic melanoma. It is often used alone or with PD-1 inhibitors like nivolumab for advanced disease.</span></li></ul>",
      "correct_choice_id": 289067,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72508,
      "choices": [
        {
          "id": 289021,
          "text": "<p><span style=\"font-size:14.0pt;\">Monthly complete blood counts for the first six months, then biannually.</span></p>"
        },
        {
          "id": 289022,
          "text": "<p><span style=\"font-size:14.0pt;\">Weekly complete blood counts for the first six months, then biweekly thereafter.</span></p>"
        },
        {
          "id": 289023,
          "text": "<p><span style=\"font-size:14.0pt;\">Daily neutrophil monitoring for the first month, then weekly.</span></p>"
        },
        {
          "id": 289024,
          "text": "<p><span style=\"font-size:14.0pt;\">Complete blood counts every visit without a defined schedule.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A psychiatrist is reviewing a 37-year-old female patient with schizophrenia on clozapine therapy during a routine follow-up. To prevent the severe adverse effect of agranulocytosis, which of the following monitoring strategies should be implemented?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6512678",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Weekly complete blood counts for the first six months, then biweekly thereafter</strong>.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The monitoring protocol for patients on clozapine requires weekly complete blood counts for the first six months due to the high risk of agranulocytosis, followed by biweekly monitoring if the initial six months are uneventful.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This stringent monitoring helps in early detection of neutropenia, allowing for prompt intervention to prevent progression to agranulocytosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Apply the appropriate monitoring protocol for neutrophil counts in patients treated with clozapine to detect early signs of agranulocytosis.</span></li></ul>",
      "correct_choice_id": 289022,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72497,
      "choices": [
        {
          "id": 288977,
          "text": "<p><span style=\"font-size:14.0pt;\">Nicotinic AChR</span></p>"
        },
        {
          "id": 288978,
          "text": "<p><span style=\"font-size:14.0pt;\">P antigen on RBCs</span></p>"
        },
        {
          "id": 288979,
          "text": "<p><span style=\"font-size:14.0pt;\">CD21</span></p>"
        },
        {
          "id": 288980,
          "text": "<p><span style=\"font-size:14.0pt;\">ACE2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 10-year-old child presents with a history of fever, malaise, and fatigue. A blood smear reveals parvovirus B19 infection, which can cause erythema infectiosum. Which of the following is the receptor that Parvovirus B19 uses to enter host cells?</span></p>",
      "unique_key": "Q4577335",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B)</strong> <strong>P antigen on RBCs</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Parvovirus B19 binds to the P antigen found on red blood cells (RBCs) to enter the host cell.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This receptor binding is essential for the virus’s ability to infect and replicate in erythroid progenitor cells, which is why parvovirus B19 often causes erythema infectiosum (fifth disease) in children.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option A. Nicotinic AChR:</strong> This is the receptor used by Rabies, not Parvovirus B19.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. CD21:</strong> This is used by EBV, not Parvovirus B19.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. ACE2:</strong> This is the receptor for SARS-CoV-2, not Parvovirus B19.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-21%20181328.jpg\" width=\"1084\" height=\"415\"></strong></span></p>",
      "correct_choice_id": 288978,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72138,
      "choices": [
        {
          "id": 287553,
          "text": "<p><span style=\"font-size:14.0pt;\">Scabies</span></p>"
        },
        {
          "id": 287554,
          "text": "<p><span style=\"font-size:14.0pt;\">Psoriasis</span></p>"
        },
        {
          "id": 287555,
          "text": "<p><span style=\"font-size:14.0pt;\">Impetigo</span></p>"
        },
        {
          "id": 287556,
          "text": "<p><span style=\"font-size:14.0pt;\">Atopic dermatitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 10-year-old child with a history of asthma presents with lesions localized to the flexural areas of the elbows and knees as shown in the image below. What is the most likely diagnosis?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-21%20132035.jpg\" width=\"584\" height=\"438\"></span></p>",
      "unique_key": "Q6688895",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>D) Atopic dermatitis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Atopic dermatitis often occurs in children with a history of atopy (asthma, allergic rhinitis).&nbsp;</span></li><li><p><span style=\"font-size:14.0pt;\">The characteristic features include pruritic, erythematous lesions in flexural areas, frequently exacerbated by environmental factors.</span></p><p>&nbsp;</p></li></ul><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Scabies:</strong> Presents with burrows and intense itching, often in interdigital spaces.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Psoriasis:</strong> Typically involves extensor surfaces with silvery scales, not flexural areas.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Impetigo:</strong> A bacterial infection characterized by honey-colored crusts, not scaly plaques.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Atopic dermatitis presents with pruritic, erythematous, scaly lesions in flexural areas, often associated with a history of atopy.</span></li></ul>",
      "correct_choice_id": 287556,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        18
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72491,
      "choices": [
        {
          "id": 288953,
          "text": "<p><span style=\"font-size:14.0pt;\">Production of enterotoxins leading to chloride ion secretion in the intestines</span></p>"
        },
        {
          "id": 288954,
          "text": "<p><span style=\"font-size:14.0pt;\">Preformed toxins causing gastrointestinal upset shortly after ingestion</span></p>"
        },
        {
          "id": 288955,
          "text": "<p><span style=\"font-size:14.0pt;\">Ingestion of spores that activate toxin production after colonization</span></p>"
        },
        {
          "id": 288956,
          "text": "<p><span style=\"font-size:14.0pt;\">Severe inflammation due to bacterial invasion and cytotoxicity</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 50-year-old woman presents with watery diarrhea and abdominal cramping after eating seafood at a beach resort. Symptoms began 6 hours after ingestion and have progressively worsened. Laboratory tests confirm the presence of Vibrio cholerae. Which of the following factors is most important in explaining the rapid onset and severity of this patient’s condition?&nbsp;</span></p>",
      "unique_key": "Q8186150",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A)</strong> <strong>Production of enterotoxins leading to chloride ion secretion in the intestines</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Vibrio cholerae</strong> is known for producing <strong>cholera toxin</strong>, which stimulates the secretion of <strong>chloride ions</strong> into the <strong>intestinal lumen</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This causes <strong>massive fluid loss</strong>, resulting in <strong>watery diarrhea</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The rapid onset (within <strong>6 hours</strong>) of symptoms is characteristic of <strong>Vibrio cholerae</strong> infection, typically associated with <strong>seafood</strong> or <strong>water</strong> contamination.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Preformed toxins causing gastrointestinal upset shortly after ingestion</strong>: This description applies to <strong>Bacillus cereus</strong> or <strong>Staphylococcus aureus</strong>, which cause <strong>vomiting and diarrhea</strong> within <strong>1–6 hours</strong> but do not cause the <strong>severe watery diarrhea</strong> seen in cholera.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option C. Ingestion of spores that activate toxin production after colonization</strong>: This describes the pathophysiology of <strong>Clostridium perfringens</strong> or <strong>Bacillus cereus</strong>, which have <strong>longer incubation periods</strong> and do not cause <strong>cholera-like diarrhea</strong>.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option D. Severe inflammation due to bacterial invasion and cytotoxicity</strong>: This fits <strong>Shigella species</strong>, which cause <strong>inflammatory diarrhea</strong> but not <strong>watery diarrhea</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Vibrio cholerae</strong> produces <strong>cholera toxin</strong>, leading to <strong>massive chloride ion secretion</strong> and <strong>watery diarrhea</strong> within <strong>6 hours</strong> after ingestion of <strong>contaminated seafood</strong> or <strong>water</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-21%20180836.jpg\" width=\"742\" height=\"720\"></span></p>",
      "correct_choice_id": 288953,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72442,
      "choices": [
        {
          "id": 288761,
          "text": "<p><span style=\"font-size:14.0pt;\">It causes acoustic shadowing</span></p>"
        },
        {
          "id": 288762,
          "text": "<p><span style=\"font-size:14.0pt;\">It appears as an echo-free structure</span></p>"
        },
        {
          "id": 288763,
          "text": "<p><span style=\"font-size:14.0pt;\">It is seen with increased echoes in deeper structures</span></p>"
        },
        {
          "id": 288764,
          "text": "<p><span style=\"font-size:14.0pt;\">It produces echoes in all regions</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is true about bile on ultrasound?</span></p>",
      "unique_key": "Q1400027",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) It appears as an echo-free structure</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Bile is a homogeneous fluid, meaning it does not produce echoes on ultrasound, and it appears as an echo-free structure.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This is a key characteristic of homogeneous fluids like bile, urine, and cyst contents.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. It causes acoustic shadowing</strong>: Incorrect. Acoustic shadowing is typically caused by solid or calcified structures, not fluid.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. It is seen with increased echoes in deeper structures:</strong> Incorrect. Posterior enhancement may occur with homogeneous fluids, not increased echoes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. It produces echoes in all regions:</strong> Incorrect. Bile does not produce echoes in general.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Bile appears as an echo-free structure on ultrasound due to its homogeneous nature.</span></p>",
      "correct_choice_id": 288762,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72084,
      "choices": [
        {
          "id": 287337,
          "text": "<p><span style=\"font-size:14.0pt;\">1-D, 2-A, 3-C, 4-B</span></p>"
        },
        {
          "id": 287338,
          "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-A, 3-D, 4-C</span></p>"
        },
        {
          "id": 287339,
          "text": "<p><span style=\"font-size:14.0pt;\">1-C, 2-B, 3-D, 4-A</span></p>"
        },
        {
          "id": 287340,
          "text": "<p><span style=\"font-size:14.0pt;\">1-A, 2-D, 3-B, 4-C&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the Following:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column A</span></p><ol><li><span style=\"font-size:14.0pt;\">Japanese encephalitis vaccine schedule</span></li><li><span style=\"font-size:14.0pt;\">Contraindication to pertussis vaccination</span></li><li><span style=\"font-size:14.0pt;\">Mission Indradhanush vaccine coverage</span></li><li><span style=\"font-size:14.0pt;\">Universal birth vaccines</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column B</span></p><ol style=\"list-style-type:upper-latin;\"><li><span style=\"font-size:14.0pt;\">Two doses 1 month apart with a booster 1-2 years later</span></li><li><span style=\"font-size:14.0pt;\">Includes DPT, OPV, Hepatitis B, but not Japanese encephalitis</span></li><li><span style=\"font-size:14.0pt;\">BCG, OPV, Hepatitis B</span></li><li><span style=\"font-size:14.0pt;\">Encephalopathy within 7 days after previous dose</span></li></ol>",
      "unique_key": "Q8417505",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans</strong>. <strong>D) 1-A, 2-D, 3-B, 4-C</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Japanese encephalitis vaccine schedule (1-A):</strong> Administered as two doses 1 month apart, with a booster 1-2 years later.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Contraindication to pertussis vaccination (2-D):</strong> Absolute contraindication includes encephalopathy within 7 days of the prior dose of DPT.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Mission Indradhanush vaccine coverage (3-B):</strong> Includes seven life-threatening diseases (DPT, Hepatitis B, OPV) but excludes Japanese encephalitis as a routine vaccine.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Universal birth vaccines (4-C):</strong> At birth, vaccines include BCG, OPV zero dose, and Hepatitis B.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Japanese encephalitis vaccine schedule : Administered as two doses 1 month apart, with a booster 1-2 years later.</span></li><li><span style=\"font-size:14.0pt;\">Contraindication to pertussis vaccination : Absolute contraindication includes encephalopathy within 7 days of the prior dose of DPT.</span></li><li><span style=\"font-size:14.0pt;\">Mission Indradhanush vaccine coverage : Includes seven life-threatening diseases (DPT, Hepatitis B, OPV) but excludes Japanese encephalitis as a routine vaccine.</span></li><li><span style=\"font-size:14.0pt;\">Universal birth vaccines : At birth, vaccines include BCG, OPV zero dose, and Hepatitis B.</span></li></ul>",
      "correct_choice_id": 287340,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72195,
      "choices": [
        {
          "id": 287781,
          "text": "<p><span style=\"font-size:14.0pt;\">Donor-specific antibody-mediated injury</span></p>"
        },
        {
          "id": 287782,
          "text": "<p><span style=\"font-size:14.0pt;\">T-cell-mediated cytotoxicity</span></p>"
        },
        {
          "id": 287783,
          "text": "<p><span style=\"font-size:14.0pt;\">Ischemia-reperfusion injury</span></p>"
        },
        {
          "id": 287784,
          "text": "<p><span style=\"font-size:14.0pt;\">Cytokine release syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old male undergoes renal transplantation. Within minutes of vascular anastomosis, the transplanted kidney becomes mottled and cyanotic. What is the underlying mechanism?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3376081",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) Donor-specific antibody-mediated injury</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Hyperacute rejection occurs due to preformed donor-specific antibodies activating the complement system, leading to immediate graft failure.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. T-cell-mediated cytotoxicity</strong>: Acute T-cell-mediated rejection occurs days to weeks later.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Ischemia-reperfusion injury</strong>: Ischemia-reperfusion injury does not cause immediate mottling.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Cytokine release syndrome</strong>: Cytokine release is unrelated to transplantation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Hyperacute rejection is mediated by preformed donor-specific antibodies, requiring pre-transplant crossmatch tests to prevent this complication.</span></li></ul>",
      "correct_choice_id": 287781,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72466,
      "choices": [
        {
          "id": 288853,
          "text": "<p><span style=\"font-size:14.0pt;\">Deletion of 13q</span></p>"
        },
        {
          "id": 288854,
          "text": "<p><span style=\"font-size:14.0pt;\">Translocation t(9;22)</span></p>"
        },
        {
          "id": 288855,
          "text": "<p><span style=\"font-size:14.0pt;\">Mutation in p53</span></p>"
        },
        {
          "id": 288856,
          "text": "<p><span style=\"font-size:14.0pt;\">Amplification of HER2/neu</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 70-year-old male with a long history of smoking presents with fatigue and intermittent fevers. Laboratory studies show a markedly elevated white blood cell count with characteristic cells as marked in the peripheral smear image. Which of the following is the most likely genetic abnormality associated with this diagnosis?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-21%20173827.jpg\" width=\"624\" height=\"464\"></strong></span></p>",
      "unique_key": "Q2331985",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong>&nbsp;<strong>A)</strong>&nbsp;<strong>Deletion of 13q</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The most common genetic abnormality in <strong>Chronic Lymphocytic Leukemia (CLL)</strong> is the <strong>deletion of 13q</strong>, which is associated with a better prognosis in CLL.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The presence of <strong>smudge cells</strong> and the clinical features further support this diagnosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other&nbsp;Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Translocation t(9;22):Translocation t(9;22)</strong> is characteristic of <strong>Chronic Myelogenous Leukemia (CML)</strong>, not CLL.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C</strong>.<strong> Mutation in p53:</strong> <strong>p53 mutations</strong> are associated with <strong>some cancers</strong> but are not common in CLL.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Amplification of HER2/neu:HER2/neu amplification</strong> is seen in <strong>breast cancer</strong>, not CLL.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Deletion of 13q</strong> is the most common genetic abnormality in <strong>Chronic Lymphocytic Leukemia (CLL)</strong>.</span></li></ul>",
      "correct_choice_id": 288853,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72476,
      "choices": [
        {
          "id": 288893,
          "text": "<p><span style=\"font-size:14.0pt;\">Zinc phosphide</span></p>"
        },
        {
          "id": 288894,
          "text": "<p><span style=\"font-size:14.0pt;\">Endosulfan</span></p>"
        },
        {
          "id": 288895,
          "text": "<p><span style=\"font-size:14.0pt;\">Malathion</span></p>"
        },
        {
          "id": 288896,
          "text": "<p><span style=\"font-size:14.0pt;\">Mosquito repellants</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">During a pesticide training session for agricultural workers, the instructor highlights a pesticide used in rodent control that is classified as extremely toxic and carries a red label. The instructor explains that this pesticide has a high mortality rate and is dangerous if ingested. Which of the following pesticides is most likely being discussed?</span></p>",
      "unique_key": "Q1595216",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) Zinc phosphide</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Zinc phosphide is extremely toxic and carries a red label. It is used in rodent control, and ingestion can result in severe poisoning.</span></li><li><span style=\"font-size:14.0pt;\">The red label is an indicator of the highest level of toxicity among pesticides.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Endosulfan:&nbsp;</strong>Endosulfan is highly toxic (yellow label) and is more likely to cause neurological symptoms rather than severe gastrointestinal distress.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option C. Malathion:&nbsp;</strong>Malathion is moderately toxic (blue label) and is much less toxic than Zinc phosphide.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option D. Mosquito repellants:&nbsp;</strong>Mosquito repellants are slightly toxic (green label), and are used for insect repellent rather than rodent control.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Toxicity Colour Labels of Pesticides in India:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Red label: Extremely toxic – Zinc phosphide&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Yellow label: Highly toxic – Endosulphan&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Blue label: Moderately toxic – Malathion&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Green label: Slightly toxic – Mosquito repellents</span></li></ul>",
      "correct_choice_id": 288893,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72078,
      "choices": [
        {
          "id": 287313,
          "text": "<p><span style=\"font-size:14.0pt;\">Twin pregnancy precludes the use of oxytocin</span></p>"
        },
        {
          "id": 287314,
          "text": "<p><span style=\"font-size:14.0pt;\">Amniotomy decreases the need for oxytocin use</span></p>"
        },
        {
          "id": 287315,
          "text": "<p><span style=\"font-size:14.0pt;\">Methods of augmentation do not increase the risk of operative delivery</span></p>"
        },
        {
          "id": 287316,
          "text": "<p><span style=\"font-size:14.0pt;\">Associated with a risk of uterine hyperstimulation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">All of the following are true about augmentation of labor except:<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1840558",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Twin pregnancy precludes the use of oxytocin</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Twin pregnancy does not preclude the use of oxytocin. Studies have shown that twin gestations are associated with similar efficacy and safety of oxytocin for labor augmentation compared to singleton pregnancies.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Amniotomy decreases the need for oxytocin use</strong>: Correct; artificial rupture of membranes can stimulate labor, reducing the need for oxytocin.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Methods of augmentation do not increase the risk of operative delivery</strong>: Correct; augmentation methods are designed to support vaginal delivery without increasing the need for cesarean or instrumental delivery.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Associated with a risk of uterine hyperstimulation</strong>: Correct; oxytocin can cause excessive uterine contractions, leading to fetal distress and other complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Labor augmentation with oxytocin is safe and effective in twin pregnancies. However, it must be used cautiously due to potential risks, such as uterine hyperstimulation.</span></li><li><span style=\"font-size:14.0pt;\">Amniotomy is another augmentation method that can reduce the need for oxytocin.</span></li></ul>",
      "correct_choice_id": 287313,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72109,
      "choices": [
        {
          "id": 287437,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 4 only</span></p>"
        },
        {
          "id": 287438,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3 and 4 only</span></p>"
        },
        {
          "id": 287439,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 3 only</span></p>"
        },
        {
          "id": 287440,
          "text": "<p><span style=\"font-size:14.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding Succinylcholine are true?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\">It is metabolized by pseudocholinesterase.</span></li><li><span style=\"font-size:14.0pt;\">It is associated with post-operative myalgia.</span></li><li><span style=\"font-size:14.0pt;\">It can be safely used in patients with burns older than 6 months.</span></li><li><span style=\"font-size:14.0pt;\">It acts by non-competitive blockade of the acetylcholine receptor.</span></li></ol>",
      "unique_key": "Q4615516",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) 1, 2 and 4 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1.</strong> <strong>It is metabolized by pseudocholinesterase:</strong> Pseudocholinesterase metabolizes succinylcholine, leading to its short duration.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2.</strong> <strong>It is associated with post-operative myalgia:</strong> Post-operative myalgia is a common side effect due to muscle fasciculations.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4.</strong> <strong>It acts by non-competitive blockade of the acetylcholine receptor:</strong> Succinylcholine acts via a non-competitive blockade at the acetylcholine receptor.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3.</strong> <strong>It can be safely used in patients with burns older than 6 months:</strong> Succinylcholine is contraindicated in burn patients even after 6 months due to persistent risk of hyperkalemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Succinylcholine acts via non-competitive acetylcholine receptor blockade, is metabolized by pseudocholinesterase, and is contraindicated in burn patients due to hyperkalemia risk, even after 6 months.</span></li></ul>",
      "correct_choice_id": 287437,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72463,
      "choices": [
        {
          "id": 288841,
          "text": "<p><span style=\"font-size:14.0pt;\">15-25 units/kg BW</span></p>"
        },
        {
          "id": 288842,
          "text": "<p><span style=\"font-size:14.0pt;\">0.25 mL/kg BW</span></p>"
        },
        {
          "id": 288843,
          "text": "<p><span style=\"font-size:14.0pt;\">0.05 mL/kg BW</span></p>"
        },
        {
          "id": 288844,
          "text": "<p><span style=\"font-size:14.0pt;\">20 mL</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 7-year-old child presents with a recent diagnosis of chickenpox and is at high risk due to a history of immunocompromised family members. The child is eligible for post-exposure prophylaxis to prevent the disease. What is the appropriate dose of varicella immunoglobulin to prevent the development of chickenpox?&nbsp;</span></p>",
      "unique_key": "Q8181736",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 15-25 units /kg BW</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">For varicella post-exposure prophylaxis, 15-25 units /kg BW of varicella immunoglobulin (VZIG) is the appropriate dose.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This immunoglobulin provides passive immunity, reducing the severity or preventing the onset of chickenpox in high-risk individuals, such as those with immunocompromised conditions or infants.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>IMMUNOGLOBULIN DOSAGES</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ZhN7T3R.png\" width=\"998\" height=\"584\"></strong></span></p>",
      "correct_choice_id": 288841,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72082,
      "choices": [
        {
          "id": 287329,
          "text": "<p><span style=\"font-size:14.0pt;\">1-C, 2-B, 3-A, 4-D</span></p>"
        },
        {
          "id": 287330,
          "text": "<p><span style=\"font-size:14.0pt;\">1-C, 2-B, 3-D, 4-A</span></p>"
        },
        {
          "id": 287331,
          "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-C, 3-D, 4-A</span></p>"
        },
        {
          "id": 287332,
          "text": "<p><span style=\"font-size:14.0pt;\">1-C, 2-D, 3-B, 4-A</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the Following:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column A</span></p><ol><li><span style=\"font-size:14.0pt;\">Social Smile</span></li><li><span style=\"font-size:14.0pt;\">Baby can walk backwards&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Immature pincer grasp</span></li><li><span style=\"font-size:14.0pt;\">Mature Pincer Grasp</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column B</span></p><ol style=\"list-style-type:upper-latin;\"><li><span style=\"font-size:14.0pt;\">Develops at 9 months</span></li><li><span style=\"font-size:14.0pt;\">Seen by 2 years&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Appears at 2 months of age</span></li><li><span style=\"font-size:14.0pt;\">Achieved at 12 months of age</span></li></ol>",
      "unique_key": "Q2006569",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans</strong>. <strong>A) 1-C, 2-B, 3-A, 4-D</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Social Smile (1-C):</strong> Social smile is a milestone that first appears around 2 months of age, as a response to social interactions.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Baby can walk backwards (2-B):</strong> A baby can walk backwards by two years</span></li><li><span style=\"font-size:14.0pt;\"><strong>Immature pincer grasp (3-A):&nbsp;</strong>Immature Pincer Grasp comes by nine months</span></li><li><span style=\"font-size:14.0pt;\"><strong>Mature Pincer Grasp (4-D):&nbsp;</strong>Mature pincer grasp comes by 12 months.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Social Smile : Social smile is a milestone that first appears around 2 months of age, as a response to social interactions.</span></li><li><span style=\"font-size:14.0pt;\">Baby can walk backwards : A baby can walk backwards by two years</span></li><li><span style=\"font-size:14.0pt;\">Immature pincer grasp : Immature Pincer Grasp comes by nine months</span></li><li><span style=\"font-size:14.0pt;\">Mature Pincer Grasp : Mature pincer grasp comes by 12 months.</span></li></ul>",
      "correct_choice_id": 287329,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72480,
      "choices": [
        {
          "id": 288909,
          "text": "<p><span style=\"font-size:14.0pt;\">Tyrosine</span></p>"
        },
        {
          "id": 288910,
          "text": "<p><span style=\"font-size:14.0pt;\">Cysteine</span></p>"
        },
        {
          "id": 288911,
          "text": "<p><span style=\"font-size:14.0pt;\">Phenylalanine</span></p>"
        },
        {
          "id": 288912,
          "text": "<p><span style=\"font-size:14.0pt;\">Glutamine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In a nutrition-focused health survey, a significant portion of the population reports low dietary intake of protein, leading to muscle wasting and generalized weakness. Biochemical testing reveals deficient levels of methionine. Considering the nutritional implications, which of the following amino acids is now conditionally essential for these individuals?&nbsp;</span></p>",
      "unique_key": "Q3780618",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B)</strong> <strong>Cysteine</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">When methionine intake is deficient, cysteine becomes conditionally essential because cysteine is synthesized from methionine.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Without adequate methionine, the body cannot produce sufficient cysteine, which leads to deficiency and necessitates supplementation through diet.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Tyrosine: </strong>Tyrosine is conditionally essential when phenylalanine is deficient, not related to methionine deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Phenylalanine: </strong>Phenylalanine is essential and not dependent on methionine metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Glutamine: </strong>Glutamine is involved in nitrogen metabolism but is not directly <strong>related to methionine deficiency.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Conditionally Essential Amino Acids (CEAA): Nonessential amino acids may turn essential if their precursors are limited in the body&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">There are 2 CEAA, namely, Tyrosine (derived from Phenylalanine) and Cysteine (derived from methionine)</span></li></ul>",
      "correct_choice_id": 288910,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72213,
      "choices": [
        {
          "id": 287853,
          "text": "<p><span style=\"font-size:14.0pt;\">Both Assertion and Reason are true, and Reason is the correct explanation of Assertion.</span></p>"
        },
        {
          "id": 287854,
          "text": "<p><span style=\"font-size:14.0pt;\">Both Assertion and Reason are true, but Reason is not the correct explanation of Assertion.</span></p>"
        },
        {
          "id": 287855,
          "text": "<p><span style=\"font-size:14.0pt;\">Assertion is true, but Reason is false.</span></p>"
        },
        {
          "id": 287856,
          "text": "<p><span style=\"font-size:14.0pt;\">Assertion is false, but Reason is true.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Assertion: Peristalsis always moves from the oral end to the anal end of the gastrointestinal tract.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Reason: The contraction segment of peristalsis is mediated by nitric oxide and vasoactive intestinal peptide (VIP).</span></p>",
      "unique_key": "Q7666239",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Assertion is true, but Reason is false.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Assertion: Peristalsis always moves from the oral end to the anal end of the gastrointestinal tract.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This statement is <strong>true</strong>. Peristalsis is a coordinated, rhythmic contraction and relaxation of smooth muscle in the gastrointestinal tract that propels food and other materials forward. The movement is unidirectional, from the oral end to the anal end, ensuring the proper progression of digestive contents.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Reason: The contraction segment of peristalsis is mediated by nitric oxide and vasoactive intestinal peptide (VIP).</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><p><span style=\"font-size:14.0pt;\">This statement is <strong>false</strong>. Nitric oxide (NO) and vasoactive intestinal peptide (VIP) are responsible for <strong>relaxation</strong> in the relaxation segment of peristalsis. These neurotransmitters help reduce muscle tone to allow the bolus to pass.</span></p><p>&nbsp;</p></li><li><span style=\"font-size:14.0pt;\">The <strong>contraction segment</strong> of peristalsis is mediated by <strong>acetylcholine (ACh)</strong> and <strong>substance P</strong>, which cause localized contraction of the smooth muscles behind the bolus to push it forward.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The contraction segment of peristalsis is mediated by acetylcholine and substance P, while nitric oxide and VIP mediate the relaxation segment.</span></p>",
      "correct_choice_id": 287855,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72086,
      "choices": [
        {
          "id": 287345,
          "text": "<p><span style=\"font-size:14.0pt;\">Bilateral cataracts and sensorineural hearing loss</span></p>"
        },
        {
          "id": 287346,
          "text": "<p><span style=\"font-size:14.0pt;\">Ventricular septal defect and single umbilical artery</span></p>"
        },
        {
          "id": 287347,
          "text": "<p><span style=\"font-size:14.0pt;\">Coarctation of the aorta and choanal atresia</span></p>"
        },
        {
          "id": 287348,
          "text": "<p><span style=\"font-size:14.0pt;\">Unilateral cataract and craniosynostosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A neonate is diagnosed with congenital rubella syndrome. Which of the following features are most likely present?&nbsp;</span></p>",
      "unique_key": "Q2956545",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) Bilateral cataracts and sensorineural hearing loss</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Congenital rubella syndrome commonly presents with the triad of bilateral cataracts, sensorineural hearing loss, and PDA.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Ventricular septal defect and single umbilical artery:</strong> VSD is less common than PDA, and single umbilical artery is not associated with rubella.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Coarctation of the aorta and choanal atresia:</strong> Coarctation of the aorta and choanal atresia are unrelated to rubella.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Unilateral cataract and craniosynostosis:</strong> Cataracts in rubella are bilateral, not unilateral.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Congenital rubella syndrome is characterized by bilateral cataracts, sensorineural hearing loss, and PDA.</span></li></ul>",
      "correct_choice_id": 287345,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72479,
      "choices": [
        {
          "id": 288905,
          "text": "<p><span style=\"font-size:14.0pt;\">Lead</span></p>"
        },
        {
          "id": 288906,
          "text": "<p><span style=\"font-size:14.0pt;\">Iron</span></p>"
        },
        {
          "id": 288907,
          "text": "<p><span style=\"font-size:14.0pt;\">Phosphorus</span></p>"
        },
        {
          "id": 288908,
          "text": "<p><span style=\"font-size:14.0pt;\">Arsenic</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following toxins is most likely to cause luminescent stools that may appear yellowish or greenish due to phosphorescence?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6330517",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Phosphorus</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Phosphorus poisoning leads to yellowish-green luminescent stools due to its phosphorescent nature.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Lead</strong>: Lead poisoning → Causes constipation, dark stools, and bluish gum lines.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Iron</strong>: Iron poisoning → Causes black or dark green stools due to iron sulfide formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Arsenic</strong>: Arsenic poisoning → Causes greenish or blackish stools but does not glow.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-21%20174337.jpg\" width=\"746\" height=\"745\"></strong></span></p>",
      "correct_choice_id": 288907,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72079,
      "choices": [
        {
          "id": 287317,
          "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-D, 3-C, 4-A</span></p>"
        },
        {
          "id": 287318,
          "text": "<p><span style=\"font-size:14.0pt;\">1-C, 2-A, 3-D, 4-B</span></p>"
        },
        {
          "id": 287319,
          "text": "<p><span style=\"font-size:14.0pt;\">1-D, 2-B, 3-A, 4-C</span></p>"
        },
        {
          "id": 287320,
          "text": "<p><span style=\"font-size:14.0pt;\">1-A, 2-C, 3-B, 4-D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the Following:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column A (Conditions):</span></p><ol><li><span style=\"font-size:14.0pt;\">Duchenne Muscular Dystrophy (DMD)</span></li><li><span style=\"font-size:14.0pt;\">Down Syndrome</span></li><li><span style=\"font-size:14.0pt;\">Fragile X Syndrome</span></li><li><span style=\"font-size:14.0pt;\">Congenital Rubella Syndrome</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column B (Key Features):</span></p><ol style=\"list-style-type:upper-latin;\"><li><span style=\"font-size:14.0pt;\">Continuous machinery murmur due to patent ductus arteriosus</span></li><li><span style=\"font-size:14.0pt;\">Gower’s sign and pseudohypertrophy of calf muscles.</span></li><li><span style=\"font-size:14.0pt;\">Intellectual disability, large ears, and prominent square jaw.</span></li><li><span style=\"font-size:14.0pt;\">Intellectual disability, flat facial profile, and single palmar crease.</span></li></ol>",
      "unique_key": "Q1872766",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) 1-B, 2-D, 3-C, 4-A</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>1-B (Duchenne Muscular Dystrophy):</strong> Hallmarked by Gower’s sign and pseudohypertrophy of calf muscles due to dystrophin deletion.</span></li><li><span style=\"font-size:14.0pt;\"><strong>2-D (Down Syndrome):</strong> Flat facial profile, single palmar crease, and intellectual disability are key features.</span></li><li><span style=\"font-size:14.0pt;\"><strong>3-C (Fragile X Syndrome):</strong> Intellectual disability with prominent jaw and large ears.</span></li><li><p><span style=\"font-size:14.0pt;\"><strong>4-A (Congenital Rubella Syndrome):</strong> PDA causes a continuous machinery murmur.</span></p><p>&nbsp;</p></li></ul><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">(Duchenne Muscular Dystrophy): Hallmarked by Gower’s sign and pseudohypertrophy of calf muscles due to dystrophin deletion.</span></li><li><span style=\"font-size:14.0pt;\">(Down Syndrome): Flat facial profile, single palmar crease, and intellectual disability are key features.</span></li><li><span style=\"font-size:14.0pt;\">(Fragile X Syndrome): Intellectual disability with prominent jaw and large ears.</span></li><li><span style=\"font-size:14.0pt;\">(Congenital Rubella Syndrome): PDA causes a continuous machinery murmur.</span></li></ul>",
      "correct_choice_id": 287317,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72075,
      "choices": [
        {
          "id": 287301,
          "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-D, 3-A, 4-C</span></p>"
        },
        {
          "id": 287302,
          "text": "<p><span style=\"font-size:14.0pt;\">1-A, 2-B, 3-D, 4-C</span></p>"
        },
        {
          "id": 287303,
          "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-A, 3-C, 4-D&nbsp;</span></p>"
        },
        {
          "id": 287304,
          "text": "<p><span style=\"font-size:14.0pt;\">1-C, 2-D, 3-B, 4-A</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the following causes of antepartum hemorrhage with their clinical features:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-19%20175942.jpg\" width=\"1172\" height=\"394\"></span></p>",
      "unique_key": "Q8886521",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;C) 1-B, 2-A, 3-C, 4-D</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>1-B. Placenta previa:</strong> Placenta previa typically causes painless bleeding due to placental implantation near the cervical os.</span></li><li><span style=\"font-size:14.0pt;\"><strong>2-A. Abruptio placentae:</strong> Painful bleeding is a hallmark of placental abruption due to separation of the placenta from the uterine wall.</span></li><li><span style=\"font-size:14.0pt;\"><strong>3-C. Uterine rupture:</strong> Fetal bradycardia and maternal shock are key findings in uterine rupture.</span></li><li><span style=\"font-size:14.0pt;\"><strong>4-D. Vasa previa:</strong> Vaginal bleeding after membrane rupture, with fetal blood loss, is characteristic of vasa previa.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Placenta previa: Placenta previa typically causes painless bleeding due to placental implantation near the cervical os.</span></li><li><span style=\"font-size:14.0pt;\">Abruptio placentae: Painful bleeding is a hallmark of placental abruption due to separation of the placenta from the uterine wall.</span></li><li><span style=\"font-size:14.0pt;\">Uterine rupture: Fetal bradycardia and maternal shock are key findings in uterine rupture.</span></li><li><span style=\"font-size:14.0pt;\">Vasa previa: Vaginal bleeding after membrane rupture, with fetal blood loss, is characteristic of vasa previa.</span></li></ul>",
      "correct_choice_id": 287303,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72478,
      "choices": [
        {
          "id": 288901,
          "text": "<p><span style=\"font-size:14.0pt;\">100,000 bacteria per ml (cfu/ml)</span></p>"
        },
        {
          "id": 288902,
          "text": "<p><span style=\"font-size:14.0pt;\">30,000 bacteria per ml(cfu/ml)&nbsp;</span></p>"
        },
        {
          "id": 288903,
          "text": "<p><span style=\"font-size:14.0pt;\">1,000 bacteria per ml(cfu/ml)</span></p>"
        },
        {
          "id": 288904,
          "text": "<p><span style=\"font-size:14.0pt;\">10,000 bacteria per ml(cfu/ml)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In a research setting, you are asked to measure the adequacy of pasteurization in milk. You use the Standard Plate Count method to determine the bacterial load. What is the maximum bacterial count permissible in pasteurized milk according to the regulatory standards?</span></p>",
      "unique_key": "Q6692706",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) 30,000 bacteria per ml(cfu/ml)</strong></span><br><br>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The Standard Plate Count method measures the total bacterial count in milk, and the regulatory standard for pasteurized milk is that the bacterial count should not exceed 30,000 bacteria per ml(cfu/ml).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This ensures that pasteurization is effective in reducing the microbial load.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_f0QPgeb.png\" width=\"1300\" height=\"638\"></strong></span></p>",
      "correct_choice_id": 288902,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72443,
      "choices": [
        {
          "id": 288765,
          "text": "<p><span style=\"font-size:14.0pt;\">The size of the lesion</span></p>"
        },
        {
          "id": 288766,
          "text": "<p><span style=\"font-size:14.0pt;\">The location of the lesion</span></p>"
        },
        {
          "id": 288767,
          "text": "<p><span style=\"font-size:14.0pt;\">The angle formed between the lesion and the chest wall</span></p>"
        },
        {
          "id": 288768,
          "text": "<p><span style=\"font-size:14.0pt;\">The density of the lesion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which radiological feature best differentiates a pleural lesion from a parenchymal lesion on a chest X-ray?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3664552",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) The angle formed between the lesion and the chest wall</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Pleural lesions form an obtuse angle with the chest wall, while parenchymal lesions form an acute angle.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This distinction is key for differentiating between the two on a chest X-ray.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. The size of the lesion</strong>: Size alone cannot definitively differentiate pleural from parenchymal lesions.</span><br><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. The location of the lesion:</strong> The location of the lesion is not the primary factor in differentiation.</span><br><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. The density of the lesion:</strong> The density of the lesion may vary, but the angle formed with the chest wall is the distinguishing feature.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Pleural lesions create an obtuse angle with the chest wall, while parenchymal lesions form an acute angle.</span></li></ul>",
      "correct_choice_id": 288767,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72458,
      "choices": [
        {
          "id": 288821,
          "text": "<p><span style=\"font-size:14.0pt;\">The overlapping confidence intervals indicate that the differences in survival between the two groups are statistically significant.</span></p>"
        },
        {
          "id": 288822,
          "text": "<p><span style=\"font-size:14.0pt;\">The overlapping confidence intervals suggest that there is a high degree of uncertainty about the true survival estimates for both groups.</span></p>"
        },
        {
          "id": 288823,
          "text": "<p><span style=\"font-size:14.0pt;\">The log-rank test should be used to determine if the observed overlap in the confidence intervals is significant.</span></p>"
        },
        {
          "id": 288824,
          "text": "<p><span style=\"font-size:14.0pt;\">The study results suggest that the Kaplan-Meier estimator is not appropriate for this type of analysis.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In a study examining the effect of two interventions on patient survival, the Kaplan-Meier survival curve is plotted for both groups. The curves show similar trends, but confidence intervals around the survival curves overlap significantly throughout the study period. Which of the following statements is most accurate regarding these findings?&nbsp;</span></p>",
      "unique_key": "Q2812855",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) The overlapping confidence intervals suggest that there is a</strong> <strong>high degree of uncertainty</strong> <strong>about the true survival estimates for both groups.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">When the confidence intervals around Kaplan-Meier survival curves overlap significantly, it indicates that there is substantial uncertainty regarding the differences in survival between the two groups.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This overlap suggests that no clear evidence supports one treatment being superior to the other, as the true survival functions for both groups may be very similar.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>The overlapping confidence intervals indicate that the differences in survival between the two groups are statistically significant:&nbsp; </strong>Overlapping confidence intervals typically indicate lack of statistical significance and should be interpreted with caution, not as evidence of significance.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>The log-rank test should be used to determine if the observed overlap in the confidence intervals is significant:</strong> While the log-rank test can assess survival differences, the overlap of confidence intervals itself does not directly indicate a need for the test; it simply reflects uncertainty.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>The study results suggest that the Kaplan-Meier estimator is not appropriate for this type of analysis:</strong> The Kaplan-Meier estimator is appropriate for survival analysis and provides valuable insight even in the presence of overlapping confidence intervals.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Overlapping confidence intervals around Kaplan-Meier survival curves indicate uncertainty about survival differences between groups and suggest the need for further statistical testing.</span></li></ul>",
      "correct_choice_id": 288822,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72104,
      "choices": [
        {
          "id": 287417,
          "text": "<p><span style=\"font-size:14.0pt;\">1-C, 2-B, 3-A, 4-D</span></p>"
        },
        {
          "id": 287418,
          "text": "<p><span style=\"font-size:14.0pt;\">1-A, 2-D, 3-C, 4-B</span></p>"
        },
        {
          "id": 287419,
          "text": "<p><span style=\"font-size:14.0pt;\">1-D, 2-C, 3-A, 4-B</span></p>"
        },
        {
          "id": 287420,
          "text": "<p><span style=\"font-size:14.0pt;\">1-C, 2-D, 3-B, 4-A</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the modifications for intubation with the respective clinical situations:<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-20%20142842.jpg\" width=\"1392\" height=\"479\"></strong></span></p>",
      "unique_key": "Q9476703",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) 1-C, 2-B, 3-A, 4-D</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1-C:</strong> Nasal intubation is preferred in oral cancer surgery</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>2-B:</strong> The prone position is used for intubation in spine surgeries.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3-A:</strong> RAMP position helps obese patients by improving alignment of the pharyngeal-laryngeal axis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4-D:</strong> MILS is used for airway management in trauma patients with cervical spine injuries.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:14.0pt;\">Nasal intubation is preferred in oral cancer surgery</span></li><li><span style=\"color:black;font-size:14.0pt;\">The prone position is used for intubation in spine surgeries.</span></li><li><span style=\"color:black;font-size:14.0pt;\">RAMP position helps obese patients by improving alignment of the pharyngeal-laryngeal axis.</span></li><li><span style=\"color:black;font-size:14.0pt;\">MILS is used for airway management in trauma patients with cervical spine injuries.</span></li></ul>",
      "correct_choice_id": 287417,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72181,
      "choices": [
        {
          "id": 287725,
          "text": "<p><span style=\"font-size:14.0pt;\">Spiculated&nbsp;</span></p>"
        },
        {
          "id": 287726,
          "text": "<p><span style=\"font-size:14.0pt;\">Laminated</span></p>"
        },
        {
          "id": 287727,
          "text": "<p><span style=\"font-size:14.0pt;\">Thick and irregular&nbsp;</span></p>"
        },
        {
          "id": 287728,
          "text": "<p><span style=\"font-size:14.0pt;\">Interrupted</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is not an aggressive periosteal reaction?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6858331",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Thick and irregular</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The inner cambium layer of periosteum responds to localized insult or injury by forming a new layer of bone along the surface of the underlying cortex; this new bone formation is called <strong>periosteal reaction</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Such periosteal reaction can be divided into <strong>aggressive </strong>and <strong>non-aggressive&nbsp;</strong>reaction or <strong>no reaction</strong> at all.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Non-aggressive</strong> reactions are thin, solid, thick and irregular.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Aggressive</strong> reactions are spiculated, laminated, hair-on-end, sun burst, disorganised, interrupted and Codman’s triangle.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-20%20162715.jpg\" width=\"465\" height=\"267\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Spiculated:&nbsp;</strong>Spiculated periosteal reactions are <strong>aggressive</strong> reactions, commonly seen in malignant lesions like osteosarcoma as sunray appearance.<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-20%20162733.jpg\" width=\"435\" height=\"343\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Laminated:&nbsp;</strong>Lamellated are <strong>aggressive</strong> reactions that are seen in malignant or chronic lesions like chronic osteomyelitis, ewing’s sarcoma as onion peel appearance.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-20%20162750_kjk13zD.jpg\" width=\"442\" height=\"286\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Interrupted:&nbsp;</strong>Interrupted type of periosteal reaction is seen when the periosteum cannot produce new bone as fast as the growth of the lesion.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">These categories are not synonymous with benign and malignant, as there are benign entities capable of inducing aggressive periosteal reaction (e.g., infection and Langerhans cell histiocytosis) and numerous malignant entities that more commonly manifest with either non-aggressive periosteal.</span></li></ul>",
      "correct_choice_id": 287727,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72200,
      "choices": [
        {
          "id": 287801,
          "text": "<p><span style=\"font-size:14.0pt;\">7</span></p>"
        },
        {
          "id": 287802,
          "text": "<p><span style=\"font-size:14.0pt;\">6</span></p>"
        },
        {
          "id": 287803,
          "text": "<p><span style=\"font-size:14.0pt;\">8</span></p>"
        },
        {
          "id": 287804,
          "text": "<p><span style=\"font-size:14.0pt;\">5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Calculate the GCS-P score of a patient brought into the ER with history of fall from a motorcycle. He is just making incomprehensible sounds, has a completely flexed posture and only opens his eyes to knuckle pressure. On examination, right pupil is unreactive to light?</span></p><p>&nbsp;</p>",
      "unique_key": "Q1579090",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 6</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">To calculate the GCS-P (Glasgow Coma Scale-Pupils) score for the patient, we will assess the eye, verbal, and motor responses, and then adjust for pupil reactivity.</span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\"><strong>Eye response</strong>: The patient opens eyes to knuckle pressure (pain), which scores a 2.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Verbal response:&nbsp;</strong>The patient is making incomprehensible sounds, which scores a 2.</span></li><li><p><span style=\"font-size:14.0pt;\"><strong>Motor response</strong>: The patient has a completely flexed posture, which is consistent with decorticate posturing, which scores a 3.</span></p><p>&nbsp;</p></li></ol></li></ul><p><span style=\"font-size:14.0pt;\"><strong>Adding these together</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Eye&nbsp;Response + Verbal&nbsp;Response + Motor&nbsp;Response=2+2+3=7</span></p><p><span style=\"font-size:14.0pt;\">Now, for the pupillary response:</span></p><p><span style=\"font-size:14.0pt;\">One pupil is unreactive to light, which subtracts 1 from the GCS score.</span></p><p><span style=\"font-size:14.0pt;\">GCS&nbsp;Score−Pupillary&nbsp;Score=7−1=6</span></p><p><span style=\"font-size:14.0pt;\">The final GCS-P score is 6.</span></p><p><span style=\"font-size:14.0pt;\">The correct answer is <strong>B. 6.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The Glasgow Coma Scale-Pupils (GCS-P) is an extension of the GCS that includes the assessment of pupillary light response.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is used to evaluate the severity of brain injuries.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The GCS-P score is derived by subtracting the pupillary score from the GCS score, providing a more comprehensive assessment of the patient's neurological status.</span></li></ul>",
      "correct_choice_id": 287802,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72492,
      "choices": [
        {
          "id": 288957,
          "text": "<p><span style=\"font-size:14.0pt;\">Gastrodiscoides hominis</span></p>"
        },
        {
          "id": 288958,
          "text": "<p><span style=\"font-size:14.0pt;\">Opistorchus viverrini</span></p>"
        },
        {
          "id": 288959,
          "text": "<p><span style=\"font-size:14.0pt;\">Fasciola gigantica</span></p>"
        },
        {
          "id": 288960,
          "text": "<p><span style=\"font-size:14.0pt;\">Ancylostoma caninum</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old male farmer develops symptoms of jaundice and abdominal pain after drinking water from a contaminated river. Stool examination reveals operculated eggs measuring 150 μm x 60–70 μm. Which of the following parasites is most likely the cause of this patient’s condition?&nbsp;</span></p>",
      "unique_key": "Q4377201",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A)</strong> <strong>Gastrodiscoides hominis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The presence of <strong>operculated eggs measuring 150 μm x 60–70 μm</strong> is characteristic of <strong>Gastrodiscoides hominis</strong>, which is typically transmitted through <strong>contaminated water</strong> or <strong>food</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This parasite can lead to symptoms such as <strong>abdominal pain</strong> and <strong>jaundice</strong> when it affects the liver.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Opistorchus viverrini</strong>: This parasite’s eggs are also operculated but are <strong>smaller</strong>, measuring <strong>27 μm x 15 μm</strong>, not the larger size observed here.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option C. Fasciola gigantica</strong>: This parasite produces <strong>much larger eggs</strong>, exceeding <strong>100 microns</strong> in length, unlike the eggs in this case.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option D. Ancylostoma caninum</strong>: This parasite does not produce <strong>eggs in human stool</strong>, and it causes <strong>cutaneous larva migrans</strong>, not gastrointestinal symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-21%20180913.jpg\" width=\"1082\" height=\"426\"></strong></span><br><br>&nbsp;</p>",
      "correct_choice_id": 288957,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72534,
      "choices": [
        {
          "id": 289125,
          "text": "<p><span style=\"font-size:14.0pt;\">Basal ganglia</span></p>"
        },
        {
          "id": 289126,
          "text": "<p><span style=\"font-size:14.0pt;\">Thalamus</span></p>"
        },
        {
          "id": 289127,
          "text": "<p><span style=\"font-size:14.0pt;\">Cerebellum</span></p>"
        },
        {
          "id": 289128,
          "text": "<p><span style=\"font-size:14.0pt;\">Occipital lobe&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 66-year-old man, Mr. Ramesh from Delhi, presents to the emergency department with sudden onset confusion and altered mental status. Earlier in the day, he complained of a severe headache and was later found disoriented. He has a history of poorly controlled hypertension but no prior strokes. On examination, his blood pressure is 210/110 mmHg, and he is lethargic but arousable. Neurological exam reveals right-sided hemiparesis. A non-contrast CT scan of the brain shown below.<strong>&nbsp;</strong>Which of the following is not a common site for hypertensive intracerebral hemorrhage?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-24%20121656.jpg\" width=\"402\" height=\"501\"></strong></span></p>",
      "unique_key": "Q9720470",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>D) Occipital lobe</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Hypertensive intracerebral hemorrhages commonly occur in deep brain structures due to chronic small vessel damage (lipohyalinosis and microaneurysm formation).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>basal ganglia</strong>, <strong>thalamus</strong>, <strong>cerebellum</strong>, and <strong>pons</strong> are the most frequent sites.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The occipital lobe, being part of the cerebral cortex, is rarely involved in hypertensive bleeds and is more commonly associated with lobar hemorrhages due to cerebral amyloid angiopathy in elderly patients.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Basal ganglia:</strong> The most common site for hypertensive hemorrhages, especially the putamen.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Thalamus:</strong> Another frequent site due to its rich small vessel network vulnerable to hypertensive damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Cerebellum:</strong> Though less common, cerebellar hemorrhages are seen in hypertension and can cause life-threatening brainstem compression.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Hypertensive intracerebral hemorrhages typically affect deep brain structures like the basal ganglia, thalamus, pons, and cerebellum.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Lobar regions, such as the occipital lobe, are uncommon sites and suggest alternative etiologies like amyloid angiopathy.</span></li></ul>",
      "correct_choice_id": 289128,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72204,
      "choices": [
        {
          "id": 287817,
          "text": "<p><span style=\"font-size:14.0pt;\">Boari flap</span></p>"
        },
        {
          "id": 287818,
          "text": "<p><span style=\"font-size:14.0pt;\">End to end anastomosis</span></p>"
        },
        {
          "id": 287819,
          "text": "<p><span style=\"font-size:14.0pt;\">Nesbitt procedure</span></p>"
        },
        {
          "id": 287820,
          "text": "<p><span style=\"font-size:14.0pt;\">Uretero-ureterostomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Following penetrating trauma to abdomen, urinary leak from left ureter was noted. Which of these is not a technique of ureteric reconstruction?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8464937",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Nesbitt procedure</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">It is used for correction of penile chordee, not for ureteric injuries.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Boari flap</strong>: A Boari flap is a surgical technique used to reconstruct the ureter when there is a longer segment loss, particularly in the pelvic ureter. It involves mobilizing the bladder and creating a flap from its wall to lengthen and reposition the ureter, allowing for a tension-free anastomosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. End to end anastomosis</strong>: End-to-end anastomosis involves directly connecting the two ends of the severed ureter to restore continuity. While it may be suitable for shorter segment losses or partial transections, it may not be feasible for cases involving major loss of ureteric length.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Uretero-ureterostomy</strong>: Uretero-ureterostomy involves surgically connecting the injured ureter to the contralateral healthy ureter. This technique is particularly useful for managing major loss of ureteric length following penetrating trauma to the abdomen, providing a viable option for restoring urinary flow without the need for complex reconstructive procedures.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In cases of partial transection, primary repair over a DJ stent may be performed.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A tension-free spatulated ureteric anastomosis using fine absorbable sutures can be done for short segment loss.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This is usually done in upper ureteric injuries.&nbsp;</span></li></ul>",
      "correct_choice_id": 287819,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72552,
      "choices": [
        {
          "id": 289197,
          "text": "<p><span style=\"font-size:14.0pt;\">Positive angle kappa</span></p>"
        },
        {
          "id": 289198,
          "text": "<p><span style=\"font-size:14.0pt;\">Telecanthus</span></p>"
        },
        {
          "id": 289199,
          "text": "<p><span style=\"font-size:14.0pt;\">Wide inter-pupillary distance</span></p>"
        },
        {
          "id": 289200,
          "text": "<p><span style=\"font-size:14.0pt;\">Eurblepharon</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 4-year-old child is brought to the clinic for a routine eye examination. The child appears to have an esotropic appearance, but there is no true misalignment of the eyes. The examiner suspects pseudostrabismus. Which of the following factors can contribute to the appearance of pseudostrabismus?&nbsp;</span></p>",
      "unique_key": "Q8127825",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Telecanthus</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Telecanthus, which refers to an increased distance between the medial canthi of the eyes, can make the eyes appear misaligned, leading to pseudostrabismus (an apparent squint without actual ocular misalignment).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This condition is often seen in children, and it is important to distinguish it from true strabismus.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-24%20122324.jpg\" width=\"834\" height=\"549\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Positive angle kappa</strong>: A positive angle kappa is a condition where the reflection of light from the cornea is displaced nasally, which can create the appearance of strabismus, but it does not directly lead to pseudostrabismus.</span><br><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Wide inter-pupillary distance</strong>: A wide inter-pupillary distance may cause a slight appearance of misalignment, but it is not a common cause of pseudostrabismus.</span><br><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Eurblepharon</strong>: This refers to a wide palpebral fissure, often associated with eyelid anomalies, but it does not directly contribute to pseudostrabismus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Telecanthus can lead to pseudostrabismus by creating the appearance of misalignment between the eyes due to an increased distance between the medial canthi.</span></li></ul>",
      "correct_choice_id": 289198,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72515,
      "choices": [
        {
          "id": 289049,
          "text": "<p><span style=\"font-size:14.0pt;\">By decreasing lower esophageal sphincter tone.</span></p>"
        },
        {
          "id": 289050,
          "text": "<p><span style=\"font-size:14.0pt;\">By stimulating chloride channels in the gut.</span></p>"
        },
        {
          "id": 289051,
          "text": "<p><span style=\"font-size:14.0pt;\">By activating 5-HT4 receptors to enhance acetylcholine release.</span></p>"
        },
        {
          "id": 289052,
          "text": "<p><span style=\"font-size:14.0pt;\">By inhibiting dopamine receptors in the enteric nervous system.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 47-year-old male with a history of chronic constipation is started on Prucalopride. What is the primary mechanism by which Prucalopride improves symptoms in this patient?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6740675",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) By activating 5-HT4 receptors to enhance acetylcholine release</strong>.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Prucalopride exerts its prokinetic effects through the selective activation of 5-HT4 receptors on enteric neurons, which leads to an increased release of acetylcholine.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This neurotransmitter plays a crucial role in enhancing colonic motility and promoting the propulsive contractions necessary for improving bowel movements in patients with chronic constipation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>By decreasing lower esophageal sphincter tone:</strong> Incorrect as Prucalopride does not specifically target lower esophageal sphincter tone.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>By stimulating chloride channels in the gut:</strong> Incorrect because it does not primarily act through stimulation of chloride channels.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>By inhibiting dopamine receptors in the enteric nervous system:</strong> Incorrect as the drug’s mechanism does not involve inhibition of dopamine receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Identify the action of Prucalopride in enhancing gastrointestinal motility through the specific activation of 5-HT4 receptors and the subsequent increase in acetylcholine release.</span></li></ul>",
      "correct_choice_id": 289051,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72448,
      "choices": [
        {
          "id": 288781,
          "text": "<p><span style=\"font-size:14.0pt;\">TTF1 positive, CK7 positive, CK20 negative, napsin A positive</span></p>"
        },
        {
          "id": 288782,
          "text": "<p><span style=\"font-size:14.0pt;\">TTF1 positive, CK7 positive, CK20 positive, GATA3 positive</span></p>"
        },
        {
          "id": 288783,
          "text": "<p><span style=\"font-size:14.0pt;\">CK20 positive, CK7 negative, TTF-1 negative&nbsp;</span></p>"
        },
        {
          "id": 288784,
          "text": "<p><span style=\"font-size:14.0pt;\">TTF1 positive, EMA positive, GFAP positive</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old woman with a 40-pack-year smoking history presents with unintentional weight loss and altered consciousness.&nbsp;CT scan revealed a single big lesion and multiple small lesions in the brain.&nbsp;A biopsy was taken from the brain lesion.&nbsp;Which of the following indicates a&nbsp;metastatic urothelial tumor in the patient?&nbsp;</span></p>",
      "unique_key": "Q8261763",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B)&nbsp;TTF1 positive, CK7 positive, CK20 positive, GATA3 positive</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This 65-year-old woman with a heavy smoking history presents with&nbsp;a single big lesion and multiple small lesions in the brain, suggesting a metastatic malignancy rather than a primary brain tumor.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This IHC profile (<strong>TTF-1+, CK7+, CK20+, GATA3+</strong>) is characteristic of <strong>metastatic urothelial carcinoma</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>TTF1 positive, CK7 positive, CK20 negative, napsin A positive: TTF-1 and napsin A positivity</strong> suggest a <strong>primary lung adenocarcinoma</strong>, not urothelial carcinoma. <strong>CK20 negative</strong> further argues against urothelial carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong>&nbsp;<strong>CK20 positive, CK7 negative, TTF-1 negative: CK20+, CK7−, TTF-1− is highly suggestive of metastatic colorectal carcinoma</strong>, not urothelial carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>TTF1 positive, EMA positive, GFAP positive: GFAP positivity</strong> is seen in <strong>primary central nervous system tumors</strong> (e.g., <strong>ependymoma, glioblastoma</strong>), not metastatic urothelial carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective</strong>:</span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">IHC profile with <strong>TTF-1+, CK7+, CK20+, GATA3+</strong> is characteristic of <strong>metastatic urothelial carcinoma</strong>&nbsp;</span></li></ul>",
      "correct_choice_id": 288782,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72449,
      "choices": [
        {
          "id": 288785,
          "text": "<p><span style=\"font-size:14.0pt;\">TRALI</span></p>"
        },
        {
          "id": 288786,
          "text": "<p><span style=\"font-size:14.0pt;\">TACO</span></p>"
        },
        {
          "id": 288787,
          "text": "<p><span style=\"font-size:14.0pt;\">Aspiration pneumonia</span></p>"
        },
        {
          "id": 288788,
          "text": "<p><span style=\"font-size:14.0pt;\">Pulmonary embolism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 72-year-old patient with a history of coronary artery disease presents after receiving a blood transfusion. He develops dyspnea and hypoxia within hours, but his chest X-ray reveals no vascular congestion or pleural effusion. His BNP levels are low, and his Pulmonary Artery Occlusion Pressure (PAOP) is also low. Which of the following is the most likely diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2033175",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) TRALI</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The combination of low BNP, low PAOP, no vascular congestion, and no pleural effusion on chest X-ray suggests Transfusion-Related Acute Lung Injury (TRALI).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">TRALI is caused by a transfusion reaction leading to acute respiratory distress, and the lack of pleural effusion and low BNP levels are key diagnostic features.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">TRALI typically presents with hypoxia and respiratory distress within hours of transfusion.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. TACO:</strong> TACO would show elevated BNP, elevated PAOP, and pleural effusion on chest X-ray, which is not seen in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Aspiration pneumonia</strong>: Aspiration pneumonia would show consolidation on chest X-ray, not normal lung fields and no vascular congestion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Pulmonary embolism</strong>: PE would present with sudden-onset dyspnea and might show a normal chest X-ray or small pleural effusions, but would not be associated with low BNP levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">TRALI presents with low BNP, low Pulmonary Artery Occlusion Pressure, no vascular congestion, and no pleural effusion, distinguishing it from TACO, aspiration pneumonia, and pulmonary embolism.</span></li></ul>",
      "correct_choice_id": 288785,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72093,
      "choices": [
        {
          "id": 287373,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3 only</span></p>"
        },
        {
          "id": 287374,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3 and 4 only</span></p>"
        },
        {
          "id": 287375,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3 and 4 only</span></p>"
        },
        {
          "id": 287376,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 4 only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding the derivatives of the septum transversum and dorsal mesogastrium are correct?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">The gastro-splenic ligament is a derivative of the dorsal mesogastrium.</span></li><li><span style=\"font-size:14.0pt;\">The central tendon of the diaphragm arises from the septum transversum.</span></li><li><span style=\"font-size:14.0pt;\">The lesser omentum is a derivative of the ventral mesogastrium.</span></li><li><span style=\"font-size:14.0pt;\">The ligaments of the liver, including the falciform, triangular, and coronary ligaments, arise from the dorsal mesogastrium.</span></li></ol>",
      "unique_key": "Q5841963",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) 1, 2 and 3 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1. The gastro-splenic ligament is a derivative of the dorsal mesogastrium:</strong> This is correct. The dorsal mesogastrium gives rise to several structures, including the gastro-splenic ligament.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2. The central tendon of the diaphragm arises from the septum transversum:</strong> This is correct. The septum transversum plays a major role in forming the central tendon of the diaphragm.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3. The lesser omentum is a derivative of the ventral mesogastrium:</strong> This is correct. The ventral mesogastrium gives rise to the lesser omentum as well as other ligaments like the falciform ligament.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4. The ligaments of the liver, including the falciform, triangular, and coronary ligaments, arise from the dorsal mesogastrium:</strong> This is incorrect. These ligaments arise from the ventral mesogastrium, which originates from the septum transversum.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-19%20181902.jpg\" width=\"1004\" height=\"340\"></strong></span></p>",
      "correct_choice_id": 287373,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72474,
      "choices": [
        {
          "id": 288885,
          "text": "<p><span style=\"font-size:14.0pt;\">Image A</span></p>"
        },
        {
          "id": 288886,
          "text": "<p><span style=\"font-size:14.0pt;\">Image B</span></p>"
        },
        {
          "id": 288887,
          "text": "<p><span style=\"font-size:14.0pt;\">Both plants are equally toxic</span></p>"
        },
        {
          "id": 288888,
          "text": "<p><span style=\"font-size:14.0pt;\">Neither plant is toxic</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Based on the images, which plant is more commonly associated with cardiotoxic effects?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-21%20174239.jpg\" width=\"711\" height=\"334\"></strong></span></p>",
      "unique_key": "Q1455609",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) Image A</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>White Oleander (Image A)</strong> is a highly <strong>toxic plant</strong>. Its toxic properties are primarily due to <strong>oleandrin</strong>, a potent <strong>cardiotoxin</strong> that affects the heart, leading to <strong>fatal arrhythmias</strong> when ingested.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>White Oleander</strong> is commonly associated with <strong>serious poisoning risks</strong>, including <strong>cardiac arrest</strong>, <strong>nausea</strong>, <strong>vomiting</strong>, and <strong>hypotension</strong>.</span></li><li><span style=\"font-size:14.0pt;\">On the other hand, <strong>White Datura (Image B)</strong>, though also toxic, is primarily known for its <strong>anticholinergic effects</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The plant contains alkaloids such as <strong>scopolamine</strong> and <strong>atropine</strong>, which can cause symptoms like <strong>delirium</strong>, <strong>hallucinations</strong>, <strong>dry mouth</strong>, and <strong>dilated pupils</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">While dangerous, it is generally considered less likely to cause <strong>immediate death</strong> compared to <strong>Oleander</strong>, whose effects on the <strong>cardiovascular system</strong> are far more severe.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>White Oleander</strong> is far more <strong>toxic</strong> and associated with <strong>cardiac poisoning</strong> due to its <strong>oleandrin</strong> content.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>White Datura</strong>, though also dangerous, primarily causes <strong>anticholinergic toxicity</strong>, leading to symptoms such as <strong>delirium</strong> and <strong>hallucinations</strong>.</span></li></ul>",
      "correct_choice_id": 288885,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        10
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72521,
      "choices": [
        {
          "id": 289073,
          "text": "<p><span style=\"font-size:14.0pt;\">They can be administered in very low doses.</span></p>"
        },
        {
          "id": 289074,
          "text": "<p><span style=\"font-size:14.0pt;\">They are irreversible and highly specific to their target enzyme.</span></p>"
        },
        {
          "id": 289075,
          "text": "<p><span style=\"font-size:14.0pt;\">They have minimal side effects due to their rapid clearance from the body.</span></p>"
        },
        {
          "id": 289076,
          "text": "<p><span style=\"font-size:14.0pt;\">They enhance the natural activity of enzymes.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">What is the primary reason why suicide inhibitors are considered an effective therapeutic strategy in drug design?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1233990",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) They are irreversible and highly specific to their target enzyme</strong>.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Suicide inhibitors are particularly effective because they bind irreversibly and specifically to their target enzyme.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This specificity is due to their ability to mimic the natural substrate of the enzyme, ensuring that they selectively inactivate only the intended enzyme.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>They can be administered in very low doses:</strong> Incorrect as dosage levels depend on the drug's pharmacokinetics and desired therapeutic effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>They have minimal side effects due to their rapid clearance from the body:</strong> Incorrect because minimal side effects are not primarily due to rapid clearance but to targeted action.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>They enhance the natural activity of enzymes:</strong> Incorrect as these inhibitors do not enhance but rather inhibit enzyme activity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Recognize the therapeutic benefits of suicide inhibitors, emphasizing their irreversible and specific nature, which makes them suitable for targeting specific enzymes in disease conditions.</span></li></ul>",
      "correct_choice_id": 289074,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72142,
      "choices": [
        {
          "id": 287569,
          "text": "<p><span style=\"font-size:14.0pt;\">Prevention of hearing loss</span></p>"
        },
        {
          "id": 287570,
          "text": "<p><span style=\"font-size:14.0pt;\">Prevention of cartilage necrosis</span></p>"
        },
        {
          "id": 287571,
          "text": "<p><span style=\"font-size:14.0pt;\">Prevention of psychological distress due to peer teasing</span></p>"
        },
        {
          "id": 287572,
          "text": "<p><span style=\"font-size:14.0pt;\">Higher surgical success rates</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 6-year-old boy is brought to the clinic for a pre-surgical consultation. The parents are concerned about their child’s prominent ears. Which of the following is the primary indication for performing pinnaplasty at this age?&nbsp;</span></p>",
      "unique_key": "Q8607102",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Prevention of psychological distress due to peer teasing</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><p><span style=\"font-size:14.0pt;\">Pinnaplasty at age 6 is performed primarily to <strong>prevent psychological distress</strong>, as children become more socially aware and interactions with peers increase during school years.</span></p><p>&nbsp;</p></li></ul><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Prevention of hearing loss:</strong> Prominent ears do not lead to hearing loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Prevention of cartilage necrosis:</strong> Cartilage necrosis is not a concern in this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Higher surgical success rates:</strong> Success rates of pinnaplasty are not dependent on age.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Understand the psychosocial rationale for the timing of pinnaplasty in children with prominent ears.</span></li></ul>",
      "correct_choice_id": 287571,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72518,
      "choices": [
        {
          "id": 289061,
          "text": "<p><span style=\"font-size:14.0pt;\">It can also treat underlying anxiety that may trigger smoking.</span></p>"
        },
        {
          "id": 289062,
          "text": "<p><span style=\"font-size:14.0pt;\">It can provide immediate relief from nicotine withdrawal symptoms.</span></p>"
        },
        {
          "id": 289063,
          "text": "<p><span style=\"font-size:14.0pt;\">It has a dual action that both reduces cravings and makes smoking less satisfying.</span></p>"
        },
        {
          "id": 289064,
          "text": "<p><span style=\"font-size:14.0pt;\">It can improve lung function directly by protecting against smoke-induced damage.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A healthcare provider is considering initiating Varenicline for a patient who has failed multiple attempts at smoking cessation. What unique property of Varenicline should be emphasized to the patient as a major benefit of choosing this medication?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9607178",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) It has a dual action that both reduces cravings and makes smoking less satisfying.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Varenicline’s unique dual action as a partial agonist and an antagonist at α4β2 nicotine receptors is key to its effectiveness.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This dual action not only helps manage withdrawal symptoms by partially stimulating the receptors but also reduces the satisfaction derived from smoking by blocking nicotine’s access to these receptors.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>It can also treat underlying anxiety that may trigger smoking:</strong> Incorrect as Varenicline does not treat anxiety.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>It can provide immediate relief from nicotine withdrawal symptoms:</strong> Incorrect because the relief from withdrawal symptoms is not immediate but builds up with consistent use.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>It can improve lung function directly by protecting against smoke-induced damage:</strong> Incorrect as Varenicline does not have direct effects on lung function or protective effects against smoke-induced damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Highlight Varenicline's dual mechanism of action in reducing nicotine cravings and making smoking less rewarding, key for patient education and compliance.</span></li></ul>",
      "correct_choice_id": 289063,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72540,
      "choices": [
        {
          "id": 289149,
          "text": "<p><span style=\"font-size:14.0pt;\">Sweating</span></p>"
        },
        {
          "id": 289150,
          "text": "<p><span style=\"font-size:14.0pt;\">Nausea</span></p>"
        },
        {
          "id": 289151,
          "text": "<p><span style=\"font-size:14.0pt;\">Hypotension</span></p>"
        },
        {
          "id": 289152,
          "text": "<p><span style=\"font-size:14.0pt;\">Headache</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Mr. Ramakrishnan, an 80-year-old man from Hyderabad, is brought to the emergency department after being found unconscious in a field on a hot day. His family reports he had been working outdoors for several hours without taking adequate water breaks and became disoriented before collapsing. On arrival, he has altered mental status but no focal neurological deficits. Initial labs reveal normal electrolytes. Which of the following is least likely to be seen in this patient?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6166791",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Sweating</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This scenario is typical of <strong>classic heat stroke</strong>, often seen in elderly individuals exposed to extreme heat without proper hydration. Key features include:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Core body temperature &gt;41°C (105.8°F)</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Altered mental status</strong> or <strong>end-organ dysfunction</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Absence of sweating</strong> (<strong>anhidrosis</strong>) due to thermoregulatory failure</span></li></ul></li><li><span style=\"font-size:14.0pt;\">In <strong>classic heat stroke</strong>, sweating is usually absent, distinguishing it from <strong>heat exhaustion</strong>, where sweating persists, and core temperature is below 41°C.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Nausea:</strong> Common in heat stroke due to systemic thermoregulatory failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Hypotension:</strong> Occurs from dehydration and vasodilation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Headache:</strong> A frequent symptom in heat-related illnesses.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Classic heat stroke</strong> is marked by <strong>anhidrosis</strong> (absence of sweating) and <strong>altered mental status</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Recognizing the lack of sweating helps differentiate it from <strong>heat exhaustion</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Rapid cooling</strong> and supportive care are critical to reduce morbidity and mortality.</span></li></ul>",
      "correct_choice_id": 289149,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72208,
      "choices": [
        {
          "id": 287833,
          "text": "<p><span style=\"font-size:14.0pt;\">Laser ablation can be used for definitive treatment</span></p>"
        },
        {
          "id": 287834,
          "text": "<p><span style=\"font-size:14.0pt;\">The CEAP stage is C6</span></p>"
        },
        {
          "id": 287835,
          "text": "<p><span style=\"font-size:14.0pt;\">Both great saphenous and accessary saphenous veins are dilated</span></p>"
        },
        {
          "id": 287836,
          "text": "<p><span style=\"font-size:14.0pt;\">Fasciotomy is done as a part of Trendelenberg procedure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient presented to OPD with dilated tortuous veins in the leg on the medial aspect. Which of these is correct?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1361827",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) Laser ablation can be used for definitive treatment</strong>.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><p><span style=\"font-size:14.0pt;\">Endovenous laser ablation (EVLA) can be used in management of varicose veins with SF junction incompetence.</span></p><p>&nbsp;</p></li></ul><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. The CEAP stage is C6:</strong> The CEAP stage is C2</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Both great saphenous and accessary saphenous veins are dilated:</strong> Medially located varicosities arise from GSV. Short saphenous varicosities are present on posterior aspect of leg/calf.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Fasciotomy is done as a part of Trendelenberg procedure:</strong> Trendelenberg procedure involves flush ligation of GSV at SF junction. Fasciotomy is done in conditions like compartment syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\">EVLA is a definitive treatment of great saphenous venous incompetence.</span></p>",
      "correct_choice_id": 287833,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72556,
      "choices": [
        {
          "id": 289213,
          "text": "<p><span style=\"font-size:14.0pt;\">SRK-II formula</span></p>"
        },
        {
          "id": 289214,
          "text": "<p><span style=\"font-size:14.0pt;\">Hoffer Q formula</span></p>"
        },
        {
          "id": 289215,
          "text": "<p><span style=\"font-size:14.0pt;\">Holladay formula</span></p>"
        },
        {
          "id": 289216,
          "text": "<p><span style=\"font-size:14.0pt;\">Haigis formula</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 68-year-old male undergoes preoperative evaluation for cataract surgery. His axial length is found to be 28 mm. Which formula is most appropriate for calculating the intraocular lens (IOL) power in this patient?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4753908",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Holladay formula</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The Holladay formula is specifically tailored for eyes with an axial length greater than 26 mm, such as in this patient.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It incorporates adjustments for long axial lengths, reducing refractive error post-surgery.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>SRK-II formula:</strong> Incorrect. The SRK-II formula is outdated and not ideal for extreme axial lengths.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Hoffer Q formula:</strong> Incorrect. The Hoffer Q formula is better suited for eyes with shorter axial lengths (&lt;22 mm).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Haigis formula:</strong> Incorrect. The Haigis formula is advanced but typically requires optical biometry, not specified here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The Holladay formula is preferred for calculating IOL power in patients with long axial lengths (&gt;26 mm).</span></li></ul>",
      "correct_choice_id": 289215,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72077,
      "choices": [
        {
          "id": 287309,
          "text": "<p><span style=\"font-size:14.0pt;\">Grade 1 molding</span></p>"
        },
        {
          "id": 287310,
          "text": "<p><span style=\"font-size:14.0pt;\">Grade 2 molding</span></p>"
        },
        {
          "id": 287311,
          "text": "<p><span style=\"font-size:14.0pt;\">Grade 3+ molding</span></p>"
        },
        {
          "id": 287312,
          "text": "<p><span style=\"font-size:14.0pt;\">Cephalhematoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following best describes the condition where excessive fetal head molding causes tears in the dura mater and underlying vessels?&nbsp;</span></p>",
      "unique_key": "Q4187427",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Grade 3+ molding</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Grade 3+ molding involves excessive overlapping of the fetal skull bones, leading to tears in the dura mater and underlying vessels. This can result in severe complications during labor.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Grade 1 molding:&nbsp;</strong>Grade 1 molding is minor and involves skull bones touching without overlap.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Grade 2 molding:&nbsp;</strong>Grade 2 molding involves overlapping bones that can be separated manually and does not cause underlying tears.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Cephalhematoma:&nbsp;</strong>Cephalhematoma involves subperiosteal hemorrhage but does not involve tears in the dura mater.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Severe molding (Grade 3+) can lead to tears in the dura mater and underlying vessels, causing significant complications.</span></li></ul>",
      "correct_choice_id": 287311,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72073,
      "choices": [
        {
          "id": 287293,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3 only</span></p>"
        },
        {
          "id": 287294,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 4 only</span></p>"
        },
        {
          "id": 287295,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3 and 4 only</span></p>"
        },
        {
          "id": 287296,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3 and 4 only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding mild preeclampsia are correct?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Diastolic BP is less than 100 mmHg.</span></li><li><span style=\"font-size:14.0pt;\">Systolic BP is less than 160 mmHg.</span></li><li><span style=\"font-size:14.0pt;\">IUGR is a common feature.</span></li><li><span style=\"font-size:14.0pt;\">There are no premonitory symptoms.</span></li></ol>",
      "unique_key": "Q1329486",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) 1, 2 and 4 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statements 1 and 2:</strong> Mild preeclampsia is characterized by BP &lt;160/100 mmHg&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4:</strong> Premonitory symptoms like severe headache or visual disturbances are absent&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3:</strong> IUGR is more commonly associated with severe preeclampsia, not mild preeclampsia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Mild preeclampsia presents with controlled BP and no significant systemic involvement or fetal growth restriction.</span></li></ul>",
      "correct_choice_id": 287294,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72444,
      "choices": [
        {
          "id": 288769,
          "text": "<p><span style=\"font-size:14.0pt;\">Gastrogrffin</span></p>"
        },
        {
          "id": 288770,
          "text": "<p><span style=\"font-size:14.0pt;\">Barium sulfate</span></p>"
        },
        {
          "id": 288771,
          "text": "<p><span style=\"font-size:14.0pt;\">Iodine-based contrast</span></p>"
        },
        {
          "id": 288772,
          "text": "<p><span style=\"font-size:14.0pt;\">Iohexol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old patient presents with a history of sudden chest pain and difficulty swallowing. A contrast study reveals leakage of contrast into the mediastinum. Based on this finding, which of the following is the most appropriate contrast medium for diagnosing esophageal perforation in this patient?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7829097",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>D) Iohexol</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Iohexol is the preferred contrast medium for esophageal perforation as it is water-soluble and does not cause mediastinal inflammation, unlike barium contrast.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Barium can worsen inflammation in the mediastinum if used in esophageal perforation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Gastrogrffin:</strong> Gastrogrffin, although water-soluble, is less preferred due to the risk of aspiration and pneumonitis.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Barium sulfate:</strong> Barium sulfate is contraindicated in esophageal perforation due to its potential to cause serious complications like mediastinal inflammation.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Iodine-based contrast</strong>: Iodine-based contrast is a broad term and not specific for the condition described in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Iohexol is the standard contrast medium used in esophageal perforation due to its water-soluble nature and safety profile.</span></li></ul>",
      "correct_choice_id": 288772,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72133,
      "choices": [
        {
          "id": 287533,
          "text": "<p><span style=\"font-size:14.0pt;\">1-c, 2-d, 3-a, 4-b</span></p>"
        },
        {
          "id": 287534,
          "text": "<p><span style=\"font-size:14.0pt;\">1-c, 2-b, 3-d, 4-a</span></p>"
        },
        {
          "id": 287535,
          "text": "<p><span style=\"font-size:14.0pt;\">1-a, 2-c, 3-d, 4-b</span></p>"
        },
        {
          "id": 287536,
          "text": "<p><span style=\"font-size:14.0pt;\">1-c, 2-b, 3-a, 4-d&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the Following (Alopecia Types and Features)&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Column A:</strong></span></p><ol><li><span style=\"font-size:14.0pt;\">Patchy alopecia</span></li><li><span style=\"font-size:14.0pt;\">Diffuse alopecia</span></li><li><span style=\"font-size:14.0pt;\">Patterned alopecia</span></li><li><span style=\"font-size:14.0pt;\">Systemic alopecia</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Column B:</strong>&nbsp;</span></p><ol style=\"list-style-type:lower-latin;\"><li><span style=\"font-size:14.0pt;\">Androgenetic alopecia</span></li><li><span style=\"font-size:14.0pt;\">Telogen effluvium</span></li><li><span style=\"font-size:14.0pt;\">Autoimmune target of anagen hair</span></li><li><span style=\"font-size:14.0pt;\">Thyroid dysfunction-related hair loss</span></li></ol>",
      "unique_key": "Q2147881",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>D) 1-c, 2-b, 3-a, 4-d</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Patchy alopecia (1-c):</strong> Seen in alopecia areata, where the autoimmune attack targets anagen hair bulbs, leading to patches of complete hair loss.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Diffuse alopecia (2-b):</strong> Includes telogen effluvium, often caused by stress, pregnancy, or systemic illness.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Patterned alopecia (3-a):</strong> Typical of androgenetic alopecia, characterized by Hamilton (male) or Ludwig (female) classifications.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Systemic alopecia (4-d):</strong> Associated with systemic conditions like thyroid dysfunction or lupus.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Alopecia types have distinct patterns and etiologies, such as autoimmune (alopecia areata), stress-induced (telogen effluvium), and systemic causes (thyroid dysfunction).</span></li></ul>",
      "correct_choice_id": 287536,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        18
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72501,
      "choices": [
        {
          "id": 288993,
          "text": "<p><span style=\"font-size:14.0pt;\">Stab culture in nutrient agar</span></p>"
        },
        {
          "id": 288994,
          "text": "<p><span style=\"font-size:14.0pt;\">Lawn culture using sterile swab&nbsp;</span></p>"
        },
        {
          "id": 288995,
          "text": "<p><span style=\"font-size:14.0pt;\">Stroke culture in zigzag pattern&nbsp;</span></p>"
        },
        {
          "id": 288996,
          "text": "<p><span style=\"font-size:14.0pt;\">Liquid culture in brain-heart infusion broth</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A clinical microbiologist needs to perform antimicrobial susceptibility testing on a Staphylococcus aureus isolate from a wound infection. Which of the following culture methods would be most appropriate for this purpose?&nbsp;</span></p>",
      "unique_key": "Q3078168",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Lawn culture using sterile swab</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Lawn culture, also known as carpet culture, is the optimal method for antimicrobial susceptibility testing using the disk diffusion method.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This technique creates a uniform bacterial lawn by spreading the inoculum evenly across the entire agar surface, allowing for consistent growth and clear, measurable zones of inhibition around antibiotic disks.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The uniform distribution of bacteria is crucial for standardized susceptibility testing and accurate interpretation of results.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options</strong>:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Stab culture in nutrient agar</strong>: This method is used for maintaining stock cultures and performing specific biochemical tests. It cannot provide the uniform surface growth needed for susceptibility testing.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Stroke culture in zigzag pattern</strong>: This technique is primarily used for biochemical tests like citrate utilization or TSI. It doesn't provide the uniform bacterial distribution required for susceptibility testing.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Liquid culture in brain-heart infusion broth</strong>: While useful for blood cultures and sterility testing, liquid cultures cannot be used for disk diffusion susceptibility testing, which requires growth on a solid medium surface.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Lawn culture technique is essential for antimicrobial susceptibility testing as it provides uniform bacterial growth necessary for standardized interpretation of inhibition zones.</span></li></ul>",
      "correct_choice_id": 288994,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72081,
      "choices": [
        {
          "id": 287325,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3 are correct.</span></p>"
        },
        {
          "id": 287326,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3 and 4 are correct.</span></p>"
        },
        {
          "id": 287327,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3 and 4 are correct.</span></p>"
        },
        {
          "id": 287328,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 4 are correct.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A neonate presents with respiratory distress, ground-glass opacities on chest X-ray, and a family history of a sibling who died from a similar condition. Which of the following statements are true regarding the most likely diagnosis?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">This condition is characterized by intraalveolar accumulation of pulmonary surfactant.</span></li><li><span style=\"font-size:14.0pt;\">Surfactant replacement is the definitive treatment for this condition.</span></li><li><span style=\"font-size:14.0pt;\">Histopathological examination with PAS-positive material is diagnostic.</span></li><li><span style=\"font-size:14.0pt;\">This condition is associated with a Protein-B component deficiency in surfactant.</span></li></ol>",
      "unique_key": "Q5349794",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans</strong>. <strong>B) 1, 3 and 4 are correct</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>This condition is characterized by intraalveolar accumulation of pulmonary surfactant:&nbsp;</strong>Correct<strong>.</strong> This condition is pulmonary alveolar proteinosis, which is characterized by intraalveolar accumulation of pulmonary surfactant due to a deficiency in surfactant metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>Histopathological examination with PAS-positive material is diagnostic:&nbsp;</strong>Correct. Histopathological examination reveals granular, eosinophilic material that is PAS-positive and diastase-resistant, confirming the diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>This condition is associated with a Protein-B component deficiency in surfactant:&nbsp;</strong>Correct. The condition is associated with a deficiency of the Protein-B component of surfactant, leading to impaired absorption and distribution of surfactant.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>Surfactant replacement is the definitive treatment for this condition: Incorrect:</strong> Surfactant replacement therapy is ineffective in pulmonary alveolar proteinosis because the condition involves functional deficiency due to improper metabolism, not absolute deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective</strong>:</span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Pulmonary alveolar proteinosis presents with respiratory distress, ground-glass opacities, and a positive family history, diagnosed through histopathological evidence of PAS-positive material and associated with surfactant Protein-B deficiency.</span></li></ul>",
      "correct_choice_id": 287326,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72457,
      "choices": [
        {
          "id": 288817,
          "text": "<p><span style=\"font-size:14.0pt;\">Kupffer cells</span></p>"
        },
        {
          "id": 288818,
          "text": "<p><span style=\"font-size:14.0pt;\">Parietal cells</span></p>"
        },
        {
          "id": 288819,
          "text": "<p><span style=\"font-size:14.0pt;\">Dust cells</span></p>"
        },
        {
          "id": 288820,
          "text": "<p><span style=\"font-size:14.0pt;\">Clara cells</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 50-year-old male presents with fatigue and hepatomegaly. On biopsy, specialized macrophages in the liver are found, which are involved in the breakdown of aged red blood cells and play an essential role in the immune response. Which of the following cell types is most likely involved in this process?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2018745",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) Kupffer cells</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Kupffer cells</strong> are specialized macrophages located in the liver. They are responsible for the breakdown of aged red blood cells and play a key role in immune responses by phagocytizing pathogens and cellular debris.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This function is specific to Kupffer cells, not the other cell types.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other&nbsp;Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Parietal cells</strong>: <strong>Parietal cells</strong> are found in the stomach and are responsible for secreting hydrochloric acid, not involved in red blood cell breakdown.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Dust cells</strong>: <strong>Dust cells</strong> (alveolar macrophages) are found in the lungs and are involved in clearing inhaled particles, not in the liver.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Clara cells</strong>: <strong>Clara cells</strong> (club cells) are located in the bronchioles and secrete surfactant proteins but are not involved in red blood cell breakdown.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Kupffer cells in the liver are specialized macrophages involved in the breakdown of red blood cells and play a vital role in immune responses.</span></li></ul>",
      "correct_choice_id": 288817,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72537,
      "choices": [
        {
          "id": 289137,
          "text": "<p><span style=\"font-size:14.0pt;\">Rituximab</span></p>"
        },
        {
          "id": 289138,
          "text": "<p><span style=\"font-size:14.0pt;\">Selenium</span></p>"
        },
        {
          "id": 289139,
          "text": "<p><span style=\"font-size:14.0pt;\">Glucocorticoids</span></p>"
        },
        {
          "id": 289140,
          "text": "<p><span style=\"font-size:14.0pt;\">Teprotumumab</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 27-year-old woman presents with a 3-week history of eye pain, redness, and swelling. She also reports blurred vision and occasional double vision, especially in the evenings. She has a history of hyperthyroidism, which is being treated with methimazole. On examination , Her eyes condition is shown in the image below. She is diagnosed with thyroid eye disease (TED). Which of the following is not considered an appropriate treatment option for TED?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-24%20121743.jpg\" width=\"651\" height=\"377\"></strong></span></p>",
      "unique_key": "Q3995994",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Rituximab</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Although effective in some autoimmune diseases, studies have shown no significant benefit for TED, making it an inappropriate choice.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Selenium:</strong> Effective in reducing inflammation and slowing disease progression in mild TED.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Glucocorticoids:</strong> The mainstay treatment for severe TED to reduce inflammation and optic nerve compression.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Teprotumumab:</strong> A targeted therapy with proven efficacy in reducing proptosis and inflammation in TED.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Management of thyroid eye disease depends on severity.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Mild-to-moderate TED: Managed conservatively with selenium (100 mg BID), which reduces oxidative stress and inflammation.</span></li><li><span style=\"font-size:14.0pt;\">Severe TED: Treated with high-dose glucocorticoids, orbital decompression, orbital radiotherapy, or teprotumumab (an IGF-1 receptor monoclonal antibody approved by the FDA in 2020).</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Rituximab is not recommended for TED, while selenium, glucocorticoids, and teprotumumab are effective treatment options based on disease severity.</span></li></ul>",
      "correct_choice_id": 289137,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72100,
      "choices": [
        {
          "id": 287401,
          "text": "<p><span style=\"font-size:14.0pt;\">Continue OHA and reduce long-acting insulin dose by half.</span></p>"
        },
        {
          "id": 287402,
          "text": "<p><span style=\"font-size:14.0pt;\">Discontinue OHA and administer short-acting insulin as needed.</span></p>"
        },
        {
          "id": 287403,
          "text": "<p><span style=\"font-size:14.0pt;\">Continue OHA and administer long-acting insulin at full dose.</span></p>"
        },
        {
          "id": 287404,
          "text": "<p><span style=\"font-size:14.0pt;\">Discontinue OHA, reduce long-acting insulin to one-third, and monitor glucose closely.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old diabetic male on oral hypoglycemic agents (OHA) and long-acting insulin is scheduled for an elective hernia repair. His preoperative glucose level is 140 mg/dL. What is the most appropriate perioperative glucose management?</span></p>",
      "unique_key": "Q8790505",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>D) Discontinue OHA, reduce long-acting insulin to one-third, and monitor glucose closely.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Long-acting insulin is reduced to one-third to prevent intraoperative hypoglycemia, and OHA is stopped to avoid unpredictable glucose levels.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Continue OHA and reduce long-acting insulin dose by half:</strong> Reducing insulin by half may still lead to hypoglycemia during fasting.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Discontinue OHA and administer short-acting insulin as needed:</strong> Short-acting insulin may be needed postoperatively but is not routinely administered preoperatively.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Continue OHA and administer long-acting insulin at full dose:</strong> Continuing full-dose insulin risks severe hypoglycemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In diabetic patients undergoing surgery, careful preoperative insulin adjustment and glucose monitoring are crucial to prevent hypoglycemia or hyperglycemia.</span></li></ul>",
      "correct_choice_id": 287404,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72475,
      "choices": [
        {
          "id": 288889,
          "text": "<p><span style=\"font-size:14.0pt;\">Bone pearls</span></p>"
        },
        {
          "id": 288890,
          "text": "<p><span style=\"font-size:14.0pt;\">Current pearls</span></p>"
        },
        {
          "id": 288891,
          "text": "<p><span style=\"font-size:14.0pt;\">Calcium phosphate droplets</span></p>"
        },
        {
          "id": 288892,
          "text": "<p><span style=\"font-size:14.0pt;\">Electrocution wax</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A forensic expert is performing an autopsy on a body that has been electrocuted, and they observe the presence of molten metal within the soft tissues. This molten metal is referred to as:<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3314475",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Current pearls</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Current pearls</strong> refer to <strong>molten metal</strong> derived from the <strong>electrode</strong> during electrocution.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These pearls can be found <strong>deep in the soft tissues</strong> and are characteristic of electrical injuries.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>current pearls</strong> are formed due to the extreme heat generated at the point of contact between the electrode and the body.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Bone pearls:</strong> <strong>Bone pearls</strong> are formed from <strong>molten calcium phosphate</strong> derived from bone and can be detected in <strong>radiological investigations</strong>, but they are not molten metal from the electrode.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Calcium phosphate droplets:</strong> <strong>Calcium phosphate droplets</strong> are found in bones and represent <strong>bone pearls</strong>, not molten metal from the electrode.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Electrocution wax:</strong> <strong>Electrocution wax</strong> is not a recognized term in postmortem examination.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Current pearls</strong> are molten metal derived from the <strong>electrode</strong> during <strong>electrocution</strong>, which can be found <strong>deep in soft tissues</strong>.</span></li></ul>",
      "correct_choice_id": 288890,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72527,
      "choices": [
        {
          "id": 289097,
          "text": "<p><span style=\"font-size:14.0pt;\">Ultrasound of the kidneys</span></p>"
        },
        {
          "id": 289098,
          "text": "<p><span style=\"font-size:14.0pt;\">CT of the kidneys</span></p>"
        },
        {
          "id": 289099,
          "text": "<p><span style=\"font-size:14.0pt;\">Renal Gallium scan</span></p>"
        },
        {
          "id": 289100,
          "text": "<p><span style=\"font-size:14.0pt;\">Kidney biopsy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 56-year-old woman is hospitalized for gram-negative sepsis secondary to a urinary tract infection and started on intravenous piperacillin-tazobactam. On day 7 of treatment, she develops acute kidney injury (AKI) with rising serum creatinine levels. She reports fatigue and decreased urine output, but no fever or rash. Urine examination reveals eosinophiluria, and blood tests confirm worsening renal function. There is no prior history of kidney disease or known drug allergies. Which of the following is the gold standard diagnostic test for her condition?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7335884",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;D) Kidney biopsy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The clinical picture is consistent with <strong>acute interstitial nephritis (AIN)</strong>, most likely drug-induced due to piperacillin-tazobactam.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Kidney biopsy is the <strong>gold standard</strong> for diagnosing AIN. It provides definitive histological evidence, such as interstitial inflammation, edema, and eosinophilic infiltration.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Ultrasound of the kidneys</strong>: May show large, swollen kidneys with increased echogenicity, but these findings are nonspecific.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. CT of the kidneys</strong>: Useful for ruling out other structural causes of AKI, but it does not confirm AIN.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Renal Gallium scan</strong>: Once considered for AIN diagnosis, it is neither sensitive nor specific and is no longer commonly used.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Kidney biopsy is the definitive diagnostic tool for acute interstitial nephritis, especially when clinical and laboratory findings strongly suggest the diagnosis.</span></li></ul>",
      "correct_choice_id": 289100,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72097,
      "choices": [
        {
          "id": 287389,
          "text": "<p><span style=\"font-size:14.0pt;\">Decerebration produces no phenomenon akin to spinal shock</span></p>"
        },
        {
          "id": 287390,
          "text": "<p><span style=\"font-size:14.0pt;\">Rigidity occurs in all the muscles of the body</span></p>"
        },
        {
          "id": 287391,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased excitability of the motor neuron pool</span></p>"
        },
        {
          "id": 287392,
          "text": "<p><span style=\"font-size:14.0pt;\">Increase in the rate of discharge of the γ efferent neuron</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old man with severe brain injury exhibits decerebrate posturing. According to the Herrington classification of decerebrate rigidity, which of the following is not a characteristic of this condition?&nbsp;</span></p>",
      "unique_key": "Q1336255",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Rigidity occurs in all the muscles of the body</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">According to the Herrington classification of decerebrate rigidity, decerebrate rigidity is primarily characterized by a specific posture resulting from severe brain injury, typically involving the brainstem.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It involves extensor rigidity of the limbs due to the loss of inhibitory control from the higher brain centers.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">However, <strong>rigidity does not occur in all the muscles of the body</strong>; it mainly affects the extensor muscles of the limbs.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The characteristic posture includes extension and internal rotation of the arms, extension of the legs, and plantar flexion of the feet.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-20%20132408.jpg\" width=\"709\" height=\"556\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Decerebration produces no phenomenon akin to spinal shock:</strong> This is true. Unlike spinal cord injury that can cause spinal shock, decerebrate rigidity does not produce an analogous phenomenon. Decerebrate rigidity involves hyperactivity in motor pathways due to the loss of descending inhibitory control.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Increased excitability of the motor neuron pool:</strong> This is correct. The increased excitability of the motor neuron pool is a characteristic feature of decerebrate rigidity, where motor neurons become hyperactive due to the loss of upper motor neuron inhibition.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Increase in the rate of discharge of the γ efferent neuron:</strong> This is correct. There is an increased rate of discharge in γ efferent neurons, which contributes to the heightened muscle tone observed in decerebrate rigidity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Decerebrate rigidity, according to the Herrington classification, is characterized by increased muscle tone primarily in the extensor muscles of the limbs, not all muscles of the body.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This condition results from the loss of descending inhibitory signals from the brain to the spinal cord, leading to hyperactivity in motor pathways and increased discharge of γ efferent neurons.</span></li></ul>",
      "correct_choice_id": 287390,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72072,
      "choices": [
        {
          "id": 287289,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased heart rate by 10–15 beats per minute</span></p>"
        },
        {
          "id": 287290,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased cardiac output and blood volume</span></p>"
        },
        {
          "id": 287291,
          "text": "<p><span style=\"font-size:14.0pt;\">Systolic ejection murmur</span></p>"
        },
        {
          "id": 287292,
          "text": "<p><span style=\"font-size:14.0pt;\">Loud diastolic murmur</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old pregnant woman in her second trimester presents for a routine antenatal visit. On examination, her heart rate is noted to be elevated by 15 beats per minute compared to her pre-pregnancy baseline. A systolic ejection murmur is also heard on auscultation, which is soft and grade 2/6. She denies any chest pain, palpitations, or shortness of breath. Which of the following cardiovascular findings is considered abnormal during pregnancy?&nbsp;</span></p>",
      "unique_key": "Q3792654",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Loud diastolic murmur</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>loud diastolic murmur</strong> is always abnormal in pregnancy and may indicate underlying valvular disease, such as mitral stenosis or aortic regurgitation. It warrants further investigation with echocardiography.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Increased heart rate by 10–15 beats per minute:&nbsp;</strong>This is a normal physiological change during pregnancy to meet the increased metabolic and circulatory demands of the mother and fetus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Increased cardiac output and blood volume:&nbsp;</strong>Cardiac output increases by 30–50%, and blood volume increases by 40–50% during pregnancy to ensure adequate perfusion of the placenta and maternal organs.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Systolic ejection murmur:&nbsp;</strong>A soft systolic ejection murmur is a common and benign finding during pregnancy, caused by increased blood flow through the heart.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Physiological changes in the cardiovascular system during pregnancy</strong> include increased heart rate, cardiac output, and blood volume, as well as benign systolic murmurs.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">However, a <strong>loud diastolic murmur</strong> is always abnormal and requires further evaluation.</span></li></ul>",
      "correct_choice_id": 287292,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72145,
      "choices": [
        {
          "id": 287581,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3 only</span></p>"
        },
        {
          "id": 287582,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 4 only</span></p>"
        },
        {
          "id": 287583,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 4 only</span></p>"
        },
        {
          "id": 287584,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3 and 4 only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old woman with a history of recurrent otitis media presents with chronic ear discharge, hearing loss, and a retracted tympanic membrane with visible keratin debris. Which of the following statements are true?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">This condition is commonly associated with chronic Eustachian tube dysfunction.</span></li><li><span style=\"font-size:14.0pt;\">Surgical management is the definitive treatment for this condition.</span></li><li><span style=\"font-size:14.0pt;\">Antibiotics alone are sufficient for treatment.</span></li><li><span style=\"font-size:14.0pt;\">Retraction pockets of the TM are the most common precursor to this condition.</span></li></ol>",
      "unique_key": "Q4142742",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) 1, 2 and 4 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>This condition is commonly associated with chronic Eustachian tube dysfunction:</strong> Correct. Chronic Eustachian tube dysfunction leads to negative pressure, causing retraction pockets that develop into cholesteatomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>Surgical management is the definitive treatment for this condition:</strong> Correct. Surgical excision is required to remove the cholesteatoma and prevent further complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>Retraction pockets of the TM are the most common precursor to this condition:</strong> Correct. Retraction pockets are the most common precursor due to chronic negative pressure.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>Antibiotics alone are sufficient for treatment:</strong> Incorrect. Antibiotics are not sufficient as cholesteatomas require surgical removal.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Understand that cholesteatomas arise from chronic Eustachian tube dysfunction and retraction pockets, requiring surgical management for definitive treatment.</span></li></ul>",
      "correct_choice_id": 287582,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72522,
      "choices": [
        {
          "id": 289077,
          "text": "<p><span style=\"font-size:14.0pt;\">Intra-aortic balloon pump placement</span></p>"
        },
        {
          "id": 289078,
          "text": "<p><span style=\"font-size:14.0pt;\">Intravenous dobutamine</span></p>"
        },
        {
          "id": 289079,
          "text": "<p><span style=\"font-size:14.0pt;\">Intravenous 0.9% saline</span></p>"
        },
        {
          "id": 289080,
          "text": "<p><span style=\"font-size:14.0pt;\">Oral metoprolol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old man presents to the emergency department with a 2-hour history of severe chest pain that started suddenly while he was watching television. The pain is described as a heavy, squeezing sensation radiating to his right shoulder and neck. He also feels lightheaded and has had one episode of nausea. On examination, his blood pressure is 90/60 mmHg, heart rate is 110/min, and jugular venous pressure is elevated. His lungs are clear on auscultation, and no rales are heard. ECG is taken and shown below. What is the most appropriate initial treatment?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-24%20121047.jpg\" width=\"856\" height=\"450\"></span></p>",
      "unique_key": "Q7533226",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans</strong>. <strong>C) Intravenous 0.9% saline</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient’s presentation suggests an inferior myocardial infarction with possible right ventricular involvement, as indicated by hypotension (BP 90/60 mmHg), elevated JVP, and clear lungs.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Right ventricular infarction leads to reduced preload, and the most appropriate initial treatment is volume resuscitation with intravenous 0.9% saline to restore preload and cardiac output.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Intra-aortic balloon pump placement</strong>: Not appropriate for isolated right ventricular infarction as it does not address the primary issue of hypovolemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Intravenous dobutamine</strong>: Can exacerbate hypotension if used without addressing hypovolemia first.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Oral metoprolol</strong>: Contraindicated in hypotension or shock as it reduces heart rate and cardiac output further.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In cases of inferior myocardial infarction with right ventricular involvement, initial treatment should focus on fluid resuscitation to optimize preload and cardiac output.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Avoid beta-blockers and vasodilators in such patients.</span></li></ul>",
      "correct_choice_id": 289079,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72096,
      "choices": [
        {
          "id": 287385,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3 are true</span></p>"
        },
        {
          "id": 287386,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 4 are true</span></p>"
        },
        {
          "id": 287387,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 4 are true</span></p>"
        },
        {
          "id": 287388,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 4 are true</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding tanycytes and circumventricular organs is/are true?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Tanycytes are specialized ependymal cells located in circumventricular organs.</span></li><li><span style=\"font-size:14.0pt;\">Circumventricular organs lack a blood-brain barrier, allowing direct communication between blood and CSF.</span></li><li><span style=\"font-size:14.0pt;\">Tanycytes play a role in chemoreception, secretion into the CSF, and transporting neurochemicals.</span></li><li><span style=\"font-size:14.0pt;\">Circumventricular organs are responsible for the production of cerebrospinal fluid (CSF).</span></li></ol>",
      "unique_key": "Q2717493",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) 1, 2 and 3 are true</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1. Tanycytes are specialized ependymal cells located in circumventricular organs:&nbsp;</strong>These cells have unique functions such as chemoreception, secretion into CSF, and transport of neurochemicals between adjacent neurons, glial cells, vessels, and CSF.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2. Circumventricular organs lack a blood-brain barrier:&nbsp;</strong>This allows them to act as sites for neuroendocrine communication by permitting free exchange of molecules between the bloodstream and cerebrospinal fluid.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3. Tanycytes play a role in chemoreception and neurochemical transport:&nbsp;</strong>These cells aid in both sensing changes in the environment and transporting neurochemicals to or from the CSF.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4. Circumventricular organs are responsible for the production of CSF:&nbsp;</strong>This is incorrect as the production of CSF is primarily a function of the choroid plexus, not circumventricular organs.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-19%20182102.jpg\" width=\"1072\" height=\"380\"></strong></span></p>",
      "correct_choice_id": 287385,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72085,
      "choices": [
        {
          "id": 287341,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3 are correct.</span></p>"
        },
        {
          "id": 287342,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 4 are correct.</span></p>"
        },
        {
          "id": 287343,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3 and 4 are correct.</span></p>"
        },
        {
          "id": 287344,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3 and 4 are correct.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A public health officer is conducting a training session on vaccination practices. Which of the following statements about vaccine administration and safety are true?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Vaccines like DPT should never be stored in a deep freezer.</span></li><li><span style=\"font-size:14.0pt;\">Encephalopathy within 7 days of DPT vaccination is an absolute contraindication to further doses.</span></li><li><span style=\"font-size:14.0pt;\">Vaccines like OPV and BCG can be frozen without harm.</span></li><li><span style=\"font-size:14.0pt;\">Mission Indradhanush includes the Japanese encephalitis vaccine in all districts.</span></li></ol>",
      "unique_key": "Q1639615",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans</strong>. <strong>A) 1, 2 and 3 are correct.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>Vaccines like DPT should never be stored in a deep freezer:&nbsp;</strong>Correct. Vaccines like DPT are aluminum adjuvant-based and are susceptible to freezing damage, so they should never be stored in a deep freezer.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>Encephalopathy within 7 days of DPT vaccination is an absolute contraindication to further doses:&nbsp;</strong>Correct. Encephalopathy within 7 days of DPT vaccination is a documented absolute contraindication for subsequent doses.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>Vaccines like OPV and BCG can be frozen without harm:&nbsp;</strong>Correct. Vaccines like OPV and BCG are live attenuated and can tolerate freezing without significant harm.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>Mission Indradhanush includes the Japanese encephalitis vaccine in all districts:&nbsp;</strong>Incorrect. Japanese encephalitis is not universally included in Mission Indradhanush and is administered only in selected high-risk districts.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Japanese encephalitis is not universally included in Mission Indradhanush and is administered only in selected high-risk districts.</span></li></ul>",
      "correct_choice_id": 287341,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72555,
      "choices": [
        {
          "id": 289209,
          "text": "<p><span style=\"font-size:14.0pt;\">Optical coherence tomography (OCT)</span></p>"
        },
        {
          "id": 289210,
          "text": "<p><span style=\"font-size:14.0pt;\">Fundus fluorescein angiography (FFA)</span></p>"
        },
        {
          "id": 289211,
          "text": "<p><span style=\"font-size:14.0pt;\">Complete blood count (CBC)</span></p>"
        },
        {
          "id": 289212,
          "text": "<p><span style=\"font-size:14.0pt;\">MRI of the brain and orbits</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 58-year-old male presents with progressive vision loss in his left eye. B-scan ultrasonography image is shown below. What is the next best diagnostic step in confirming the nature of this lesion?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-24%20122340.jpg\" width=\"549\" height=\"345\"></strong></span></p>",
      "unique_key": "Q4508966",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Fundus fluorescein angiography (FFA)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Fundus fluorescein angiography (FFA) is the next best diagnostic step in patients with suspected choroidal melanoma.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">FFA helps evaluate the vascularity of the lesion, which is critical for distinguishing malignant melanomas from benign lesions.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Choroidal melanomas typically exhibit early hyperfluorescence with late leakage on FFA, reflecting the tumor's vascular characteristics.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This information is essential for accurate diagnosis and planning treatment.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Optical coherence tomography (OCT):</strong> Optical coherence tomography (OCT) is useful for assessing retinal thickness and macular conditions but does not provide the necessary information to evaluate a choroidal melanoma's vascularity.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Complete blood count (CBC)</strong>: A complete blood count (CBC) is not useful for diagnosing choroidal melanoma and would not provide relevant information for this patient.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. MRI of the brain and orbits:</strong> MRI of the brain and orbits can be helpful in assessing the extent of intraocular and orbital involvement but is not the primary tool for diagnosing choroidal melanoma. FFA is more specific for this purpose.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Fundus fluorescein angiography (FFA) is essential for assessing the vascular characteristics of suspected choroidal melanoma and is crucial for confirming the diagnosis.</span></li></ul>",
      "correct_choice_id": 289210,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        8
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72461,
      "choices": [
        {
          "id": 288833,
          "text": "<p><span style=\"font-size:14.0pt;\">Mobile surgical units that bring operating rooms to remote villages for on-site surgeries</span></p>"
        },
        {
          "id": 288834,
          "text": "<p><span style=\"font-size:14.0pt;\">NGO-organized eye screening campaigns followed by surgeries at a designated hospital</span></p>"
        },
        {
          "id": 288835,
          "text": "<p><span style=\"font-size:14.0pt;\">Establishing partnerships with private hospitals to perform discounted surgeries for rural patients</span></p>"
        },
        {
          "id": 288836,
          "text": "<p><span style=\"font-size:14.0pt;\">Government-sponsored cataract surgery programs offering free surgeries through public hospitals</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A healthcare policy team is evaluating options to expand access to cataract surgery in a low-resource country. After reviewing several options, they want to ensure the strategy minimizes costs while maximizing surgical reach. Which strategy would likely provide the best outcome in terms of accessibility and affordability?&nbsp;</span></p>",
      "unique_key": "Q8432610",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) NGO-organized eye screening campaigns followed by surgeries at a designated hospital</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">NGO-organized eye screening campaigns paired with surgeries at a designated hospital are cost-effective because they allow for high patient throughput and efficient resource use.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">By screening large populations and performing surgeries in centralized settings, economies of scale reduce the per-patient cost.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This approach provides widespread access without the logistical challenges or high costs of traveling to mobile surgical units or relying on private hospitals.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Mobile surgical units that bring operating rooms to remote villages for on-site surgeries:&nbsp;</strong>While mobile surgical units may reach remote areas, they are costly due to travel expenses and the need to transport surgical equipment and staff, making them less efficient for high-volume procedures.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Establishing partnerships with private hospitals to perform discounted surgeries for rural patients:&nbsp;</strong>Partnering with private hospitals may not always lead to affordability, especially for rural populations who may still face financial barriers to care despite discounts.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Government-sponsored cataract surgery programs offering free surgeries through public hospitals:&nbsp;</strong>Government-sponsored programs are beneficial, but they often face budgetary limitations and might not scale efficiently, especially without adequate community-based outreach.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The most cost-effective strategy for expanding access to cataract surgeries involves NGO-led screening campaigns and centralized hospital surgeries, ensuring broad reach and minimizing operational costs.</span></li></ul>",
      "correct_choice_id": 288834,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72532,
      "choices": [
        {
          "id": 289117,
          "text": "<p><span style=\"font-size:14.0pt;\">Alcoholic cirrhosis</span></p>"
        },
        {
          "id": 289118,
          "text": "<p><span style=\"font-size:14.0pt;\">Peritoneal malignancy</span></p>"
        },
        {
          "id": 289119,
          "text": "<p><span style=\"font-size:14.0pt;\">Constrictive pericarditis</span></p>"
        },
        {
          "id": 289120,
          "text": "<p><span style=\"font-size:14.0pt;\">Veno-occlusive disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old man presents to the gastroenterology clinic with complaints of progressive abdominal distension over the past month. He reports associated mild discomfort but denies fever, significant weight loss, or changes in bowel habits. His medical history includes chronic liver disease due to long-term alcohol use. A diagnostic paracentesis is performed, revealing the following ascitic fluid analysis:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Ascitic fluid protein: 1.9 g/dL</span></li><li><span style=\"font-size:14.0pt;\">Serum-ascites albumin gradient (SAAG): 1.4 g/dL</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Which of the following is the most likely cause of his ascites?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8492015",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) Alcoholic cirrhosis</strong></span></p><p>&nbsp;</p><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\"><strong>Serum-ascites albumin gradient (SAAG):</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">A <strong>SAAG &gt;1.1 g/dL</strong> suggests <strong>sinusoidal hypertension</strong>, commonly seen in conditions like cirrhosis and cardiac-related ascites.</span></li><li><span style=\"font-size:14.0pt;\">A <strong>SAAG &lt;1.1 g/dL</strong> suggests peritoneal causes of ascites (e.g., malignancy, infections).</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Ascitic fluid protein levels:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Cirrhosis:</strong> Low ascitic fluid protein (&lt;2.5 g/dL) due to capillarized sinusoids that leak less protein.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Cardiac ascites:</strong> High protein (&gt;2.5 g/dL) due to normal sinusoidal function.</span></li></ul></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This patient’s findings of <strong>low ascitic fluid protein (&lt;2.5 g/dL)</strong> and <strong>elevated SAAG (&gt;1.1 g/dL)</strong> are characteristic of cirrhotic ascites, most commonly due to <strong>alcoholic cirrhosis.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Peritoneal malignancy:</strong> Typically presents with <strong>low SAAG (&lt;1.1 g/dL)</strong> and high ascitic protein levels (&gt;2.5 g/dL).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Constrictive pericarditis:</strong> Causes ascites with <strong>high SAAG (&gt;1.1 g/dL)</strong> and high protein levels (&gt;2.5 g/dL).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Veno-occlusive disease:</strong> Associated with <strong>high SAAG (&gt;1.1 g/dL)</strong> and ascitic protein levels &gt;2.5 g/dL.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>SAAG &gt;1.1 g/dL</strong> with <strong>low protein levels (&lt;2.5 g/dL)</strong> is characteristic of <strong>cirrhotic ascites</strong>, most commonly due to <strong>alcoholic cirrhosis</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Diagnostic paracentesis is essential in evaluating the cause of ascites and guiding management.</span></li></ul>",
      "correct_choice_id": 289117,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72452,
      "choices": [
        {
          "id": 288797,
          "text": "<p><span style=\"font-size:14.0pt;\">Embryonic stem cells</span></p>"
        },
        {
          "id": 288798,
          "text": "<p><span style=\"font-size:14.0pt;\">Somatic cells of the testis</span></p>"
        },
        {
          "id": 288799,
          "text": "<p><span style=\"font-size:14.0pt;\">Germ cells from the embryonal period</span></p>"
        },
        {
          "id": 288800,
          "text": "<p><span style=\"font-size:14.0pt;\">Mature teratomatous tissues</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old male with a testicular mass undergoes immunohistochemistry, and the tumor expresses KIT (CD117), OCT 3 (OCT3/4), and PLAP. What is the most likely source of the tumor’s origin?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5907472",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Germ cells from the embryonal period</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The expression of KIT (CD117), OCT 3 (OCT3/4), and PLAP suggests a seminoma, which originates from pluripotent germ cells that maintain an embryonal origin.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">OCT 3/4 is a transcription factor essential for maintaining pluripotency in germ cells, and the presence of PLAP further indicates the germ cell lineage of the tumor.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These findings are characteristic of seminomas, a type of germ cell tumor.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Embryonic stem cells</strong>: While OCT 3/4 is also associated with embryonic stem cells, in this context, the markers are more specific to seminomas, which are derived from germ cells, not stem cells.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Somatic cells of the testis</strong>: Somatic cells, such as Sertoli or Leydig cells, do not express these markers, which are specific to germ cell tumors.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Mature teratomatous tissues</strong>: Teratomas are more differentiated and involve a mix of tissues from all three germ layers, but they do not express KIT, OCT 3/4, and PLAP in the same manner as seminomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Seminomas arise from pluripotent germ cells from the embryonal period and are characterized by the expression of KIT (CD117), OCT 3 (OCT3/4), and PLAP.</span></li></ul>",
      "correct_choice_id": 288799,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72446,
      "choices": [
        {
          "id": 288773,
          "text": "<p><span style=\"font-size:14.0pt;\">Tc-99m MAG3 scan</span></p>"
        },
        {
          "id": 288774,
          "text": "<p><span style=\"font-size:14.0pt;\">Ultrasound of the renal transplant</span></p>"
        },
        {
          "id": 288775,
          "text": "<p><span style=\"font-size:14.0pt;\">Serum creatinine measurement</span></p>"
        },
        {
          "id": 288776,
          "text": "<p><span style=\"font-size:14.0pt;\">CT scan of the abdomen</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old man who received a renal transplant two months ago presents for routine follow-up. His renal function appears stable, but there is concern regarding possible urinary leak or obstruction due to post-surgical complications. Which of the following diagnostic tests is most appropriate to assess renal function and detect any urinary leaks or obstructions in this patient?</span></p>",
      "unique_key": "Q5135091",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Tc-99m MAG3 scan</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The Tc-99m MAG3 scan is a dynamic renography technique used for assessing renal function and urinary drainage in renal transplant patients.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It helps detect issues such as urinary leaks or obstructions by evaluating glomerular filtration and tubular excretion.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This test is highly sensitive in detecting post-surgical complications that can affect renal function and urinary drainage.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ultrasound of the renal transplant</strong>: While useful for detecting structural abnormalities, ultrasound cannot assess renal function or detect subtle obstructions or leaks as effectively as a dynamic scan.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Serum creatinine measurement:</strong> Serum creatinine levels provide information about renal function but are not specific for detecting urinary leaks or obstructions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. CT scan of the abdomen</strong>: A CT scan can detect anatomical issues, but it does not provide the functional assessment required to evaluate kidney performance or urinary drainage issues in the post-transplant setting.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The Tc-99m MAG3 scan is the preferred diagnostic tool for evaluating renal function, urinary drainage, and potential leaks or obstructions in post-renal transplant patients.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It assesses both glomerular filtration and tubular excretion to provide a comprehensive understanding of renal status.</span></li></ul>",
      "correct_choice_id": 288773,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72511,
      "choices": [
        {
          "id": 289033,
          "text": "<p><span style=\"font-size:14.0pt;\">Transition to an integrase inhibitor-based regimen.</span></p>"
        },
        {
          "id": 289034,
          "text": "<p><span style=\"font-size:14.0pt;\">Supplement with metformin for insulin resistance.</span></p>"
        },
        {
          "id": 289035,
          "text": "<p><span style=\"font-size:14.0pt;\">Introduce pioglitazone to reduce central obesity.</span></p>"
        },
        {
          "id": 289036,
          "text": "<p><span style=\"font-size:14.0pt;\">Enhance dietary and exercise regimes exclusively.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In monitoring a 50-year-old female with HIV treated with Indinavir who develops central obesity and insulin resistance, which therapeutic adjustment is considered optimal to address her metabolic complications without compromising viral control?</span></p>",
      "unique_key": "Q9032940",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) Transition to an integrase inhibitor-based regimen</strong>.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Shifting to an integrase inhibitor-based regimen might be optimal for managing metabolic side effects like central obesity and insulin resistance associated with Indinavir, as these newer agents have a more favorable metabolic profile.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This adjustment maintains effective HIV control while potentially reducing the risk of diabetes and cardiovascular disease.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Supplement with metformin for insulin resistance:</strong> Incorrect as while metformin treats insulin resistance, it does not address all the metabolic issues induced by Indinavir.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Introduce pioglitazone to reduce central obesity:</strong> Incorrect because pioglitazone could help with obesity but may exacerbate other metabolic issues like lipid abnormalities.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Enhance dietary and exercise regimes exclusively:</strong> Incorrect as lifestyle changes alone are often insufficient to counteract medication-induced metabolic disturbances.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Optimize HIV treatment regimens in patients experiencing significant metabolic side effects from protease inhibitors by considering transitions to therapies with fewer metabolic burdens.</span></li></ul>",
      "correct_choice_id": 289033,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72113,
      "choices": [
        {
          "id": 287453,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3 only</span></p>"
        },
        {
          "id": 287454,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 4 only</span></p>"
        },
        {
          "id": 287455,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 3 only</span></p>"
        },
        {
          "id": 287456,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3 and 4 only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements about dermatopathology are true?&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Spongiosis is commonly seen in eczematous dermatitis.</span></li><li><span style=\"font-size:14.0pt;\">Acanthosis is a hallmark of only psoriasis.</span></li><li><span style=\"font-size:14.0pt;\">Parakeratosis indicates nucleated cells in the stratum corneum.</span></li><li><span style=\"font-size:14.0pt;\">Acantholysis is caused by defective hemidesmosomes.</span></li></ol>",
      "unique_key": "Q3812926",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) 1 and 3 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>Spongiosis is commonly seen in eczematous dermatitis:</strong> True. Spongiosis, or intraepidermal intercellular edema, is a key feature of eczematous dermatitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>Parakeratosis indicates nucleated cells in the stratum corneum:</strong> True. Parakeratosis is the presence of nucleated keratinocytes in the stratum corneum, often seen in psoriasis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>Acanthosis is a hallmark of only psoriasis:</strong> False. Acanthosis is a thickening of the stratum spinosum, which can occur in conditions like lichen planus also along with psoriasis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>Acantholysis is caused by defective hemidesmosomes:</strong> False. Acantholysis is due to defective desmosomes, not hemidesmosomes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Spongiosis and parakeratosis are key histological findings in eczematous dermatitis and psoriasis, respectively, while acantholysis results from defective desmosomes.</span></li></ul>",
      "correct_choice_id": 287455,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        18
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72076,
      "choices": [
        {
          "id": 287305,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute fatty liver of pregnancy</span></p>"
        },
        {
          "id": 287306,
          "text": "<p><span style=\"font-size:14.0pt;\">Gestational hypertension</span></p>"
        },
        {
          "id": 287307,
          "text": "<p><span style=\"font-size:14.0pt;\">HELLP syndrome</span></p>"
        },
        {
          "id": 287308,
          "text": "<p><span style=\"font-size:14.0pt;\">Chronic hypertension</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 34-year-old woman in her third trimester presents with severe hypertension, proteinuria, and right upper quadrant pain. Her labs show elevated liver enzymes and a platelet count of 90,000/mm³. What is the most likely diagnosis?</span></p>",
      "unique_key": "Q9952188",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;C) HELLP syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>HELLP syndrome</strong> is a severe form of <strong>preeclampsia</strong> characterized by:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>H</strong>emolysis (<strong>H</strong>emolysis, as seen with schistocytes on a peripheral smear, elevated lactate dehydrogenase [LDH])</span></li><li><span style=\"font-size:14.0pt;\"><strong>E</strong>levated <strong>L</strong>iver enzymes (AST, ALT)</span></li><li><span style=\"font-size:14.0pt;\"><strong>L</strong>ow <strong>P</strong>latelets (<strong>thrombocytopenia</strong>, &lt;100,000/mm3)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>This patient’s clinical presentation (hypertension, proteinuria, right upper quadrant pain, elevated liver enzymes, and thrombocytopenia) is highly suggestive of HELLP syndrome.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Right upper quadrant pain</strong> results from <strong>hepatic swelling and microvascular injury</strong> leading to <strong>Glisson’s capsule distension</strong> in the liver.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Acute fatty liver of pregnancy:&nbsp;</strong>Acute fatty liver of pregnancy also involves liver dysfunction but is rarer and associated with hypoglycemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Gestational hypertension:&nbsp;</strong>Gestational hypertension lacks proteinuria and systemic involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Chronic hypertension:&nbsp;</strong>Chronic hypertension is present before 20 weeks of pregnancy and lacks associated symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">HELLP syndrome presents with elevated liver enzymes, low platelets, and right upper quadrant pain in the context of severe preeclampsia.</span></p>",
      "correct_choice_id": 287307,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72146,
      "choices": [
        {
          "id": 287585,
          "text": "<p><span style=\"font-size:14.0pt;\">1-A, 2-B, 3-D, 4-C</span></p>"
        },
        {
          "id": 287586,
          "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-A, 3-C, 4-D</span></p>"
        },
        {
          "id": 287587,
          "text": "<p><span style=\"font-size:14.0pt;\">1-C, 2-D, 3-B, 4-A</span></p>"
        },
        {
          "id": 287588,
          "text": "<p><span style=\"font-size:14.0pt;\">1-D, 2-B, 3-A, 4-C&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the following:<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Column A (Pathological Concepts)</strong></span></p><ol><li><span style=\"font-size:14.0pt;\">Tympanic membrane perforation</span></li><li><span style=\"font-size:14.0pt;\">Barotrauma</span></li><li><span style=\"font-size:14.0pt;\">Cholesteatoma</span></li><li><span style=\"font-size:14.0pt;\">Eustachian tube dysfunction</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Column B (Clinical Features)</strong></span></p><ol style=\"list-style-type:upper-latin;\"><li><span style=\"font-size:14.0pt;\">Chronic foul-smelling ear discharge with white mass behind TM</span></li><li><span style=\"font-size:14.0pt;\">Severe ear pain and hearing loss during descent in air travel</span></li><li><span style=\"font-size:14.0pt;\">Negative middle ear pressure causing TM retraction pockets</span></li><li><span style=\"font-size:14.0pt;\">Rupture of TM due to sudden negative pressure</span></li></ol>",
      "unique_key": "Q5814182",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>D) 1-D, 2-B, 3-A, 4-C</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Tympanic membrane perforation (1-D):</strong> Rupture due to sudden negative middle ear pressure caused by altitude changes during air travel.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Barotrauma (2-B):</strong> Presents as severe ear pain and hearing loss during descent when the Eustachian tube fails to equalize pressure.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Cholesteatoma (3-A):</strong> Chronic discharge with a white mass behind the TM in a retraction pocket.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Eustachian tube dysfunction (4-C):</strong> Chronic negative middle ear pressure causing TM retraction pockets.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Understand that tympanic membrane perforation is linked to sudden negative pressure, barotrauma occurs during descent, and cholesteatoma manifests with chronic symptoms and retraction pockets.</span></li></ul>",
      "correct_choice_id": 287588,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72543,
      "choices": [
        {
          "id": 289161,
          "text": "<p><span style=\"font-size:14.0pt;\">Inosine (I)</span></p>"
        },
        {
          "id": 289162,
          "text": "<p><span style=\"font-size:14.0pt;\">Methylguanosine (mG)</span></p>"
        },
        {
          "id": 289163,
          "text": "<p><span style=\"font-size:14.0pt;\">Pseudouridine (ψ)</span></p>"
        },
        {
          "id": 289164,
          "text": "<p><span style=\"font-size:14.0pt;\">Dihydrouridine (D)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Considering the wobble hypothesis, which tRNA modification is most critical for maintaining the flexibility of codon recognition during translation?&nbsp;</span></p>",
      "unique_key": "Q7196530",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Inosine (I)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Inosine is a modified nucleotide found in the anticodon loop of tRNA and plays a key role in the <strong>wobble hypothesis</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The hypothesis explains how a single tRNA can recognize multiple codons for the same amino acid.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Inosine, particularly at the wobble position (the 3rd base of the codon), can pair with <strong>A, U, or C</strong> in mRNA, providing flexibility in codon recognition and allowing the genetic code to be translated with fewer tRNAs.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This flexibility is crucial for efficient protein synthesis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Methylguanosine (mG):&nbsp;</strong>Methylguanosine is a modified nucleotide found in tRNA, but its primary role is structural, stabilizing the tRNA molecule. It is not directly involved in wobble pairing. Methylation protects tRNA from degradation and enhances the accuracy of codon-anticodon pairing, but it does not provide the flexibility seen with wobble base pairing.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Pseudouridine (ψ)</strong>: Pseudouridine is another modified nucleotide found in tRNA, but its function is more related to the stability and proper folding of the tRNA molecule. It helps in maintaining the correct 3D structure of tRNA, which is essential for accurate translation, but it does not directly contribute to codon flexibility in the wobble position.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Dihydrouridine (D):&nbsp;</strong>Dihydrouridine is a modified base found in the D-loop of tRNA. Its primary function is to influence the flexibility of the tRNA structure, particularly during the folding and interaction with ribosomes. However, it is not involved in the wobble hypothesis or codon recognition flexibility.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Inosine in the anticodon allows tRNA to pair with multiple mRNA bases, increasing the flexibility of codon recognition during translation.</span></li></ul>",
      "correct_choice_id": 289161,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72091,
      "choices": [
        {
          "id": 287365,
          "text": "<p><span style=\"font-size:14.0pt;\">Junction of superior vena cava and left brachiocephalic vein</span></p>"
        },
        {
          "id": 287366,
          "text": "<p><span style=\"font-size:14.0pt;\">Junction of left internal jugular and left subclavian vein</span></p>"
        },
        {
          "id": 287367,
          "text": "<p><span style=\"font-size:14.0pt;\">Directly into coronary sinus</span></p>"
        },
        {
          "id": 287368,
          "text": "<p><span style=\"font-size:14.0pt;\">Into the azygos vein</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Thoracic duct opens into the systemic circulation at which of the following locations?</span></p>",
      "unique_key": "Q7727554",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Junction of left internal jugular and left subclavian vein</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The thoracic duct is the largest lymphatic duct, approximately 45 cm long, and drains lymph from the body below the diaphragm and the left upper quadrant above the diaphragm.</span></li><li><span style=\"font-size:14.0pt;\">It begins at the cisterna chyli near the lower border of the T12 vertebra, enters the thorax through the aortic opening of the diaphragm, and ascends through the posterior mediastinum.</span></li><li><span style=\"font-size:14.0pt;\">At the level of the C7 vertebra, it arches to the left and opens into the systemic circulation at the junction of the left internal jugular vein and the left subclavian vein.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Junction of Superior vena cava and left brachiocephalic vein:</strong> The thoracic duct does not drain into the superior vena cava or its tributaries other than the left subclavian vein.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Directly into coronary sinus:</strong> The coronary sinus is part of the venous drainage of the heart, and the thoracic duct has no anatomical connection with it.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Into azygos vein:</strong> Although the thoracic duct passes close to the azygos vein in the posterior mediastinum, it does not drain into it.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-19%20181530.jpg\" width=\"1144\" height=\"520\"></strong></span></p>",
      "correct_choice_id": 287366,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72068,
      "choices": [
        {
          "id": 287273,
          "text": "<p><span style=\"font-size:14.0pt;\">Magnesium sulfate</span></p>"
        },
        {
          "id": 287274,
          "text": "<p><span style=\"font-size:14.0pt;\">Antihypertensive therapy</span></p>"
        },
        {
          "id": 287275,
          "text": "<p><span style=\"font-size:14.0pt;\">Bed rest</span></p>"
        },
        {
          "id": 287276,
          "text": "<p><span style=\"font-size:14.0pt;\">Delivery of the baby and placenta</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">What is the definitive treatment of preeclampsia?</span></p>",
      "unique_key": "Q5275148",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;D) Delivery of the baby and placenta</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Delivery is the only definitive cure for preeclampsia, as it resolves the underlying placental pathology.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Magnesium sulfate:&nbsp;</strong>Magnesium sulfate is used for seizure prophylaxis but does not treat the underlying condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B and C. Antihypertensive therapy and Bed rest</strong>:<strong>&nbsp;</strong>These are supportive measures but not definitive treatments.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The only definitive treatment for preeclampsia is delivery of the baby and placenta</span></li></ul>",
      "correct_choice_id": 287276,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72495,
      "choices": [
        {
          "id": 288969,
          "text": "<p><span style=\"font-size:14.0pt;\">T-cell activation and massive cytokine release</span></p>"
        },
        {
          "id": 288970,
          "text": "<p><span style=\"font-size:14.0pt;\">Down-regulation of MHC II expression on APCs</span></p>"
        },
        {
          "id": 288971,
          "text": "<p><span style=\"font-size:14.0pt;\">Suppression of antigen presentation</span></p>"
        },
        {
          "id": 288972,
          "text": "<p><span style=\"font-size:14.0pt;\">Inhibition of T-cell receptor diversity</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 40-year-old male presents with a history of frequent sore throats, fever, and joint pain. Further testing shows high levels of C-reactive protein (CRP). His tonsillar culture grows beta-hemolytic streptococci, and a rapid test for SPE-A comes positive. Which of the following is most likely to occur due to this superantigen?&nbsp;</span></p>",
      "unique_key": "Q9961075",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A)</strong> <strong>T-cell activation and massive cytokine release</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>SPE-A</strong> (Streptococcal pyrogenic exotoxin) is a <strong>bacterial superantigen</strong> that causes <strong>massive T-cell activation</strong>, bypassing the usual antigen processing.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This leads to a <strong>cytokine storm</strong>, which contributes to symptoms such as fever, sore throat, and systemic inflammation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Down-regulation of MHC II expression on APCs</strong>: This is not a typical effect of <strong>SPE-A</strong>. It generally promotes T-cell activation rather than suppressing <strong>MHC II expression</strong>.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option C. Suppression of antigen presentation</strong>: Superantigens <strong>do not suppress antigen presentation</strong>; instead, they <strong>bypass normal antigen processing</strong>.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option D. Inhibition of T-cell receptor diversity</strong>: Superantigens do not inhibit T-cell diversity but instead stimulate T-cells non-specifically.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Examples of Superantigens</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-21%20181229.jpg\" width=\"937\" height=\"688\"></span></p>",
      "correct_choice_id": 288969,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72198,
      "choices": [
        {
          "id": 287793,
          "text": "<p><span style=\"font-size:14.0pt;\">Maydl hernia</span></p>"
        },
        {
          "id": 287794,
          "text": "<p><span style=\"font-size:14.0pt;\">Littre hernia</span></p>"
        },
        {
          "id": 287795,
          "text": "<p><span style=\"font-size:14.0pt;\">Richter’s hernia</span></p>"
        },
        {
          "id": 287796,
          "text": "<p><span style=\"font-size:14.0pt;\">Amyand hernia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old male presents with a 3-day history of abdominal pain and vomiting. Examination reveals a tender irreducible swelling as shown below. What is the diagnosis?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-20%20165653.jpg\" width=\"447\" height=\"332\"></strong></span></p>",
      "unique_key": "Q9002931",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Richter’s hernia</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This condition involves the herniation of only a portion of the circumference of the bowel wall (typically the antimesenteric border), unlike other hernias where the entire bowel wall is involved.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This can lead to ischemia and necrosis of the bowel wall without causing complete bowel obstruction.&nbsp;</span></li><li><p><span style=\"font-size:14.0pt;\">The image provided illustrates this partial herniation, characteristic of Richter’s hernia.</span></p><p>&nbsp;</p></li></ul><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Maydl hernia:</strong> Involves herniation of two bowel loops through a single defect, with the central portion of the bowel potentially at risk of strangulation (W-loop hernia). This is not consistent with the image.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Littre hernia:</strong> Refers to the herniation of a Meckel’s diverticulum, typically seen in inguinal or femoral regions. There is no evidence of Meckel’s diverticulum in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Amyand hernia:</strong> Involves the herniation of the appendix into the inguinal canal. This is not depicted in the image.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Richter’s hernia involves the herniation of part of the bowel wall (antimesenteric border), leading to ischemia and necrosis without complete bowel obstruction.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It presents with localized swelling and tenderness, often without overt signs of intestinal obstruction.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Early surgical intervention is essential to prevent complications like bowel perforation.</span></li></ul>",
      "correct_choice_id": 287795,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72477,
      "choices": [
        {
          "id": 288897,
          "text": "<p><span style=\"font-size:14.0pt;\">Heteroplasmy</span></p>"
        },
        {
          "id": 288898,
          "text": "<p><span style=\"font-size:14.0pt;\">Atavism</span></p>"
        },
        {
          "id": 288899,
          "text": "<p><span style=\"font-size:14.0pt;\">Genetic anticipation</span></p>"
        },
        {
          "id": 288900,
          "text": "<p><span style=\"font-size:14.0pt;\">Genetic mosaics</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A geneticist is analyzing a family where a rare trait is not visible in the parents but appears in the child. The child closely resembles a grandparent who had this trait. What is the most likely explanation for this inheritance pattern?</span></p>",
      "unique_key": "Q9055214",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Atavism</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Atavism</strong> refers to the <strong>reappearance of traits</strong> that have been absent for multiple generations, usually caused by <strong>genetic recombination</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In this case, the trait is reappearing in the child after several generations due to the genes having been recombined in a way that brought the trait back, resembling the <strong>grandparent</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Heteroplasmy:</strong> <strong>Heteroplasmy</strong> refers to the presence of more than one type of mitochondrial DNA within a cell, not the reappearance of a trait after generations.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Genetic anticipation:</strong> <strong>Genetic anticipation</strong> refers to a genetic condition becoming more severe or appearing earlier in subsequent generations, which is unrelated to the reappearance of traits.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Genetic mosaics:</strong> <strong>Genetic mosaics</strong> describe individuals with two or more genetically different sets of cells, not the reappearance of an ancestral trait after generations.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Atavism</strong> describes the <strong>reappearance of ancestral traits</strong> after several generations due to <strong>genetic recombination</strong>, leading to a resemblance to a <strong>grandparent</strong>.</span></li></ul>",
      "correct_choice_id": 288898,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72061,
      "choices": [
        {
          "id": 287245,
          "text": "<p><span style=\"font-size:14.0pt;\">1-C, 2-A, 3-B, 4-D</span></p>"
        },
        {
          "id": 287246,
          "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-A, 3-D, 4-C&nbsp;</span></p>"
        },
        {
          "id": 287247,
          "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-D, 3-C, 4-A</span></p>"
        },
        {
          "id": 287248,
          "text": "<p><span style=\"font-size:14.0pt;\">1-A, 2-B, 3-D, 4-C</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the following concepts with their correct descriptions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column A:</span></p><ol><li><span style=\"font-size:14.0pt;\">Capacitation of sperm</span></li><li><span style=\"font-size:14.0pt;\">Aspermia</span></li><li><span style=\"font-size:14.0pt;\">Superfetation</span></li><li><span style=\"font-size:14.0pt;\">Progesterone during luteal phase</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column B:</span></p><ol style=\"list-style-type:upper-latin;\"><li><span style=\"font-size:14.0pt;\">No ejaculate due to ejaculation failure</span></li><li><span style=\"font-size:14.0pt;\">Physiological changes enabling sperm to fertilize an oocyte</span></li><li><span style=\"font-size:14.0pt;\">Dominant hormone during the second half of the menstrual cycle</span></li><li><span style=\"font-size:14.0pt;\">Fertilization of two ova released in two different menstrual cycles</span></li></ol>",
      "unique_key": "Q9213524",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) 1-B, 2-A, 3-D, 4-C</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Capacitation of sperm (1-B):</strong> Physiochemical changes in sperm make them capable of fertilizing an oocyte.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Aspermia (2-A):</strong> Refers to the absence of ejaculate caused by ejaculation failure.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Superfetation (3-D):</strong> Occurs when two ova are fertilized during different menstrual cycles.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Progesterone during luteal phase (4-C):</strong> This hormone dominates the second half of the menstrual cycle, maintaining the uterine lining.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Capacitation of sperm : Physiochemical changes in sperm make them capable of fertilizing an oocyte.</span></li><li><span style=\"font-size:14.0pt;\">Aspermia : Refers to the absence of ejaculate caused by ejaculation failure.</span></li><li><span style=\"font-size:14.0pt;\">Superfetation : Occurs when two ova are fertilized during different menstrual cycles.</span></li><li><span style=\"font-size:14.0pt;\">Progesterone during luteal phase : This hormone dominates the second half of the menstrual cycle, maintaining the uterine lining.</span></li></ul>",
      "correct_choice_id": 287246,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72453,
      "choices": [
        {
          "id": 288801,
          "text": "<p><span style=\"font-size:14.0pt;\">Geometric mean</span></p>"
        },
        {
          "id": 288802,
          "text": "<p><span style=\"font-size:14.0pt;\">Range</span></p>"
        },
        {
          "id": 288803,
          "text": "<p><span style=\"font-size:14.0pt;\">Deviation</span></p>"
        },
        {
          "id": 288804,
          "text": "<p><span style=\"font-size:14.0pt;\">Standard error</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A researcher is conducting a study to assess the accuracy of the sample mean as an estimate of the population mean. The researcher is concerned about how much variability exists between the sample mean and the true population mean. Which statistical measure should be calculated to determine how precisely the sample mean approximates the population mean?&nbsp;</span></p>",
      "unique_key": "Q3857306",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Standard error</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The standard error quantifies the precision of the sample mean as an estimate of the population mean.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It reflects how much the sample mean is expected to vary from the population mean due to random sampling.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A smaller standard error indicates that the sample mean is a more reliable estimate of the population mean.</span></li><li><span style=\"font-size:14.0pt;\">The standard error is calculated as the standard deviation of the sample divided by the square root of the sample size (n).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Geometric mean</strong>: It is typically used for data that involves multiplicative relationships (e.g., rates of growth), but it does not provide any information about the accuracy of the sample mean.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option B. Range:&nbsp;</strong>It is the difference between the highest and lowest values in a dataset and does not address the accuracy of the sample mean as an estimate of the population mean.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option C. Deviation:&nbsp;</strong>Measures the difference between individual data points and the mean but does not give a direct measure of the sample mean’s precision.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The standard error is the statistical measure that evaluates how accurately the sample mean approximates the population mean and is inversely related to sample size.</span></li></ul>",
      "correct_choice_id": 288804,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72183,
      "choices": [
        {
          "id": 287733,
          "text": "<p><span style=\"font-size:14.0pt;\">Rolando Fracture&nbsp;</span></p>"
        },
        {
          "id": 287734,
          "text": "<p><span style=\"font-size:14.0pt;\">Boxer's Fracture&nbsp;</span></p>"
        },
        {
          "id": 287735,
          "text": "<p><span style=\"font-size:14.0pt;\">Bennett's Fracture&nbsp;</span></p>"
        },
        {
          "id": 287736,
          "text": "<p><span style=\"font-size:14.0pt;\">Colles' Fracture</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old male presents to the emergency department with pain and swelling in his right thumb after punching a wall. He reports that he hit the wall with a closed fist, and immediately afterward, he noticed pain at the base of his thumb along with difficulty moving it. On examination, there is significant swelling, bruising, and tenderness over the first metacarpal joint. X-ray is shown below. Which of the following is the most likely diagnosis?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-20%20163321.jpg\" width=\"554\" height=\"363\"></span></p><p>&nbsp;</p><p>&nbsp;</p>",
      "unique_key": "Q1736433",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Bennett’s Fracture&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The provided clinical history and X-ray are classic for a <strong>Bennett's fracture</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This is an intra-articular fracture at the base of the first metacarpal bone.</span></li><li><span style=\"font-size:14.0pt;\">It is often caused by an axial load on a partially flexed thumb, such as when punching a wall with a closed fist.</span></li><li><span style=\"font-size:14.0pt;\">The fracture typically involves a small piece of the metacarpal base remaining attached to the trapezial bone, while the rest of the metacarpal is dislocated laterally and proximally due to the pull of the abductor pollicis longus tendon.</span></li><li><span style=\"font-size:14.0pt;\">The X-ray image shows this characteristic fracture and dislocation at the carpometacarpal (CMC) joint of the thumb.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Rolando Fracture:&nbsp;</strong>This is also a fracture at the base of the first metacarpal, but it is a comminuted fracture, meaning the bone is broken into three or more pieces, forming a T or Y shape. The provided X-ray does not show this comminution.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-13%20171520.jpeg\" width=\"673\" height=\"324\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Boxer's Fracture</strong>: A Boxer’s fracture typically refers to a fracture of the distal fifth metacarpal and is most often caused by punching something with a closed fist. This fracture generally involves a single, transverse fracture at the neck of the fifth metacarpal, which is not the case here since the injury is at the base of the first metacarpal.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-13%20171554.jpeg\" width=\"283\" height=\"417\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Colles' Fracture</strong>: A Colles' fracture is a fracture of the distal radius near the wrist, often caused by falling onto an outstretched hand. This fracture does not involve the metacarpal bone of the thumb.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-13%20171627.jpeg\" width=\"319\" height=\"351\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Rolando fracture</strong>: Comminuted, Y- or T-shaped fracture at the base of the first metacarpal, usually due to forceful trauma like punching.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Boxer's fracture</strong>: Fracture of the distal fifth metacarpal, often caused by punching.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Bennett’s fracture</strong>: Fracture at the base of the first metacarpal, often with dislocation but not comminuted.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Colles’ fracture</strong>: Fracture of the distal radius at the wrist, usually due to falling on an outstretched hand.</span></li></ul>",
      "correct_choice_id": 287735,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        15
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72488,
      "choices": [
        {
          "id": 288941,
          "text": "<p><span style=\"font-size:14.0pt;\">Percentage of deliveries with skilled assistance</span></p>"
        },
        {
          "id": 288942,
          "text": "<p><span style=\"font-size:14.0pt;\">Infant mortality rate (IMR)</span></p>"
        },
        {
          "id": 288943,
          "text": "<p><span style=\"font-size:14.0pt;\">Percentage of JSY claims made to ASHA</span></p>"
        },
        {
          "id": 288944,
          "text": "<p><span style=\"font-size:14.0pt;\">Percentage of fever cases that received chloroquine within 1 week in endemic areas</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">During a public health audit, an evaluator is asked to determine the impact of the ASHA program on health outcomes. Which of the following would be the best impact indicator for assessing the program’s long-term effects?&nbsp;</span></p>",
      "unique_key": "Q1071685",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Infant mortality rate (IMR)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Impact indicators assess the long-term effects of health interventions.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The infant mortality rate (IMR) is an impact indicator because it measures the overall success of the health program in reducing infant mortality, which reflects the effectiveness of multiple health interventions over time.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Percentage of deliveries with skilled assistance:</strong> Is an outcome indicator, focusing on the immediate effects of the program on delivery care.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option C</strong>. <strong>Percentage of JSY claims made to</strong> <strong>ASHA: </strong>Is a process indicator, measuring administrative aspects of the program rather than its impact on health outcomes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Percentage of fever cases that received chloroquine within 1 week in endemic areas</strong>: Is an outcome indicator, measuring the immediate success of treatment but not the long-term impact.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Indicators for Monitoring and Evaluation of ASHA’s Work</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_qKkr65t.png\" width=\"1212\" height=\"751\"></span></p>",
      "correct_choice_id": 288942,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72441,
      "choices": [
        {
          "id": 288757,
          "text": "<p><span style=\"font-size:14.0pt;\">Pregnancy and lactation - Increase prolactin secretion</span></p>"
        },
        {
          "id": 288758,
          "text": "<p><span style=\"font-size:14.0pt;\">Dopamine blockers - Increase prolactin secretion</span></p>"
        },
        {
          "id": 288759,
          "text": "<p><span style=\"font-size:14.0pt;\">Bromocriptine - Increases prolactin secretion</span></p>"
        },
        {
          "id": 288760,
          "text": "<p><span style=\"font-size:14.0pt;\">Somatostatin - Inhibits prolactin secretion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following combinations regarding factors influencing prolactin secretion is incorrect?&nbsp;</span></p>",
      "unique_key": "Q3666058",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Bromocriptine - Increases prolactin secretion</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Bromocriptine is a dopamine agonist, which inhibits prolactin secretion by mimicking the action of dopamine, a natural inhibitor of prolactin.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Pregnancy and lactation - Increase prolactin secretion: </strong>Correct. Prolactin secretion significantly increases during pregnancy and lactation to prepare the mammary glands for milk production.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Dopamine blockers - Increase prolactin secretion: </strong>Correct. Dopamine blockers inhibit dopamine's suppressive effect on prolactin, leading to an increase in prolactin levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Somatostatin - Inhibits prolactin secretion: </strong>Correct. Somatostatin has an inhibitory effect on prolactin secretion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Bromocriptine is a dopamine agonist that decreases prolactin secretion, while dopamine blockers increase it.</span></p>",
      "correct_choice_id": 288759,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72202,
      "choices": [
        {
          "id": 287809,
          "text": "<p><span style=\"font-size:14.0pt;\">Both A and R are true, and R is the correct explanation for A.</span></p>"
        },
        {
          "id": 287810,
          "text": "<p><span style=\"font-size:14.0pt;\">Both A and R are true, but R is not the correct explanation for A.</span></p>"
        },
        {
          "id": 287811,
          "text": "<p><span style=\"font-size:14.0pt;\">A is true, but R is false.</span></p>"
        },
        {
          "id": 287812,
          "text": "<p><span style=\"font-size:14.0pt;\">A is false, but R is true.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Assertion (A): Barrett’s esophagus increases the risk of adenocarcinoma.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Reason (R): The Prague C &amp; M criteria assess the extent of Barrett’s esophagus, with a higher C &amp; M value correlating to a higher cancer risk.</span></p>",
      "unique_key": "Q1437991",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) Both A and R are true, and R is the correct explanation for A</strong>.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><p><span style=\"font-size:14.0pt;\"><strong>Assertion:</strong> Barrett’s esophagus is a known risk factor for adenocarcinoma due to the transformation of squamous to columnar epithelium with intestinal metaplasia.</span></p><p>&nbsp;</p></li><li><span style=\"font-size:14.0pt;\"><strong>Reason:</strong> The Prague C &amp; M criteria measure the circumferential (C) and maximum (M) extent of Barrett’s esophagus. Higher values indicate a greater extent and a higher risk of progression to adenocarcinoma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The Prague C &amp; M criteria measure the circumferential (C) and maximum (M) extent of Barrett’s esophagus.</span></li></ul>",
      "correct_choice_id": 287809,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72205,
      "choices": [
        {
          "id": 287821,
          "text": "<p><span style=\"font-size:14.0pt;\">Mattress suture - used for wound edge eversion</span></p>"
        },
        {
          "id": 287822,
          "text": "<p><span style=\"font-size:14.0pt;\">Purse-string suture - used in cervical cerclage and to bury the appendicular stump.</span></p>"
        },
        {
          "id": 287823,
          "text": "<p><span style=\"font-size:14.0pt;\">Purse string suture - used for cosmetic skin closure.</span></p>"
        },
        {
          "id": 287824,
          "text": "<p><span style=\"font-size:14.0pt;\">Interrupted suture - used for individual wound closure points.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Identify the type of suture shown in the image and its primary uses:<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-21%20143019.jpg\" width=\"583\" height=\"311\"></strong></span></p>",
      "unique_key": "Q3378443",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Purse-string suture - used in cervical cerclage and to bury the appendicular stump.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The image depicts a purse-string suture, characterized by a continuous circular pattern that tightens when pulled.&nbsp;</span></li><li><p><span style=\"font-size:14.0pt;\">It is commonly used in cervical cerclage to prevent preterm labor and to secure the appendicular stump during appendectomy.</span></p><p>&nbsp;</p></li></ul><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Mattress suture - used for wound edge eversion</strong>: Mattress sutures are used for edge eversion and hemostasis but do not involve a circular pattern.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Purse string suture - used for cosmetic skin closure:</strong> Subcuticular sutures are buried within the skin for cosmetic closure and not purse string suture.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Interrupted suture - used for individual wound closure points:</strong> Interrupted sutures are discrete and individually tied, lacking the circular continuity of the purse-string technique.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The purse-string suture is a circular technique used in cervical cerclage and appendicular stump closure to achieve tension and secure closure.</span></li></ul>",
      "correct_choice_id": 287822,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72505,
      "choices": [
        {
          "id": 289009,
          "text": "<p><span style=\"font-size:14.0pt;\">Reduced AUC</span></p>"
        },
        {
          "id": 289010,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased Tmax</span></p>"
        },
        {
          "id": 289011,
          "text": "<p><span style=\"font-size:14.0pt;\">Decreased half-life</span></p>"
        },
        {
          "id": 289012,
          "text": "<p><span style=\"font-size:14.0pt;\">Lower Cmax</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A new oral drug undergoes pharmacokinetic testing in two patient populations. Group A has significantly lower peak drug concentrations, while Group B exhibits prolonged drug exposure despite similar dosing. Further analysis reveals differences in gastric emptying rates and hepatic enzyme activity. Which parameter best explains the lower peak drug levels observed in Group A?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9349584",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>D) Lower Cmax</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Cmax (maximum plasma concentration)</strong> represents the peak level of the drug in the bloodstream.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A lower Cmax suggests <strong>slower or reduced absorption</strong>, which can be due to factors like delayed gastric emptying or increased first-pass metabolism.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In Group A, differences in gastric emptying or hepatic metabolism likely reduce the amount of drug reaching peak concentration.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Reduced AUC:</strong> Incorrect. AUC represents <strong>total drug exposure</strong> over time, which may not necessarily correlate with peak plasma concentration.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Increased Tmax:</strong> Incorrect. An increased Tmax means the drug reaches peak levels <strong>more slowly</strong>, but does not directly explain the <strong>lower</strong> Cmax.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Decreased half-life:</strong> Incorrect. A reduced half-life means the drug is eliminated more quickly, but does not directly impact peak plasma levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Cmax reflects the highest drug concentration achieved in plasma, and factors such as gastric emptying, enzyme activity, and first-pass metabolism can significantly alter its value.</span></li></ul>",
      "correct_choice_id": 289012,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72066,
      "choices": [
        {
          "id": 287265,
          "text": "<p><span style=\"font-size:14.0pt;\">Cytomegalovirus</span></p>"
        },
        {
          "id": 287266,
          "text": "<p><span style=\"font-size:14.0pt;\">Toxoplasmosis</span></p>"
        },
        {
          "id": 287267,
          "text": "<p><span style=\"font-size:14.0pt;\">Rubella</span></p>"
        },
        {
          "id": 287268,
          "text": "<p><span style=\"font-size:14.0pt;\">Parvovirus B19</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which infection during pregnancy leads to periventricular calcifications?&nbsp;</span></p>",
      "unique_key": "Q2206943",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A) Cytomegalovirus</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Cytomegalovirus causes periventricular calcifications and is the most common cause of congenital deafness.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Toxoplasmosis:&nbsp;</strong>Toxoplasmosis leads to intracerebral calcifications.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Rubella:&nbsp;</strong>Rubella does not cause calcifications.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Parvovirus B19:&nbsp;</strong>Parvovirus B19 causes hydrops fetalis but no calcifications.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Cytomegalovirus infection in pregnancy is associated with periventricular calcifications and sensorineural hearing loss.</span></li></ul>",
      "correct_choice_id": 287265,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72063,
      "choices": [
        {
          "id": 287253,
          "text": "<p><span style=\"font-size:14.0pt;\">Endometrial biopsy on Day 21–23</span></p>"
        },
        {
          "id": 287254,
          "text": "<p><span style=\"font-size:14.0pt;\">Serum estrogen levels on Day 12</span></p>"
        },
        {
          "id": 287255,
          "text": "<p><span style=\"font-size:14.0pt;\">Progesterone level on Day 7 before menses</span></p>"
        },
        {
          "id": 287256,
          "text": "<p><span style=\"font-size:14.0pt;\">Serial ultrasonography</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old woman presents with regular menstrual cycles but infertility for the past year. She reports mittelschmerz and premenstrual symptoms. What is the most appropriate next step to confirm ovulation?</span></p>",
      "unique_key": "Q3557555",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;C) Progesterone level on Day 7 before menses</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Progesterone level &gt;5 ng/mL 7 days before menses confirms ovulation. This is the most practical and reliable test for confirming ovulation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Endometrial biopsy on Day 21–23:&nbsp;</strong>Incorrect because endometrial biopsy is invasive and less commonly used.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Serum estrogen levels on Day 12:&nbsp;</strong>Incorrect because estrogen levels are not reliable indicators of ovulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Serial ultrasonography:&nbsp;</strong>Incorrect because serial ultrasonography, while accurate, is resource-intensive.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Serum progesterone &gt;5 ng/mL, 7 days before menses, is the gold standard for confirming ovulation in clinical practice.</span></li></ul>",
      "correct_choice_id": 287255,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72188,
      "choices": [
        {
          "id": 287753,
          "text": "<p><span style=\"font-size:14.0pt;\">Total parenteral nutrition (TPN)</span></p>"
        },
        {
          "id": 287754,
          "text": "<p><span style=\"font-size:14.0pt;\">Enteral nutrition via nasogastric tube</span></p>"
        },
        {
          "id": 287755,
          "text": "<p><span style=\"font-size:14.0pt;\">Oral supplementation with electrolyte solutions</span></p>"
        },
        {
          "id": 287756,
          "text": "<p><span style=\"font-size:14.0pt;\">Intravenous glucose-only solution</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old male in the ICU following bowel resection develops a high-output jejunostomy. He is unable to tolerate enteral feeds. What is the most appropriate nutritional support?&nbsp;</span></p>",
      "unique_key": "Q4613454",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) Total parenteral nutrition (TPN)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">TPN is indicated when enteral feeding is not feasible due to non-functioning gut (e.g., high-output ileostomy).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Enteral nutrition via nasogastric tube</strong>: Enteral nutrition is not feasible in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Oral supplementation with electrolyte solutions</strong>: Oral supplementation is inadequate for nutritional needs.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Intravenous glucose-only solution:</strong> IV glucose alone does not provide adequate nutrition.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">TPN is the preferred option when enteral feeding is contraindicated or impossible due to gastrointestinal dysfunction.</span></li></ul>",
      "correct_choice_id": 287753,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72060,
      "choices": [
        {
          "id": 287241,
          "text": "<p><span style=\"font-size:14.0pt;\">Congenital deafness</span></p>"
        },
        {
          "id": 287242,
          "text": "<p><span style=\"font-size:14.0pt;\">Hydrops fetalis</span></p>"
        },
        {
          "id": 287243,
          "text": "<p><span style=\"font-size:14.0pt;\">Microcephaly</span></p>"
        },
        {
          "id": 287244,
          "text": "<p><span style=\"font-size:14.0pt;\">Neural tube defect</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old pregnant woman presents with fever and a \"slapped-cheek\" appearance. She is diagnosed with Parvovirus B19 infection. Which of the following complications is most likely in the fetus?&nbsp;</span></p>",
      "unique_key": "Q7497336",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Hydrops fetalis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Parvovirus B19 infection leads to anemia and hydrops fetalis due to its cytotoxicity to fetal RBCs.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Congenital deafness:&nbsp;</strong>Congenital deafness is a feature of cytomegalovirus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Microcephaly:&nbsp;</strong>Microcephaly is associated with Zika virus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Neural tube defect:&nbsp;</strong>Neural tube defects are not associated with Parvovirus B19.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Parvovirus B19 infection in pregnancy primarily causes fetal anemia and hydrops fetalis, not teratogenic anomalies.</span></li></ul>",
      "correct_choice_id": 287242,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72530,
      "choices": [
        {
          "id": 289109,
          "text": "<p><span style=\"font-size:14.0pt;\">Leflunomide</span></p>"
        },
        {
          "id": 289110,
          "text": "<p><span style=\"font-size:14.0pt;\">Methotrexate</span></p>"
        },
        {
          "id": 289111,
          "text": "<p><span style=\"font-size:14.0pt;\">NSAIDs</span></p>"
        },
        {
          "id": 289112,
          "text": "<p><span style=\"font-size:14.0pt;\">Certolizumab</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 31-year-old pregnant woman presents for evaluation of worsening symptoms of rheumatoid arthritis (RA) at 32 weeks of gestation. She reports increasing joint pain, stiffness, and swelling, particularly in the hands and knees, making daily activities difficult. Her RA was well-controlled before pregnancy on hydroxychloroquine (HCQ) and sulfasalazine, but her symptoms have progressively worsened during the third trimester. She is concerned about the potential impact of her condition on her ability to care for her baby after delivery. She has no history of other autoimmune conditions, drug allergies, or complications in this pregnancy so far. Which drug can be safely added to her treatment at this stage of pregnancy?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8961663",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;D) Certolizumab</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Certolizumab, an anti-TNF agent, is the safest biologic for use during pregnancy and can be continued throughout gestation without significant risk to the fetus.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Its unique structure lacks an Fc fragment, preventing significant placental transfer, making it ideal for use in the later stages of pregnancy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Leflunomide</strong>: Contraindicated due to teratogenicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Methotrexate</strong>: Contraindicated because of teratogenicity and risk of pregnancy loss. It should be discontinued at least 3 months before conception.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. NSAIDs</strong>: May be used in the first and second trimesters but must be avoided after 30 weeks due to the risk of premature closure of the ductus arteriosus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Certolizumab is a safe and effective treatment option for managing RA in pregnancy, particularly in the later stages, without posing significant risk to the fetus.</span></li></ul>",
      "correct_choice_id": 289112,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72201,
      "choices": [
        {
          "id": 287805,
          "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-A, 3-D, 4-C</span></p>"
        },
        {
          "id": 287806,
          "text": "<p><span style=\"font-size:14.0pt;\">1-D, 2-A, 3-B, 4-C</span></p>"
        },
        {
          "id": 287807,
          "text": "<p><span style=\"font-size:14.0pt;\">1-D, 2-B, 3-C, 4-A&nbsp;</span></p>"
        },
        {
          "id": 287808,
          "text": "<p><span style=\"font-size:14.0pt;\">1-A, 2-D, 3-B, 4-C</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the types of grafts in Column A with their definitions in Column B:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Column A:</strong></span></p><ol><li><span style=\"font-size:14.0pt;\">Allograft</span></li><li><span style=\"font-size:14.0pt;\">Xenograft</span></li><li><span style=\"font-size:14.0pt;\">Orthotopic graft</span></li><li><span style=\"font-size:14.0pt;\">Heterotopic graft</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Column B:</strong>&nbsp;</span></p><ol style=\"list-style-type:upper-latin;\"><li><span style=\"font-size:14.0pt;\">A graft placed in a site other than its natural location.</span></li><li><span style=\"font-size:14.0pt;\">A graft taken from a donor of a different species.</span></li><li><span style=\"font-size:14.0pt;\">A graft placed in the same anatomical site as the original tissue.</span></li><li><span style=\"font-size:14.0pt;\">A graft taken from a genetically non-identical individual of the same species.</span></li></ol>",
      "unique_key": "Q9092032",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) 1-D, 2-B, 3-C, 4-A</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Allograft (1-D):</strong> This is a graft taken from a genetically non-identical individual of the same species.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Xenograft (2-B):</strong> This is a graft taken from a donor of a different species, such as porcine skin for burn patients.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Orthotopic graft (3-C):</strong> A graft transplanted into the same anatomical site as the original tissue.</span></li><li><p><span style=\"font-size:14.0pt;\"><strong>Heterotopic graft (4-A):</strong> A graft transplanted into a site other than its natural location.</span></p><p>&nbsp;</p></li></ul><p><span style=\"color:black;font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:14.0pt;\">Allograft : This is a graft taken from a genetically non-identical individual of the same species.</span></li><li><span style=\"color:black;font-size:14.0pt;\">Xenograft : This is a graft taken from a donor of a different species, such as porcine skin for burn patients.</span></li><li><span style=\"color:black;font-size:14.0pt;\">Orthotopic graft : A graft transplanted into the same anatomical site as the original tissue.</span></li><li><span style=\"color:black;font-size:14.0pt;\">Heterotopic graft : A graft transplanted into a site other than its natural location.</span></li></ul>",
      "correct_choice_id": 287807,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72490,
      "choices": [
        {
          "id": 288949,
          "text": "<p><span style=\"font-size:14.0pt;\">It estimates Disability-Free Life Expectancy (DFLE).</span></p>"
        },
        {
          "id": 288950,
          "text": "<p><span style=\"font-size:14.0pt;\">It considers both mortality and morbidity in its calculation.</span></p>"
        },
        {
          "id": 288951,
          "text": "<p><span style=\"font-size:14.0pt;\">It measures the overall disease burden in a population, including premature mortality and disability.</span></p>"
        },
        {
          "id": 288952,
          "text": "<p><span style=\"font-size:14.0pt;\">It subtracts years lived with disability from total life expectancy.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements about Sullivan’s Index is incorrect?&nbsp;</span></p>",
      "unique_key": "Q4623399",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) It measures the overall disease burden in a population, including premature mortality and disability.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Sullivan’s Index is an epidemiological measure used to calculate Disability-Free Life Expectancy (DFLE) by subtracting the number of years lived with disability from the total life expectancy.</span></li><li><span style=\"font-size:14.0pt;\">This indicator is useful for estimating the proportion of life spent in good health and is widely used in public health planning.</span></li><li><span style=\"font-size:14.0pt;\">Sullivan’s Index does not measure the overall disease burden in a population, which includes both premature mortality and disability-adjusted life years (DALYs). Instead, it focuses solely on disability-free years and does not account for diseases causing premature death.</span></li><li><span style=\"font-size:14.0pt;\">DALY (Disability-Adjusted Life Years) is the best metric for measuring the overall burden of disease because it includes both Years of Life Lost (YLL) due to premature mortality and Years Lived with Disability (YLD).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. It estimates Disability-Free Life Expectancy (DFLE):&nbsp;</strong>This is correct, as Sullivan’s Index directly quantifies the number of years a person is expected to live without disability in a given population.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. It considers both mortality and morbidity in its calculation</strong>: This is correct since Sullivan’s Index integrates both life expectancy and morbidity data to determine how many years are spent without disability.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. It subtracts years lived with disability</strong> <strong>from total life expectancy</strong>: This is correct, as Sullivan’s Index uses the formula:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">DFLE = Total&nbsp;Life&nbsp;Expectancy − Years&nbsp;Lived&nbsp;with&nbsp;Disability&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">It helps estimate healthy life expectancy, which is an important metric for evaluating public health interventions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Sullivan’s Index is the Life Expectancy minus Duration of disability (bed disability and inability to perform major activities).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is one of the most advanced indicators currently available to measure ‘Disability free life expectancy (DFLE)’</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Note - Disability Adjusted Life Years [DALYs]</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Is best measure of burden of disease in a defined population and the effectiveness of interventions.</span></li><li><span style=\"font-size:14.0pt;\">It expresses years lost to premature death and years lived with disability (adjusted for its’ severity).</span></li><li><span style=\"font-size:14.0pt;\">DALYs can measure ‘both mortality and disability together’.</span></li></ul>",
      "correct_choice_id": 288951,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72147,
      "choices": [
        {
          "id": 287589,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3 only</span></p>"
        },
        {
          "id": 287590,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3 and 4 only</span></p>"
        },
        {
          "id": 287591,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 3 only</span></p>"
        },
        {
          "id": 287592,
          "text": "<p><span style=\"font-size:14.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 14-year-old male presents with nasal obstruction, recurrent epistaxis, and a smooth, vascular mass in the nasopharynx. Imaging shows bony erosion of the sphenoid sinus. Which of the following statements are true?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">This condition is common in adolescent males.</span></li><li><span style=\"font-size:14.0pt;\">The tumor arises from the sphenopalatine foramen.</span></li><li><span style=\"font-size:14.0pt;\">Surgical resection is the treatment of choice.</span></li><li><span style=\"font-size:14.0pt;\">The tumor is malignant.</span></li></ol>",
      "unique_key": "Q1806564",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) 1, 2 and 3 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1.</strong> <strong>This condition is common in adolescent males: True.</strong> Juvenile Nasopharyngeal Angiofibroma is most common in adolescent males.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2.</strong> <strong>The tumor arises from the sphenopalatine foramen: True.</strong> The tumor arises from sphenopalatine foramen and grows aggressively.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3.</strong> <strong>Surgical resection is the treatment of choice: True.</strong> Surgical resection is necessary due to its local invasion and vascular nature.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4.</strong> <strong>The tumor is malignant: False.</strong> JNA is a benign tumor, although it can grow aggressively and erode local structures.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Juvenile Nasopharyngeal Angiofibroma is a benign but aggressive tumor common in adolescent males, requiring surgical resection.</span></li></ul>",
      "correct_choice_id": 287589,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72102,
      "choices": [
        {
          "id": 287409,
          "text": "<p><span style=\"font-size:14.0pt;\">Both Assertion and Reason are true, and the Reason is the correct explanation for the Assertion.</span></p>"
        },
        {
          "id": 287410,
          "text": "<p><span style=\"font-size:14.0pt;\">Both Assertion and Reason are true, but the Reason is not the correct explanation for the Assertion.</span></p>"
        },
        {
          "id": 287411,
          "text": "<p><span style=\"font-size:14.0pt;\">Assertion is true, but the Reason is false.</span></p>"
        },
        {
          "id": 287412,
          "text": "<p><span style=\"font-size:14.0pt;\">Both Assertion and Reason are false.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Assertion: Patients with severe systemic disease, classified as ASA IV, have a higher risk of perioperative complications.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Reason: ASA IV classification includes patients with life-threatening conditions that compromise organ function.</span></p>",
      "unique_key": "Q2989647",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) Both Assertion and Reason are true, and the Reason is the correct explanation for the Assertion.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><p><span style=\"font-size:14.0pt;\">ASA IV patients have systemic conditions like unstable angina or severe heart failure, which lead to compromised outcomes.</span></p><p>&nbsp;</p></li></ul><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Patients in ASA IV have life-threatening systemic illnesses, requiring meticulous perioperative planning to mitigate complications.</span></li></ul>",
      "correct_choice_id": 287409,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72549,
      "choices": [
        {
          "id": 289185,
          "text": "<p><span style=\"font-size:14.0pt;\">Blood level of cystathionine</span></p>"
        },
        {
          "id": 289186,
          "text": "<p><span style=\"font-size:14.0pt;\">Blood level of homocysteine</span></p>"
        },
        {
          "id": 289187,
          "text": "<p><span style=\"font-size:14.0pt;\">Blood level of methionine</span></p>"
        },
        {
          "id": 289188,
          "text": "<p><span style=\"font-size:14.0pt;\">Blood level of methylmalonate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old male presents with fatigue, pallor, and neurological symptoms, including tingling in his hands and feet. His blood work reveals macrocytic anemia. The physician suspects either a folate or vitamin B12 deficiency. Which of the following laboratory tests would best differentiate between these two deficiencies?&nbsp;</span></p>",
      "unique_key": "Q1428657",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Blood level of methylmalonate</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Methylmalonyl-CoA mutase</strong>, an enzyme requiring <strong>vitamin B12 (cobalamin)</strong>, converts <strong>methylmalonyl-CoA to succinyl-CoA</strong> in fatty acid metabolism.</span></li><li><span style=\"font-size:14.0pt;\">In <strong>vitamin B12 deficiency</strong>, methylmalonyl-CoA accumulates, leading to <strong>increased methylmalonate (MMA) levels in the blood</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Folate deficiency does not affect methylmalonate levels</strong>, making <strong>MMA the best test to differentiate between B12 and folate deficiency</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Blood level of cystathionine: Incorrect.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Cystathionine is an intermediate in the <strong>transsulfuration pathway</strong>, where homocysteine is converted to cystathionine via <strong>cystathionine β-synthase (CBS)</strong>, a process requiring vitamin <strong>B6 (pyridoxine)</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Folate or B12 deficiencies do not significantly affect cystathionine levels</strong>, so this test is not useful for distinguishing between the two.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Blood level of homocysteine: Incorrect</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Both folate and vitamin B12 deficiencies lead to elevated homocysteine levels</strong>, because both are involved in its metabolism.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Folate deficiency impairs the conversion of homocysteine to methionine</strong>, and <strong>B12 deficiency prevents methylation of homocysteine by methionine synthase</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Since both deficiencies result in <strong>homocysteine accumulation</strong>, this test <strong>cannot differentiate between them</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Blood level of methionine: Incorrect</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Methionine is produced when <strong>homocysteine is converted via methionine synthase</strong>, a process requiring <strong>vitamin B12</strong>.</span></li><li><span style=\"font-size:14.0pt;\">However, methionine levels are <strong>not a reliable marker for distinguishing folate from B12 deficiency</strong>, as multiple metabolic pathways regulate methionine levels.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Both B12 and folate deficiencies increase homocysteine levels.</span></li><li><span style=\"font-size:14.0pt;\">Only B12 deficiency elevates methylmalonate levels.</span></li><li><span style=\"font-size:14.0pt;\">A high methylmalonate level confirms vitamin B12 deficiency, while a normal level suggests folate deficiency.</span></li></ul>",
      "correct_choice_id": 289188,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72560,
      "choices": [
        {
          "id": 289229,
          "text": "<p><span style=\"font-size:14.0pt;\">Haloperidol</span></p>"
        },
        {
          "id": 289230,
          "text": "<p><span style=\"font-size:14.0pt;\">Intravenous lorazepam</span></p>"
        },
        {
          "id": 289231,
          "text": "<p><span style=\"font-size:14.0pt;\">Oral chlordiazepoxide</span></p>"
        },
        {
          "id": 289232,
          "text": "<p><span style=\"font-size:14.0pt;\">Intravenous phenytoin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old man is brought to an emergency with acute onset confusion, visual hallucinations, tremors, profuse sweating, and tachycardia. His wife reports he usually drinks 12-14 drinks daily but hasn't had alcohol for 2 days as he was trying to quit. On examination, he is disoriented, and agitated, with a BP of 160/100 mmHg. What is the most appropriate immediate management?&nbsp;</span></p>",
      "unique_key": "Q7449983",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Intravenous lorazepam</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient presents with <strong>acute confusion, visual hallucinations, tremors, autonomic instability (tachycardia, hypertension), and disorientation</strong> after stopping alcohol for <strong>48 hours</strong>, which is highly suggestive of <strong>alcohol withdrawal delirium (delirium tremens, DTs)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This is a <strong>life-threatening</strong> condition requiring <strong>immediate treatment with intravenous benzodiazepines</strong>, such as <strong>lorazepam</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Benzodiazepines reduce <strong>hyperexcitability of the CNS</strong>, prevent seizures, and control agitation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Haloperidol</strong>: <strong>Incorrect.</strong> While <strong>antipsychotics</strong> like haloperidol may help control hallucinations, they <strong>do not treat the underlying cause</strong> of withdrawal and <strong>do not prevent seizures</strong>, making them inappropriate as first-line therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Oral chlordiazepoxide</strong>: <strong>Incorrect.Chlordiazepoxide</strong> is a long-acting benzodiazepine used for <strong>mild alcohol withdrawal</strong>, but it is given <strong>orally</strong> and is <strong>not suitable for severe withdrawal</strong> or <strong>delirium tremens</strong>, where IV benzodiazepines are preferred.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Intravenous phenytoin</strong>: <strong>Incorrect</strong>. <strong>Phenytoin is ineffective for alcohol withdrawal seizures</strong>. Withdrawal seizures are best prevented and managed with <strong>benzodiazepines</strong>, not anticonvulsants like phenytoin.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Delirium Tremens (DTs) (alcohol withdrawal delirium) is a medical emergency and if untreated the mortality rate is around 20%.</span></li><li><span style=\"font-size:14.0pt;\">The symptoms and signs include disturbances of consciousness, disorientation to time, place, and person, hallucination (most commonly visual), coarse tremors, and autonomic hyperactivity.</span></li><li><span style=\"font-size:14.0pt;\">It usually occurs after 48-72 hours of the last alcohol intake or reduction in the amount of alcohol use.</span></li></ul>",
      "correct_choice_id": 289230,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72199,
      "choices": [
        {
          "id": 287797,
          "text": "<p><span style=\"font-size:14.0pt;\">Nasal cannula oxygen</span></p>"
        },
        {
          "id": 287798,
          "text": "<p><span style=\"font-size:14.0pt;\">Non-rebreather mask oxygen</span></p>"
        },
        {
          "id": 287799,
          "text": "<p><span style=\"font-size:14.0pt;\">Hyperbaric oxygen therapy</span></p>"
        },
        {
          "id": 287800,
          "text": "<p><span style=\"font-size:14.0pt;\">Endotracheal intubation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old male rescued from a house fire presents with confusion, tachycardia, and SpO2 of 98%. Carboxyhemoglobin levels are 25%. What is the next step in management?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8130186",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong>&nbsp;<strong>C) Hyperbaric oxygen therapy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><p><span style=\"font-size:14.0pt;\">Hyperbaric oxygen therapy is indicated for severe carbon monoxide poisoning (carboxyhemoglobin &gt;25%) to reduce half-life and prevent neurological complications.</span></p><p>&nbsp;</p></li></ul><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Nasal cannula oxygen</strong>: Nasal cannula oxygen is insufficient.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Non-rebreather mask oxygen</strong>: Non-rebreather mask oxygen is for mild cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Endotracheal intubation:</strong> Endotracheal Intubation is only required for respiratory distress.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Hyperbaric oxygen therapy is the treatment of choice for severe carbon monoxide poisoning with high carboxyhemoglobin levels.</span></li></ul>",
      "correct_choice_id": 287799,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72502,
      "choices": [
        {
          "id": 288997,
          "text": "<p><span style=\"font-size:14.0pt;\">Multiplex PCR with multiple primers</span></p>"
        },
        {
          "id": 288998,
          "text": "<p><span style=\"font-size:14.0pt;\">Real-time PCR with SYBR Green</span></p>"
        },
        {
          "id": 288999,
          "text": "<p><span style=\"font-size:14.0pt;\">Nested PCR with internal primers</span></p>"
        },
        {
          "id": 289000,
          "text": "<p><span style=\"font-size:14.0pt;\">Conventional PCR with extended cycles</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A molecular laboratory needs to detect a low-copy bacterial gene with maximum specificity. The sample is precious and limited in quantity. Which of the following PCR modifications would provide the highest sensitivity while maintaining specificity?&nbsp;</span></p>",
      "unique_key": "Q9280583",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;C) Nested PCR with internal primers</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Nested PCR is ideal for detecting low-copy genes as it involves two rounds of amplification using different primer sets, with the second primer pair targeting a sequence within the first-round product.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This double amplification significantly increases sensitivity, while the use of two specific primer sets targeting the same organism enhances specificity, making it optimal for detecting low-copy genes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Multiplex PCR with multiple primers: </strong>While this allows detection of multiple targets, it may reduce sensitivity due to primer competition and is not optimized for low-copy number detection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Real-time PCR with SYBR Green:&nbsp;</strong>Although quantitative, it doesn't provide the enhanced sensitivity of nested PCR for very low copy numbers and may detect non-specific products.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Conventional PCR with extended cycles:&nbsp;</strong>Simply increasing cycle numbers can lead to non-specific amplification and doesn't provide the specificity of nested PCR.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Nested PCR provides maximum sensitivity through double amplification while maintaining specificity by using two sets of primers targeting the same organism.</span></li></ul>",
      "correct_choice_id": 288999,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72450,
      "choices": [
        {
          "id": 288789,
          "text": "<p><span style=\"font-size:14.0pt;\">Elevated serum creatine kinase (CK)</span></p>"
        },
        {
          "id": 288790,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased urine myoglobin concentration</span></p>"
        },
        {
          "id": 288791,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased serum calcium levels</span></p>"
        },
        {
          "id": 288792,
          "text": "<p><span style=\"font-size:14.0pt;\">Decreased hemoglobin concentration</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old male patient presents with progressive muscle weakness, cataracts, and difficulty relaxing his grip after shaking hands. Genetic testing confirms a trinucleotide repeat expansion in the DMPK gene. Which of the following findings is most likely associated with his condition?</span></p>",
      "unique_key": "Q4083218",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Elevated serum creatine kinase (CK)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Myotonic dystrophy type 1 (DM1) is associated with an elevated serum creatine kinase (CK) level due to muscle damage.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Muscle weakness and myotonia lead to muscle breakdown, releasing CK into the bloodstream.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This is a key diagnostic clue in DM1. Unlike other conditions like rhabdomyolysis, where myoglobin is released, DM1 typically shows high CK levels without significantly elevated myoglobin.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Increased urine myoglobin concentration</strong>: Myoglobinuria is seen in conditions like rhabdomyolysis, not myotonic dystrophy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Increased serum calcium levels</strong>: Hypercalcemia is not a typical feature of myotonic dystrophy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Decreased hemoglobin concentration</strong>: Anemia is not a prominent feature of myotonic dystrophy, though it may occur secondarily in severe cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Elevated serum creatine kinase (CK) is commonly seen in myotonic dystrophy due to muscle damage, aiding in the diagnosis of the condition.</span></li></ul>",
      "correct_choice_id": 288789,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72469,
      "choices": [
        {
          "id": 288865,
          "text": "<p><span style=\"font-size:14.0pt;\">Nested case-control studies are typically less costly than cohort studies because fewer participants are needed for analysis.</span></p>"
        },
        {
          "id": 288866,
          "text": "<p><span style=\"font-size:14.0pt;\">Nested case-control studies involve the collection of exposure data from participants after the outcome has occurred, making them more efficient than cohort studies.</span></p>"
        },
        {
          "id": 288867,
          "text": "<p><span style=\"font-size:14.0pt;\">Nested case-control studies require a cohort study to be already in place, which may limit their feasibility in certain settings.</span></p>"
        },
        {
          "id": 288868,
          "text": "<p><span style=\"font-size:14.0pt;\">Nested case-control studies allow for efficient analysis of rare outcomes within large cohorts, without the need for extensive participant recruitment.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is the misconception about nested case-control studies?&nbsp;</span></p>",
      "unique_key": "Q9389437",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Nested case-control studies involve the collection of exposure data from participants after the outcome has occurred, making them more efficient than cohort studies.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The misconception is that nested case-control studies involve collecting exposure data after the outcome has occurred, which is not true.</span></li><li><span style=\"font-size:14.0pt;\">In fact, nested case-control studies collect exposure data before the disease occurs, which helps to minimize bias.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These studies can be cost-effective because they utilize existing cohort data, but they are not more efficient than cohort studies in all cases, especially when the cohort is large and follow-up is lengthy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Nested case-control studies are typically less costly than cohort studies because fewer participants are needed for analysis:&nbsp;</strong>Nested case-control studies are less expensive than cohort studies because only a subset of participants (cases and controls) is required for analysis.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option C. Nested case-control studies require a cohort study to be already in place, which may limit their feasibility in certain settings:&nbsp;</strong>Nested case-control studies are based on existing cohort studies, which may limit their use in new populations.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option D. Nested case-control studies allow for efficient analysis of rare outcomes within large cohorts, without the need for extensive participant recruitment:&nbsp;</strong>These studies are particularly useful in studying rare outcomes by focusing on a subset of the cohort, which can reduce recruitment costs.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">In a nested case-control study, exposure data is collected before the disease develops, and it is more cost-effective than cohort studies due to the use of existing cohort data.</span></li></ul>",
      "correct_choice_id": 288866,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72507,
      "choices": [
        {
          "id": 289017,
          "text": "<p><span style=\"font-size:14.0pt;\">Methyldopa</span></p>"
        },
        {
          "id": 289018,
          "text": "<p><span style=\"font-size:14.0pt;\">Amiodarone</span></p>"
        },
        {
          "id": 289019,
          "text": "<p><span style=\"font-size:14.0pt;\">Procainamide</span></p>"
        },
        {
          "id": 289020,
          "text": "<p><span style=\"font-size:14.0pt;\">Phenytoin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 58-year-old woman with a history of hypertension and paroxysmal supraventricular tachycardia presents with fatigue, arthralgia, and pleuritic<strong>&nbsp;</strong>chest pain for the past 3 months. She reports no prior history of autoimmune disease. Physical exam reveals a malar rash, swollen small joints, and mild pleural effusion. Laboratory results show positive antinuclear antibody (ANA)<strong>&nbsp;</strong>and anti-histone antibodies, but anti-dsDNA and anti-Smith antibodies are negative. Which of the following medications is most likely responsible for this patient’s symptoms?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4581357",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Procainamide</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient presents with <strong>drug-induced lupus erythematosus (DILE)</strong>, a condition associated with <strong>hydralazine, procainamide, isoniazid, and sulfonamides (SHIPP mnemonic)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The hallmark of <strong>DILE</strong> includes <strong>arthralgia, fever, serositis (pleuritis, pericarditis), and positive ANA and anti-histone antibodies</strong>, with <strong>negative anti-dsDNA and anti-Smith antibodies</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Procainamide</strong>, an antiarrhythmic, is one of the highest-risk drugs for DILE.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Methyldopa</strong>: While methyldopa is associated with <strong>autoimmune hemolytic anemia</strong>, it is <strong>not a common cause of DILE</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Amiodarone</strong>: Amiodarone can cause <strong>thyroid dysfunction, pulmonary fibrosis, and hepatotoxicity</strong> but is <strong>not linked to DILE</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Phenytoin</strong>: Phenytoin toxicity can lead to <strong>drug reaction with eosinophilia and systemic symptoms (DRESS)</strong> rather than lupus-like syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Drug-induced lupus erythematosus (DILE) is most commonly associated with hydralazine, procainamide, isoniazid, and sulfonamides.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It presents with arthralgia, serositis, and positive anti-histone antibodies. Anti-dsDNA and anti-Smith antibodies are usually absent.</span></li></ul>",
      "correct_choice_id": 289019,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72470,
      "choices": [
        {
          "id": 288869,
          "text": "<p><span style=\"font-size:14.0pt;\">Genomic imprinting results in the silencing of the maternal allele, making the paternal deletion manifest.</span></p>"
        },
        {
          "id": 288870,
          "text": "<p><span style=\"font-size:14.0pt;\">The child inherited two active copies of chromosome 15 from the father and mother, resulting in expression of the mutated gene.</span></p>"
        },
        {
          "id": 288871,
          "text": "<p><span style=\"font-size:14.0pt;\">Anticipation caused the gene to become more severe as it was passed down through the generations.</span></p>"
        },
        {
          "id": 288872,
          "text": "<p><span style=\"font-size:14.0pt;\">Gonadal mosaicism in the father led to a second, unaffected allele being passed on to the child.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A couple presents with a history of recurrent miscarriages and a child with developmental delay. Genetic testing reveals that the child has Prader-Willi syndrome due to a paternal deletion on chromosome 15. What is the most likely reason the child inherited this genetic condition?</span></p>",
      "unique_key": "Q4220766",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) Genomic imprinting results in the silencing of the maternal allele, making the paternal deletion manifest.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Prader-Willi syndrome</strong> is caused by a <strong>paternal deletion</strong> on chromosome 15, and the condition manifests due to <strong>maternal imprinting</strong>, which silences the maternal allele.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Genomic imprinting</strong> causes the <strong>paternal allele</strong> to be expressed while the <strong>maternal allele</strong> is silenced by <strong>DNA methylation</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other&nbsp;Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B</strong>.<strong> The child inherited two active copies of chromosome 15 from the father and mother, resulting in expression of the mutated gene:</strong> <strong>Anticipation</strong> involves earlier onset and increased severity of the disorder in successive generations, which is not relevant here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C</strong>.<strong> Anticipation caused the gene to become more severe as it was passed down through the generations:</strong> <strong>Gonadal mosaicism</strong> refers to genetically distinct cell lines within the gonads but is not relevant to <strong>Prader-Willi syndrome</strong> in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Gonadal mosaicism in the father led to a second, unaffected allele being passed on to the child:&nbsp;</strong>Gonadal mosaicism refers to mutation in some sperm or egg cells while the rest remain normal, leading to some offspring inheriting a genetic disorder while others do not. While gonadal mosaicism can explain some genetic disorders, Prader-Willi syndrome is not typically caused by this mechanism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Genomic imprinting</strong> involves the <strong>silencing</strong> of one allele (maternal or paternal) through <strong>DNA methylation</strong>, leading to <strong>differential expression</strong> based on the <strong>parent of origin</strong>.</span></li></ul>",
      "correct_choice_id": 288869,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72498,
      "choices": [
        {
          "id": 288981,
          "text": "<p><span style=\"font-size:14.0pt;\">Group A Coxsackievirus</span></p>"
        },
        {
          "id": 288982,
          "text": "<p><span style=\"font-size:14.0pt;\">Group B Coxsackievirus</span></p>"
        },
        {
          "id": 288983,
          "text": "<p><span style=\"font-size:14.0pt;\">Enterovirus</span></p>"
        },
        {
          "id": 288984,
          "text": "<p><span style=\"font-size:14.0pt;\">Human Herpesvirus 6 (HHV-6)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old male presents to the emergency department with sudden-onset chest pain, fever, and significant intercostal muscle tenderness. He works in agriculture, and his symptoms started after eating street food. Upon examination, he shows signs of pleuritic chest pain and muscle stiffness. He reports a recent fever and generalized muscle aches. He also has a past medical history of diabetes. Given the context and clinical presentation, which of the following pathogens is most likely responsible for his condition?&nbsp;</span></p>",
      "unique_key": "Q5543416",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B)</strong> <strong>Group B Coxsackievirus</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient is presenting with pleurodynia (Bornholm disease), which is caused by Group B Coxsackievirus.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This virus is particularly associated with sudden-onset chest pain, pleuritic symptoms, and muscle stiffness, commonly following exposure to contaminated food or water, particularly in immunocompromised individuals, such as those with diabetes.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The presence of intercostal muscle tenderness and pleuritic chest pain further supports this diagnosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Group A Coxsackievirus:</strong> This virus typically causes Herpangina (oral and throat vesicles), not pleuritic chest pain or muscle stiffness.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Enterovirus:</strong> Although Enterovirus can cause similar systemic symptoms, it does not typically cause pleuritic chest pain with muscle tenderness.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Human Herpesvirus 6 (HHV-6):</strong> This virus is associated with roseola in children, not with pleuritic chest pain or muscle stiffness in adults.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Group B Coxsackievirus, specifically Coxsackievirus B, causes pleurodynia (Bornholm disease), which presents with pleuritic chest pain and intercostal muscle tenderness, commonly following foodborne exposure, especially in patients with diabetes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-21%20181358.jpg\" width=\"960\" height=\"413\"></span></p>",
      "correct_choice_id": 288982,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72554,
      "choices": [
        {
          "id": 289205,
          "text": "<p><span style=\"font-size:14.0pt;\">The connection between the left abducens nucleus and the right oculomotor nucleus</span></p>"
        },
        {
          "id": 289206,
          "text": "<p><span style=\"font-size:14.0pt;\">The connection between the right abducens nucleus and the left oculomotor nucleus</span></p>"
        },
        {
          "id": 289207,
          "text": "<p><span style=\"font-size:14.0pt;\">The connection between the left oculomotor nucleus and the left lateral rectus</span></p>"
        },
        {
          "id": 289208,
          "text": "<p><span style=\"font-size:14.0pt;\">The connection between the left oculomotor nucleus and the right lateral rectus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old patient with multiple sclerosis presents with an acute episode of diplopia and difficulty tracking objects to the right. During examination, you find that the left eye does not adduct when the patient looks to the right. The right eye moves normally. MRI reveals demyelination of the medial longitudinal fasciculus (MLF). Which of the following pathways is most directly disrupted by this lesion?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7995453",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) The connection between the right abducens nucleus and the left oculomotor nucleus</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The MLF connects the abducens nucleus on one side with the oculomotor nucleus on the other side to allow conjugate horizontal eye movements.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A lesion in the MLF, such as in multiple sclerosis, disrupts the pathway between the right abducens nucleus (which controls the right lateral rectus) and the left oculomotor nucleus (which controls the left medial rectus). This results in impaired adduction of the left eye during rightward gaze.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. The connection between the left abducens nucleus and the right oculomotor nucleus:</strong> The connection between the left abducens nucleus and the right oculomotor nucleus is not disrupted in this case, as the lesion is on the right MLF.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. The connection between the left oculomotor nucleus and the left lateral rectus</strong>: The left oculomotor nucleus and the left lateral rectus are not connected; the lateral rectus is controlled by the abducens nucleus.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. The connection between the left oculomotor nucleus and the right lateral rectus:</strong> The left oculomotor nucleus controls the left medial rectus, not the right lateral rectus.</span><br><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A lesion in the medial longitudinal fasciculus (MLF) disrupts the coordination between the abducens nucleus and the oculomotor nucleus, resulting in internuclear ophthalmoplegia.</span></li></ul>",
      "correct_choice_id": 289206,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72558,
      "choices": [
        {
          "id": 289221,
          "text": "<p><span style=\"font-size:14.0pt;\">A-2, B-4, C-1, D-3</span></p>"
        },
        {
          "id": 289222,
          "text": "<p><span style=\"font-size:14.0pt;\">A-1, B-3, C-2, D-4</span></p>"
        },
        {
          "id": 289223,
          "text": "<p><span style=\"font-size:14.0pt;\">A-2, B-3, C-1, D-4</span></p>"
        },
        {
          "id": 289224,
          "text": "<p><span style=\"font-size:14.0pt;\">A-3, B-4, C-2, D-1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the following<strong>:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-24%20135826.jpg\" width=\"909\" height=\"390\"></strong></span></p>",
      "unique_key": "Q6448700",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) A-2, B-4, C-1, D-3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>A. La belle indifférence → 2. Lack of concern about symptoms</strong>: <strong>La belle indifférence</strong> refers to a paradoxical <strong>lack of concern</strong> about neurological symptoms, commonly seen in <strong>conversion disorder</strong> (functional neurological symptom disorder).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>B. Phobic stimulus → 4. Situation that triggers irrational fear and avoidance despite recognition:</strong> A <strong>phobic stimulus</strong> is an object or situation that triggers <strong>irrational fear and avoidance</strong>, even though the person recognizes that their fear is excessive (e.g., fear of heights, or flying).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>C. Panic sensitivity → 1. Fear of experiencing anxiety symptoms</strong>: <strong>Panic sensitivity</strong> refers to heightened <strong>fear of experiencing anxiety symptoms</strong> (e.g., rapid heartbeat, breathlessness), leading to <strong>anticipatory anxiety</strong> about having panic attacks.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>D. Agoraphobia → 3. Fear of situations from where escape may be difficult:</strong> <strong>Agoraphobia</strong> is <strong>fear of situations where escape may be difficult</strong> (e.g., public places, crowded areas), even in <strong>neutral</strong> or safe environments.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>La belle indifférence</strong> is characteristic of <strong>conversion disorder</strong> (unconcerned about symptoms).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Phobic stimuli</strong> are avoided despite the person knowing their fear is irrational.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Panic sensitivity</strong> involves fear of anxiety symptoms themselves.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Agoraphobia</strong> is triggered in situations that are otherwise neutral but are perceived as <strong>difficult to escape from</strong>.</span></li></ul>",
      "correct_choice_id": 289221,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72531,
      "choices": [
        {
          "id": 289113,
          "text": "<p><span style=\"font-size:14.0pt;\">Interstitial lung disease</span></p>"
        },
        {
          "id": 289114,
          "text": "<p><span style=\"font-size:14.0pt;\">Recurrent pulmonary embolism</span></p>"
        },
        {
          "id": 289115,
          "text": "<p><span style=\"font-size:14.0pt;\">Left ventricular systolic dysfunction</span></p>"
        },
        {
          "id": 289116,
          "text": "<p><span style=\"font-size:14.0pt;\">Bronchiectasis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Mrs. Nandini, a 52-year-old woman from Hyderabad, presents with deformity of her hands which is shown below. She also reports progressive shortness of breath. Chest radiography reveals bilateral lower lobe infiltrates, and further evaluation raises concern for pulmonary complications associated with her condition. Which of the following is the most likely cause of her pulmonary hypertension?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-24%20121626.jpg\" width=\"574\" height=\"401\"></strong></span></p>",
      "unique_key": "Q5164013",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) Interstitial lung disease</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Scleroderma can lead to pulmonary hypertension due to interstitial lung disease (ILD), where progressive fibrosis and scarring of the lung tissue increase pulmonary vascular resistance.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This is a leading cause of morbidity and mortality in scleroderma patients.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">ILD often presents with bilateral lower lobe infiltrates on imaging and is commonly associated with dyspnea and reduced exercise tolerance.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Recurrent pulmonary embolism:</strong> While pulmonary embolism can cause pulmonary hypertension, there is no clinical evidence of embolic events in this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Left ventricular systolic dysfunction:</strong> This would cause pulmonary congestion but is not directly linked to scleroderma-related pulmonary hypertension.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Bronchiectasis:</strong> Leads to chronic cough and sputum production but is not a typical pulmonary manifestation of scleroderma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In scleroderma, pulmonary hypertension commonly results from interstitial lung disease or pulmonary arterial hypertension.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Early recognition and management of ILD are crucial to improving outcomes in these patients.</span></li></ul>",
      "correct_choice_id": 289113,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72553,
      "choices": [
        {
          "id": 289201,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 5</span></p>"
        },
        {
          "id": 289202,
          "text": "<p><span style=\"font-size:14.0pt;\">2 only&nbsp;</span></p>"
        },
        {
          "id": 289203,
          "text": "<p><span style=\"font-size:14.0pt;\">4 only</span></p>"
        },
        {
          "id": 289204,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3 and 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old woman with a history of recurrent optic neuritis and transverse myelitis presents to the clinic after experiencing a new episode of weakness and sensory loss. Her past medical history is significant for multiple relapses of vision loss and difficulty walking, each of which improved with corticosteroid therapy. During this visit, you suspect a potential relapse. Which of the following immunopathological findings is most likely to be present in the acute phase of this patient's disease, contributing to her symptoms?</span></p><p>&nbsp;</p><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\">Activation of autoreactive CD4+ T cells against myelin oligodendrocyte glycoprotein (MOG)</span></li><li><span style=\"font-size:14.0pt;\">Presence of aquaporin-4 antibodies binding to the astrocytic foot processes</span></li><li><span style=\"font-size:14.0pt;\">A shift toward Th1 helper T cell differentiation leading to increased interferon-gamma secretion</span></li><li><span style=\"font-size:14.0pt;\">Increased expression of glial fibrillary acidic protein (GFAP) within the spinal cord</span></li><li><span style=\"font-size:14.0pt;\">Elevated interleukin-10 levels promoting B-cell differentiation into plasma cells</span></li></ol>",
      "unique_key": "Q8567471",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) 2 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">2. Neuromyelitis optica (NMO) is characterized by the presence of autoantibodies against aquaporin-4 (AQP4), a water channel protein found on the astrocytic foot processes. These antibodies lead to the destruction of astrocytes and subsequent demyelination of the optic nerves and spinal cord, which manifest as optic neuritis and transverse myelitis. This finding is pivotal in diagnosing NMO, especially during acute relapses.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">1. <strong>Activation of autoreactive CD4+ T cells against myelin oligodendrocyte glycoprotein (MOG):</strong> This is more typical of MOG antibody-associated encephalomyelitis, not NMO.</span><br><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\">3. <strong>A shift toward Th1 helper T cell differentiation leading to increased interferon-gamma secretion</strong>: This shift is seen in other autoimmune diseases, but it is not a hallmark of NMO.</span><br><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\">4. <strong>Increased expression of glial fibrillary acidic protein (GFAP):</strong> GFAP is a marker for astrocytes and is typically associated with reactive gliosis, not the autoimmune attack seen in NMO.</span><br><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\">5. <strong>Elevated interleukin-10 levels promoting B-cell differentiation into plasma cells</strong>: IL-10 is involved in B-cell differentiation and suppression of inflammatory responses, but it is not directly related to the pathophysiology of NMO.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><p><span style=\"font-size:14.0pt;\">In neuromyelitis optica, the presence of aquaporin-4 antibodies is a key diagnostic marker and plays a significant role in the pathophysiology of the disease.</span></p><p>&nbsp;</p></li></ul><p><span style=\"font-size:14.0pt;\"><strong>Note –</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Management of acute attacks:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">High-dose glucocorticoids</span></li><li><span style=\"font-size:14.0pt;\">Plasma exchange.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Drugs used for prophylaxis against relapses:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Mycophenolate mofetil</span></li><li><span style=\"font-size:14.0pt;\">Rituximab</span></li><li><span style=\"font-size:14.0pt;\">Glucocorticoids</span></li><li><span style=\"font-size:14.0pt;\">Azathioprine.</span></li></ul>",
      "correct_choice_id": 289202,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72087,
      "choices": [
        {
          "id": 287349,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute lymphoblastic leukemia (ALL)</span></p>"
        },
        {
          "id": 287350,
          "text": "<p><span style=\"font-size:14.0pt;\">Juvenile myelomonocytic leukemia (JMML)</span></p>"
        },
        {
          "id": 287351,
          "text": "<p><span style=\"font-size:14.0pt;\">Aplastic anemia</span></p>"
        },
        {
          "id": 287352,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute myeloid leukemia (AML)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">6-year-old child presents with fever, pancytopenia, generalized weakness, and weight loss. On examination, the child is pale and has generalized lymphadenopathy. A peripheral smear is shown below. What is the most likely diagnosis?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-19%20180346.jpg\" width=\"550\" height=\"422\"></span></p>",
      "unique_key": "Q8877314",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans</strong>. <strong>A) Acute lymphoblastic leukemia (ALL)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The peripheral smear shows lymphoblasts, which are immature cells with a high nuclear-to-cytoplasmic ratio, prominent nucleoli, and scant agranular cytoplasm.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These findings, along with pancytopenia, are diagnostic of ALL.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Juvenile myelomonocytic leukemia (JMML):</strong> Incorrect. JMML presents with features like leukocytosis, monocytosis, and splenomegaly, which are not present here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Aplastic anemia:</strong> Incorrect. Aplastic anemia presents with pancytopenia but no lymphoblasts or lymphadenopathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Acute myeloid leukemia (AML):</strong> Incorrect. AML presents with myeloblasts, which have cytoplasmic granules, Auer rods, and a lower nuclear-to-cytoplasmic ratio compared to lymphoblasts.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">ALL presents with lymphoblasts, pancytopenia, and systemic symptoms such as fever, weight loss, and lymphadenopathy, requiring a high index of suspicion in pediatric patients.</span></li></ul>",
      "correct_choice_id": 287349,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72559,
      "choices": [
        {
          "id": 289225,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3 are correct</span></p>"
        },
        {
          "id": 289226,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 2 are correct</span></p>"
        },
        {
          "id": 289227,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3 and 4 are correct</span></p>"
        },
        {
          "id": 289228,
          "text": "<p><span style=\"font-size:14.0pt;\">All are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Consider the following statements about eating disorders:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Statement 1: Body image disturbance is essential for diagnosing anorexia nervosa</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Statement 2: Binge eating disorder has the highest prevalence among eating disorders</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Statement 3: Bulimia nervosa is characterized by a better prognosis compared to anorexia nervosa</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Statement 4: Night eating syndrome is classified under Other Specified Feeding and Eating Disorders</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Which of the following is correct?</span></p>",
      "unique_key": "Q8370653",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) All are correct</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1: Body image disturbance is essential for diagnosing anorexia nervosa</strong>: <strong>Correct.</strong> Anorexia nervosa is characterized by <strong>intense fear of gaining weight, persistent behaviors leading to significantly low body weight, and body image disturbance</strong> (distorted perception of body weight or shape). This disturbance is a <strong>core diagnostic criterion</strong> in the <strong>DSM-5</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2: Binge eating disorder has the highest prevalence among eating disorders</strong>. <strong>Correct:</strong> <strong>Binge Eating Disorder (BED)</strong> is the <strong>most common eating disorder</strong>, with a higher prevalence than anorexia nervosa and bulimia nervosa. Unlike bulimia, BED does <strong>not involve compensatory behaviors</strong> (e.g., purging, excessive exercise).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3: Bulimia nervosa is characterized by a better prognosis compared to anorexia nervosa</strong>: <strong>Correct.</strong> <strong>Bulimia nervosa&nbsp;</strong>is characterized by <strong>higher rates of recovery</strong> (partial and full) compared to <strong>anorexia nervosa.&nbsp;</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4: Night eating syndrome is classified under Other Specified Feeding and Eating Disorders (OSFED)</strong>: <strong>Correct</strong>. <strong>Night Eating Syndrome (NES)</strong> is classified under <strong>Other Specified Feeding and Eating Disorders (OSFED)</strong> in <strong>DSM-5</strong>. It involves <strong>excessive nighttime eating, morning anorexia, and sleep disturbances</strong>. Unlike binge eating disorder, it has a distinct circadian pattern.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Body image disturbance</strong> is required for <strong>anorexia nervosa</strong>, <strong>binge eating disorder</strong> is the most prevalent eating disorder, <strong>bulimia</strong> has a better prognosis compared to anorexia nervosa, and <strong>night eating syndrome</strong> is part of <strong>OSFED</strong>.</span></li></ul>",
      "correct_choice_id": 289228,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72484,
      "choices": [
        {
          "id": 288925,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 2</span></p>"
        },
        {
          "id": 288926,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 3</span></p>"
        },
        {
          "id": 288927,
          "text": "<p><span style=\"font-size:14.0pt;\">4 only</span></p>"
        },
        {
          "id": 288928,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A health response team is implementing measures to prevent further spread of infectious diseases in the aftermath of a massive earthquake. These measures are focused on improving food safety, water supply, and controlling vectors. In which phase of the disaster cycle would these measures most likely be implemented?&nbsp;</span></p><p>&nbsp;</p><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\">Primary phase</span></li><li><span style=\"font-size:14.0pt;\">Secondary phase&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Tertiary phase</span></li><li><span style=\"font-size:14.0pt;\">Mitigation</span></li></ol>",
      "unique_key": "Q8691205",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 2 and 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">2. The secondary phase (6-24 hours) focuses on disease prevention through sanitation, waste disposal, and medical interventions, which align with early food safety and water purification efforts.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">3. The tertiary phase (1-60 days) involves rehabilitation and rebuilding, ensuring sustainable public health measures, including long-term vector control and stable food/water supplies.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">1. The primary phase is focused on immediate response, such as first aid, triage, and initial emergency care.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">4. Mitigation aims to prevent future disasters, rather than manage the current disaster's immediate health and safety needs.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Stages of a Disaster Cycle</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_CjkH08z.png\" width=\"1230\" height=\"873\"></span></p>",
      "correct_choice_id": 288926,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72196,
      "choices": [
        {
          "id": 287785,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2</span></p>"
        },
        {
          "id": 287786,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3</span></p>"
        },
        {
          "id": 287787,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 4</span></p>"
        },
        {
          "id": 287788,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Identify the correct statements:<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Tranexamic acid reduces the&nbsp;risk of mortality only in patients of penetrating trauma with no role in blunt trauma cases</span></li><li><span style=\"font-size:14.0pt;\">All patients with signs of shock should receive tranexamic acid within 3 hours of injury</span></li><li><span style=\"font-size:14.0pt;\">Crystalloids are preferred over blood and blood products for resuscitation of severely hypovolemic patients with trauma</span></li><li><span style=\"font-size:14.0pt;\">Damage control surgery is done only in unstable patients in trauma</span></li></ol>",
      "unique_key": "Q1810694",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 2, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Based on the given statements, let's identify the correct ones regarding the management of trauma patients:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2. All patients with signs of shock should receive tranexamic acid within 3 hours of injury:</strong> This statement is correct. The CRASH-2 trial also indicated that tranexamic acid is beneficial when administered within 3 hours of injury to patients with signs of significant hemorrhage or shock.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4.</strong> <strong>Damage control surgery is done only in unstable patients in trauma:&nbsp;</strong>Damage control surgery is done only in unstable patients in trauma. This is correct, as only unstable patients with ongoing hemorrhage following complex injuries are candidates.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1. Tranexamic acid reduces risk of mortality only in patients of penetrating trauma with no role in blunt trauma cases</strong> This statement is incorrect. Tranexamic acid has been shown to reduce the risk of mortality from bleeding in both penetrating and blunt trauma cases, as evidenced by the CRASH-2 trial.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3. Crystalloids are preferred over blood and blood products for resuscitation of severely hypovolemic patients of trauma</strong> This statement is incorrect. In severely hypovolemic trauma patients, blood and blood products are preferred to restore circulating volume and oxygen-carrying capacity. Crystalloids can be used temporarily while awaiting blood products but are not the resuscitation fluid of choice in severe hemorrhage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The key points in trauma management include administering tranexamic acid within 3 hours to patients with signs of significant hemorrhage, using blood and blood products for the resuscitation of severely hypovolemic patients, and controlling life-threatening hemorrhage as a first step in the primary survey of trauma patients.</span></li></ul>",
      "correct_choice_id": 287787,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72547,
      "choices": [
        {
          "id": 289177,
          "text": "<p><span style=\"font-size:14.0pt;\">Apoprotein A-I</span></p>"
        },
        {
          "id": 289178,
          "text": "<p><span style=\"font-size:14.0pt;\">Apoprotein B-100</span></p>"
        },
        {
          "id": 289179,
          "text": "<p><span style=\"font-size:14.0pt;\">Apoprotein C-II</span></p>"
        },
        {
          "id": 289180,
          "text": "<p><span style=\"font-size:14.0pt;\">Apoprotein E</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 50-year-old male with uncontrolled diabetes and hyperlipidemia presents with eruptive xanthomas. His lipid panel reveals markedly elevated triglycerides. Genetic testing suggests a defect in the apoprotein responsible for activating lipoprotein lipase (LPL). Which of the following apoproteins is most likely deficient in this patient?</span></p>",
      "unique_key": "Q1902854",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Apoprotein C-II</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>ApoC-II is required to activate LPL</strong>, which hydrolyzes triglycerides from chylomicrons and VLDL.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A deficiency in <strong>ApoC-II leads to severe hypertriglyceridemia</strong>, causing conditions like <strong>familial chylomicronemia syndrome</strong>, which presents with <strong>eruptive xanthomas, pancreatitis, and lipemia retinalis</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Apoprotein A-I: Incorrect</strong>. ApoA-I is the main structural protein of <strong>HDL</strong> and an activator of <strong>LCAT</strong> (lecithin–cholesterol acyltransferase), which helps in cholesterol esterification. It does not play a role in <strong>LPL activation</strong> or triglyceride metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Apoprotein B-100: Incorrect.</strong> ApoB-100 is a structural component of <strong>VLDL, IDL, and LDL</strong>. It is important for <strong>LDL receptor binding</strong> but has no role in LPL activation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Apoprotein E: Incorrect.</strong> ApoE is involved in <strong>remnant lipoprotein clearance</strong> by mediating uptake via hepatic LDL receptors. It is not directly involved in <strong>LPL activation</strong> or triglyceride metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">ApoC-II deficiency leads to <strong>severe hypertriglyceridemia</strong> due to defective <strong>LPL activation</strong>, causing complications like <strong>pancreatitis</strong> and <strong>xanthomas</strong>.</span></li></ul>",
      "correct_choice_id": 289179,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72535,
      "choices": [
        {
          "id": 289129,
          "text": "<p><span style=\"font-size:14.0pt;\">Elevated protein, normal glucose</span></p>"
        },
        {
          "id": 289130,
          "text": "<p><span style=\"font-size:14.0pt;\">Decreased beta-amyloid 42, elevated tau protein</span></p>"
        },
        {
          "id": 289131,
          "text": "<p><span style=\"font-size:14.0pt;\">Elevated WBCs, decreased glucose</span></p>"
        },
        {
          "id": 289132,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased beta-amyloid 42, elevated tau protein</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 68-year-old man from Chennai presents with progressive memory loss, confusion, and difficulty performing daily activities over the past year. His family reports frequent forgetfulness and episodes of getting lost in familiar places. Neurological examination reveals no motor deficits, but cognitive testing confirms significant short-term memory impairment. MRI shown below. What cerebrospinal fluid (CSF) finding is most consistent with this patient’s condition?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-24%20121717.jpg\" width=\"471\" height=\"587\"></span></p>",
      "unique_key": "Q4760699",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Decreased beta-amyloid 42, elevated tau protein</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In Alzheimer’s dementia, CSF analysis typically reveals decreased beta-amyloid 42 due to its deposition as amyloid plaques in the brain, and elevated tau protein levels reflecting neuronal damage and neurofibrillary tangles.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These biomarkers aid in diagnosis and monitoring disease progression.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Elevated protein, normal glucose:</strong> Suggestive of Guillain-Barré syndrome, not Alzheimer’s.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Elevated WBCs, decreased glucose:</strong> Indicates bacterial or fungal meningitis, not neurodegeneration.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Increased beta-amyloid 42, elevated tau protein:</strong> Increased beta-amyloid is not seen in Alzheimer’s; it is characteristically decreased.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Alzheimer’s dementia is marked by decreased CSF beta-amyloid 42 and elevated tau proteins, which are critical biomarkers for confirming the diagnosis and tracking disease progression.</span></li></ul>",
      "correct_choice_id": 289130,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72494,
      "choices": [
        {
          "id": 288965,
          "text": "<p><span style=\"font-size:14.0pt;\">Overstimulation of D1 receptors leading to excessive renal vasodilation</span></p>"
        },
        {
          "id": 288966,
          "text": "<p><span style=\"font-size:14.0pt;\">Dopamine-induced β1 stimulation causing tachycardia and myocardial ischemia</span></p>"
        },
        {
          "id": 288967,
          "text": "<p><span style=\"font-size:14.0pt;\">Vasoconstriction from α1 receptor activation reducing peripheral blood flow</span></p>"
        },
        {
          "id": 288968,
          "text": "<p><span style=\"font-size:14.0pt;\">Direct negative inotropic effect of dopamine reducing cardiac output</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A critically ill patient receiving high-dose dopamine infusion (&gt;10 mg/kg/min) for severe hypotension shows signs of worsening peripheral perfusion. What is the most likely explanation for this clinical observation?&nbsp;</span></p>",
      "unique_key": "Q6076632",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Vasoconstriction from α1 receptor activation reducing peripheral blood flow</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">At doses greater than 10 mg/kg/min, dopamine primarily stimulates α1-adrenergic receptors, leading to systemic vasoconstriction.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This effect can reduce peripheral blood flow despite increasing systemic blood pressure, potentially exacerbating conditions like limb ischemia or contributing to worsening organ perfusion.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Overstimulation of D1 receptors leading to excessive renal vasodilation:</strong> Incorrect as D1 receptor stimulation, which promotes renal vasodilation, occurs at lower doses.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Dopamine-induced β1 stimulation causing tachycardia and myocardial ischemia:</strong> Incorrect although β1-related tachycardia can occur, the primary issue at this dose is α1-mediated effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Direct negative inotropic effect of dopamine reducing cardiac output:</strong> Incorrect because dopamine generally has a positive inotropic effect, not a negative one, though high doses primarily affect vascular tone via α1 receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Identify the consequences of high-dose dopamine infusion, particularly the risks associated with excessive α1 receptor activation, and its impact on peripheral and organ perfusion in critically ill patients.</span></li></ul>",
      "correct_choice_id": 288967,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72451,
      "choices": [
        {
          "id": 288793,
          "text": "<p><span style=\"font-size:14.0pt;\">Hemophilia A</span></p>"
        },
        {
          "id": 288794,
          "text": "<p><span style=\"font-size:14.0pt;\">Disseminated intravascular coagulation (DIC)</span></p>"
        },
        {
          "id": 288795,
          "text": "<p><span style=\"font-size:14.0pt;\">Factor VIII inhibitor</span></p>"
        },
        {
          "id": 288796,
          "text": "<p><span style=\"font-size:14.0pt;\">Vitamin K deficiency</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old woman with no significant past medical history presents with new-onset bruising and joint pain. Laboratory workup shows a prolonged partial thromboplastin time (PTT), but her prothrombin time (PT) and bleeding time are normal. A mixing study is performed, where the patient's plasma is mixed with normal plasma. The PTT remains prolonged after mixing. Further tests reveal decreased factor VIII activity. Which of the following is the most likely diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4936511",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Factor VIII inhibitor</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient presents with a prolonged <strong>PTT</strong> and a mixing study that fails to correct the PTT.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This suggests the presence of an <strong>inhibitor</strong>, rather than a deficiency in clotting factors.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The decreased <strong>factor VIII activity</strong> and failure of the mixing study to normalize the PTT point toward a <strong>factor VIII inhibitor</strong> as the cause of the coagulopathy.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Factor VIII inhibitor&nbsp;</strong>is an acquired antibody against factor VIII, often presenting with a prolonged PTT that does not correct on mixing studies.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Hemophilia A: Hemophilia A&nbsp;</strong>causes factor VIII deficiency but typically corrects with a mixing study.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Disseminated intravascular coagulation (DIC): DIC&nbsp;</strong>leads to prolonged PT, PTT, and decreased platelets, but this patient has normal PT and bleeding time.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Vitamin K deficiency: Vitamin K deficiency</strong> leads to deficiencies in factors II, VII, IX, and X, but this would affect both PT and PTT.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Acquired hemophilia (Factor VIII inhibitors)</strong> should be suspected in adults with <strong>sudden-onset bleeding, prolonged PTT, and no prior history of bleeding disorders.</strong></span></li><li><span style=\"font-size:14.0pt;\">The <strong>mixing study is crucial</strong> to differentiate between <strong>factor deficiencies (e.g., Hemophilia A, which corrects)</strong> and <strong>factor inhibitors (which do not correct).</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Patients with Factor VIII inhibitors</strong> require immunosuppressive therapy (e.g., corticosteroids, rituximab) to reduce antibody production.</span></li></ul>",
      "correct_choice_id": 288795,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72197,
      "choices": [
        {
          "id": 287789,
          "text": "<p><span style=\"font-size:14.0pt;\">Urethral catheterization</span></p>"
        },
        {
          "id": 287790,
          "text": "<p><span style=\"font-size:14.0pt;\">Retrograde urethrogram</span></p>"
        },
        {
          "id": 287791,
          "text": "<p><span style=\"font-size:14.0pt;\">Suprapubic catheter placement</span></p>"
        },
        {
          "id": 287792,
          "text": "<p><span style=\"font-size:14.0pt;\">Immediate exploratory laparotomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old male presents with a history of pelvic trauma following a road traffic accident. He has blood at the urethral meatus, a high-riding prostate, and inability to void. What is the next step in management?</span></p>",
      "unique_key": "Q2382044",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Retrograde urethrogram</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Retrograde urethrogram confirms the diagnosis of posterior urethral injury, avoiding further damage from catheterization.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Urethral catheterization</strong>: Catheterization risks worsening the injury.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Suprapubic catheter placement:</strong> Suprapubic catheter placement is done after confirming the diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Immediate exploratory laparotomy</strong>: Laparotomy is unnecessary without evidence of intra-abdominal injury.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Posterior urethral injuries require confirmation via retrograde urethrogram before any further intervention.</span></li></ul>",
      "correct_choice_id": 287790,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72149,
      "choices": [
        {
          "id": 287597,
          "text": "<p><span style=\"font-size:14.0pt;\">Synovial Chondromatosis</span></p>"
        },
        {
          "id": 287598,
          "text": "<p><span style=\"font-size:14.0pt;\">Synovial Sarcoma</span></p>"
        },
        {
          "id": 287599,
          "text": "<p><span style=\"font-size:14.0pt;\">Osteosarcoma</span></p>"
        },
        {
          "id": 287600,
          "text": "<p><span style=\"font-size:14.0pt;\">Giant Cell Tumour</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 40-year-old male presents with a 6-month history of progressive pain and swelling in both knees. The pain is particularly aggravated by activity, and he has noticed a decrease in range of motion in the joint. On physical examination, there is moderate effusion and tenderness over the joint line. X-ray is shown below. Which of the following is the most likely diagnosis?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-21%20134337.jpg\" width=\"373\" height=\"367\"></span></p>",
      "unique_key": "Q1937373",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Synovial Chondromatosis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Synovial chondromatosis is a rare benign condition where the synovial membrane of joints forms multiple cartilaginous nodules.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These nodules can become free-floating bodies within the joint, and over time, they may undergo calcification or ossification.</span></li><li><span style=\"font-size:14.0pt;\">It results from the metaplasia of the synovial lining, leading to the formation of cartilaginous nodules, which may later calcify or ossify.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These free-floating nodules can cause pain, joint effusion, and limited range of motion, as the synovium becomes inflamed and irritated.</span></li><li><span style=\"font-size:14.0pt;\">X-rays typically reveal multiple, well-defined, round or oval-shaped calcified bodies within the joint, which may be free-floating or fixed to the synovial lining.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The classic \"popcorn\" appearance on imaging is a hallmark of synovial chondromatosis.</span></li><li><span style=\"font-size:14.0pt;\">Pain, swelling, stiffness, and a decreased range of motion are common due to irritation of the synovium, along with mechanical symptoms from free-floating bodies in the joint.</span></li><li><span style=\"font-size:14.0pt;\">Most commonly affects large joints like the knee, hip, or elbow, and it can involve both unilateral and bilateral joints.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The knee is a very common site of involvement.</span></li><li><span style=\"font-size:14.0pt;\">Surgical excision of the nodules is the treatment of choice, and the prognosis is generally good once the nodules are removed.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Synovial Sarcoma:&nbsp;</strong>Synovial sarcoma is a malignant soft tissue tumour that often arises near large joints, usually in the deep tissues of the limbs. It can occur in younger adults, commonly affecting the knee or elbow. It is a malignant tumour that arises from synovial tissue or surrounding soft tissues. Synovial sarcoma is typically characterized by a complex chromosomal translocation (t(X;18)), which leads to abnormal gene expression. Synovial sarcoma may present as a soft tissue mass near the joint. X-ray may show a well-circumscribed mass or calcifications within the soft tissue, but the tumour itself is often better seen on MRI or CT. These masses can be heterogeneous and irregular in shape, often extending into the joint or surrounding structures. Symptoms are usually related to the mass effect of the tumour. Patients may present with a palpable mass, pain, swelling, and decreased joint mobility due to the tumour’s involvement of the soft tissues around the joint. Pain often worsens with activity. Synovial sarcoma can be diagnosed with imaging studies (MRI is most helpful) and confirmed with biopsy to detect characteristic histological features. Treatment usually involves surgical resection, and adjuvant chemotherapy and/or radiation therapy may be necessary depending on the stage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-21%20134355.jpg\" width=\"328\" height=\"347\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Osteosarcoma:&nbsp;</strong>Osteosarcoma is a malignant bone tumour that often arises in the metaphysis of long bones, particularly around the knee. It is more common in adolescents and young adults. Osteosarcoma arises from the osteoblasts and typically produces bone or osteoid. It can be associated with a genetic mutation (e.g., in the TP53 gene), and it often occurs in the metaphysis of long bones (femur, tibia, humerus). X-rays often show a destructive bone lesion with an aggressive appearance. There is typically an ill-defined periosteal reaction, which may result in the formation of a \"Codman's triangle\" (a raised periosteum seen on the edge of a tumour). There may also be bone fragmentation or a mixed lytic and sclerotic pattern in the lesion. Osteosarcoma typically presents with localized pain, swelling, and, in some cases, a palpable mass. The pain often worsens over time, and there may be a history of injury that exacerbates the pain. It often presents in the younger population, typically between ages 10 and 30. Imaging studies (X-ray, MRI) and biopsy are used for diagnosis. CT scans or PET scans may be performed to evaluate for metastasis, as osteosarcoma commonly metastasizes to the lungs. Treatment typically involves a combination of chemotherapy and surgical resection of the tumour.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-21%20134410.jpg\" width=\"398\" height=\"397\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Giant Cell Tumour:&nbsp;</strong>Giant cell tumour (GCT) is a benign but locally aggressive bone tumour that commonly affects the epiphysis of long bones, particularly around the knee. Giant cell tumours are composed of multinucleated giant cells and are typically found in the epiphyseal region of long bones. Although they are benign, they can cause significant local bone destruction and may recur after surgery. X-rays often show a lytic, expansile lesion in the epiphysis of long bones, commonly affecting the distal femur, proximal tibia, or radius. The lesion has a \"soap bubble\" appearance, with well-defined borders but an expansile, destructive nature. Giant cell tumours typically present with pain, swelling, and a decrease in range of motion, especially in weight-bearing joints. However, it is usually a solitary lesion and not typically associated with multiple nodules or calcifications in the joint space. Imaging studies and biopsy are used to confirm the diagnosis. MRI is helpful to determine the extent of the tumour, and biopsy confirms the presence of multinucleated giant cells. Treatment involves curettage and bone grafting, although recurrence is common. In some cases, surgical resection or joint replacement may be required.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-21%20134426.jpg\" width=\"310\" height=\"419\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">While giant cell tumours can cause pain and swelling in the knee, they typically do not present with multiple calcified bodies in the joint space.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The radiographic appearance would be more characteristic of a lytic lesion rather than the calcified nodules of synovial chondromatosis.</span></li></ul>",
      "correct_choice_id": 287597,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        15
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72483,
      "choices": [
        {
          "id": 288921,
          "text": "<p><span style=\"font-size:14.0pt;\">Systemic candidiasis</span></p>"
        },
        {
          "id": 288922,
          "text": "<p><span style=\"font-size:14.0pt;\">Pulmonary aspergillosis</span></p>"
        },
        {
          "id": 288923,
          "text": "<p><span style=\"font-size:14.0pt;\">Mucormycosis</span></p>"
        },
        {
          "id": 288924,
          "text": "<p><span style=\"font-size:14.0pt;\">Dermatophytosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">The colonies shown in the image, is most likely associated with which of the following infections?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-21%20180638.jpg\" width=\"541\" height=\"454\"></span></p>",
      "unique_key": "Q5565224",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;C)</strong> <strong>Mucormycosis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>lid-lifting colony formation</strong> of <strong>black-white wooly colonies</strong> is a distinctive feature of <strong>Mucor species</strong>, which are the causative agents of <strong>mucormycosis</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This opportunistic fungal infection commonly affects immunocompromised individuals, especially those with diabetes and neutropenia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Systemic candidiasis</strong>:&nbsp; Typically presents with <strong>creamy, pasty colonies</strong> rather than wooly colonies.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Pulmonary aspergillosis</strong>: It is associated with <strong>greenish colonies</strong>, not the wooly appearance typical of <strong>Mucor</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Dermatophytosis:</strong> It causes <strong>powdery colonies</strong> and does not produce the distinctive <strong>wooly colonies</strong> seen in <strong>Mucor</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Mucormycosis</strong>, caused by <strong>Mucor species</strong>, is characterized by <strong>black-white wooly colonies</strong> and a <strong>lid-lifting growth pattern</strong>.</span></li></ul>",
      "correct_choice_id": 288923,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72059,
      "choices": [
        {
          "id": 287237,
          "text": "<p><span style=\"font-size:14.0pt;\">Both A and R are true, and R is the correct explanation of A.</span></p>"
        },
        {
          "id": 287238,
          "text": "<p><span style=\"font-size:14.0pt;\">Both A and R are true, but R is not the correct explanation of A.</span></p>"
        },
        {
          "id": 287239,
          "text": "<p><span style=\"font-size:14.0pt;\">A is true, but R is false.</span></p>"
        },
        {
          "id": 287240,
          "text": "<p><span style=\"font-size:14.0pt;\">A is false, but R is true.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Assertion (A): Patients with dystocia dystrophica syndrome often have difficult labor.</span></p><p><br><span style=\"font-size:14.0pt;\">Reason (R): They have an android pelvis and frequently experience deep transverse arrest.&nbsp;</span></p>",
      "unique_key": "Q5050499",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A) Both A and R are true, and R is the correct explanation of A.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Dystocia dystrophica syndrome is characterized by an android pelvis, which predisposes patients to deep transverse arrest, leading to difficult labor. This explains the assertion that labor is often challenging in these patients.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Android pelvis and deep transverse arrest are hallmark features of dystocia dystrophica syndrome, often leading to difficult labor.</span></li></ul>",
      "correct_choice_id": 287237,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72545,
      "choices": [
        {
          "id": 289169,
          "text": "<p><span style=\"font-size:14.0pt;\">The cells are senescing due to an accumulation of DNA mutations during replication.</span></p>"
        },
        {
          "id": 289170,
          "text": "<p><span style=\"font-size:14.0pt;\">The cells are senescing due to critical telomere shortening, as indicated by the Hayflick limit.</span></p>"
        },
        {
          "id": 289171,
          "text": "<p><span style=\"font-size:14.0pt;\">The cells are undergoing apoptosis due to excessive oxidative stress.</span></p>"
        },
        {
          "id": 289172,
          "text": "<p><span style=\"font-size:14.0pt;\">The cells are undergoing transformation into a cancerous state, bypassing the Hayflick limit.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In an experiment studying human cell division, a scientist observes that a cultured normal human fetal cell population divides 50 times before entering senescence. What is the most likely explanation for this observation?&nbsp;</span></p>",
      "unique_key": "Q6040007",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) The cells are senescing due to critical telomere shortening, as indicated by the Hayflick limit.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Normal human fetal cells can divide between 40 and 60 times in culture before entering senescence, which is due to telomere shortening.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Once the telomeres reach a critical length, further division stops, leading to senescence.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>The cells are senescing due to an accumulation of DNA mutations during replication: Incorrect.</strong> DNA mutations may accumulate with age but are not the primary cause of the Hayflick limit.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>The cells are undergoing apoptosis due to excessive oxidative stress: Incorrect.</strong> Oxidative stress can lead to apoptosis, but this is not the main cause of senescence due to the Hayflick limit.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>The cells are undergoing transformation into a cancerous state, bypassing the Hayflick limit: Incorrect.</strong> Cancer cells can bypass the Hayflick limit, but normal cells do not undergo transformation to become cancerous due to telomere shortening.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Normal human fetal cells divide between 40 and 60 times before entering senescence, primarily due to telomere shortening, a phenomenon known as the Hayflick limit.</span></li></ul>",
      "correct_choice_id": 289170,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72557,
      "choices": [
        {
          "id": 289217,
          "text": "<p><span style=\"font-size:14.0pt;\">Anticholinergic toxicity</span></p>"
        },
        {
          "id": 289218,
          "text": "<p><span style=\"font-size:14.0pt;\">Neuroleptic malignant syndrome</span></p>"
        },
        {
          "id": 289219,
          "text": "<p><span style=\"font-size:14.0pt;\">Serotonin syndrome</span></p>"
        },
        {
          "id": 289220,
          "text": "<p><span style=\"font-size:14.0pt;\">Malignant hyperthermia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old female who was started on an antidepressant 2 weeks ago for major depression presents to emergency with confusion, diaphoresis, tremors, and myoclonus. On examination, she has hyperreflexia, temperature 38.2°C, pulse 112/min, BP 160/95 mmHg. On further questioning, she reveals that she is using over-the-counter cough syrup containing dextromethorphan for her recent cold. Which is the most likely diagnosis?</span></p>",
      "unique_key": "Q4562735",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Serotonin Syndrome</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient presents with <strong>confusion, diaphoresis, tremors, myoclonus, hyperreflexia, autonomic instability (hypertension, tachycardia), and fever</strong>, which are characteristic of <strong>serotonin syndrome</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The recent use of an <strong>antidepressant (likely an SSRI) and dextromethorphan (a serotonergic agent)</strong> increases the risk of <strong>serotonin toxicity</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key Features of Serotonin Syndrome:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Neuromuscular excitability → Tremors, myoclonus, hyperreflexia, clonus</span></li><li><span style=\"font-size:14.0pt;\">Autonomic instability → Diaphoresis, hyperthermia, hypertension, tachycardia</span></li><li><span style=\"font-size:14.0pt;\">Altered mental status → Confusion, agitation</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Anticholinergic toxicity</strong>: <strong>Incorrect.</strong> Features <strong>dry skin (rather than diaphoresis), mydriasis, urinary retention, decreased bowel sounds</strong>, and <strong>delirium</strong>, which are absent here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Neuroleptic Malignant Syndrome (NMS)</strong>: <strong>Incorrect.</strong> NMS presents with <strong>lead-pipe rigidity (not hyperreflexia), altered mental status, autonomic instability, and fever</strong> but lacks myoclonus and hyperreflexia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Malignant Hyperthermia</strong>. <strong>Incorrect:</strong> Triggered by <strong>anesthetic agents</strong>, causing <strong>severe muscle rigidity, hyperthermia, rhabdomyolysis, and metabolic acidosis</strong>, which are not seen in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Serotonin syndrome</strong> is a <strong>life-threatening condition</strong> due to serotonergic excess, often caused by combining <strong>SSRIs, MAOIs, SNRIs, dextromethorphan, linezolid, tramadol, or MDMA</strong>.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-24%20135714.jpg\" width=\"735\" height=\"461\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Management includes discontinuation of serotonergic agents (most crucial), supportive car, and cyproheptadine.</span></p>",
      "correct_choice_id": 289219,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72510,
      "choices": [
        {
          "id": 289029,
          "text": "<p><span style=\"font-size:14.0pt;\">Inhibition of platelet aggregation.</span></p>"
        },
        {
          "id": 289030,
          "text": "<p><span style=\"font-size:14.0pt;\">Stabilization of fibrin clots.</span></p>"
        },
        {
          "id": 289031,
          "text": "<p><span style=\"font-size:14.0pt;\">Reduction in blood viscosity.</span></p>"
        },
        {
          "id": 289032,
          "text": "<p><span style=\"font-size:14.0pt;\">Competitive inhibition of plasminogen.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old woman with a history of recurrent, severe menorrhagia due to uterine fibroids is treated with EACA to manage her bleeding during her menstrual cycles. She presents to the clinic complaining of sudden onset of chest pain and shortness of breath. A CT pulmonary angiogram reveals a pulmonary embolism (PE). Which aspect of EACA's mechanism of action is most likely responsible for this adverse effect?</span></p>",
      "unique_key": "Q5863175",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>D) Competitive inhibition of plasminogen.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">EACA's primary mechanism, the competitive inhibition of plasminogen, prevents its conversion to plasmin, which is crucial in fibrin clot breakdown.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">By inhibiting this pathway, EACA not only reduces bleeding but also increases the risk for thrombotic events such as PE, especially in predisposed individuals.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Inhibition of platelet aggregation:</strong> Incorrect as EACA does not directly affect platelet aggregation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Stabilization of fibrin clots:</strong> Incorrect because while it stabilizes fibrin clots, this answer does not directly link to the mechanism causing PE.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Reduction in blood viscosity:</strong> Incorrect as EACA does not reduce blood viscosity; it may actually increase the risk of thrombosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Understand the complications associated with the antifibrinolytic activity of EACA, highlighting the increased risk of thromboembolic events.</span></li></ul>",
      "correct_choice_id": 289032,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72493,
      "choices": [
        {
          "id": 288961,
          "text": "<p><span style=\"font-size:14.0pt;\">Polysaccharide capsule</span></p>"
        },
        {
          "id": 288962,
          "text": "<p><span style=\"font-size:14.0pt;\">Type IV pili</span></p>"
        },
        {
          "id": 288963,
          "text": "<p><span style=\"font-size:14.0pt;\">Type III secretion system</span></p>"
        },
        {
          "id": 288964,
          "text": "<p><span style=\"font-size:14.0pt;\">Siderophore for iron acquisition</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 50-year-old man presents with acute bloodstream infection in the form of septicemia, following a traumatic injury while working in a paddy field. His clinical features also include fever, chills, and generalized muscle aches. A microbiological culture from the wound grows colonies, as shown in the image. What virulence factor is most likely contributing to the pathogenicity of this organism?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-21%20180925.jpg\" width=\"422\" height=\"306\"></span></p>",
      "unique_key": "Q8001594",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;C)</strong> <strong>Type III secretion system</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>type III secretion system</strong> is a critical virulence factor for <strong>Burkholderia pseudomallei</strong> and is responsible for <strong>injecting toxins</strong> into host cells to <strong>promote infection</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This pathogen’s ability to produce <strong>wrinkled purple colonies</strong> on <strong>Ashdown’s medium</strong> is a further clue. <strong>B. pseudomallei</strong> has a <strong>long latency</strong> period and can lead to severe infections such as <strong>septicemia</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Polysaccharide capsule</strong>: While this is important in some pathogens like <strong>Streptococcus pneumoniae</strong>, <strong>B. pseudomallei</strong> relies more on its <strong>type III secretion system</strong> for virulence.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option B. Type IV pili</strong>: These pili are involved in <strong>adhesion</strong>, but <strong>B. pseudomallei</strong> utilizes its <strong>type III secretion system</strong> for a more aggressive pathogenic mechanism.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option D. Siderophore for iron acquisition</strong>: While <strong>iron acquisition</strong> is important, <strong>B. pseudomallei</strong>'s virulence is more associated with its <strong>type III secretion system</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>type III secretion system</strong> is a major <strong>virulence factor</strong> of <strong>Burkholderia pseudomallei</strong>, contributing to its pathogenicity in <strong>melioidosis</strong>.</span></li></ul>",
      "correct_choice_id": 288963,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72447,
      "choices": [
        {
          "id": 288777,
          "text": "<p><span style=\"font-size:14.0pt;\">Measles</span></p>"
        },
        {
          "id": 288778,
          "text": "<p><span style=\"font-size:14.0pt;\">Kimura disease</span></p>"
        },
        {
          "id": 288779,
          "text": "<p><span style=\"font-size:14.0pt;\">HIV-associated lymphadenopathy</span></p>"
        },
        {
          "id": 288780,
          "text": "<p><span style=\"font-size:14.0pt;\">Tuberculosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 7-year-old child presents with fever, cough, and a characteristic maculopapular rash. A biopsy from a lymph node is performed, and the following histopathological image is observed. Which of the following conditions is least likely to be associated with these cells?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-21%20173740.jpg\" width=\"566\" height=\"390\"></span></p>",
      "unique_key": "Q2188529",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Tuberculosis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Warthin-Finkeldey giant cells are typically associated with measles, Kimura disease, and HIV-associated lymphadenopathy, but are not a feature of tuberculosis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Tuberculosis usually presents with granulomas and caseous necrosis, not multinucleated giant cells like those seen in measles or Kimura disease.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Measles</strong>: Warthin-Finkeldey giant cells are pathognomonic for measles.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Kimura disease</strong>: This is a rare disorder of unknown etiology, often associated with eosinophilia and Warthin-Finkeldey cells in the lymph nodes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. HIV-associated lymphadenopathy</strong>: Can present with Warthin-Finkeldey giant cells in the lymph nodes, particularly in the context of opportunistic infections</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Warthin-Finkeldey giant cells are found in conditions like measles, Kimura disease, and HIV-associated lymphadenopathy but are not characteristic of tuberculosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Diseases Associated with Warthin-Finkeldey Cells:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">1. Measles (Rubeola) – Classical association</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Most characteristic setting</span></li><li><span style=\"font-size:14.0pt;\">Found in lymphoid tissue (e.g., tonsils, lymph nodes)</span></li><li><span style=\"font-size:14.0pt;\">Early appearance before the rash</span></li><li><span style=\"font-size:14.0pt;\">Accompanied by necrosis and paracortical hyperplasia</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">2. HIV-associated lymphadenopathy</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">WFCs have been reported in reactive hyperplasia in HIV</span></li><li><span style=\"font-size:14.0pt;\">Believed to be part of immune dysregulation</span></li><li><span style=\"font-size:14.0pt;\">However, not pathognomonic and less frequent than in measles</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">3. Kimura disease</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Rarely reported, likely due to florid immune response</span></li><li><span style=\"font-size:14.0pt;\">Not a classic feature, but giant cells may be seen in inflammatory background</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">4. Systemic lupus erythematosus (SLE)</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Occasionally seen in lymph nodes showing \"lupus lymphadenitis\"</span></li><li><span style=\"font-size:14.0pt;\">Represents part of an exaggerated immune response</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">5. Post-vaccination lymphadenitis (especially MMR vaccine)</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Measles component of MMR vaccine can trigger appearance of WFCs</span></li></ul>",
      "correct_choice_id": 288780,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72561,
      "choices": [
        {
          "id": 289233,
          "text": "<p><span style=\"font-size:14.0pt;\">A patient receiving chemotherapy for non-Hodgkin’s lymphoma</span></p>"
        },
        {
          "id": 289234,
          "text": "<p><span style=\"font-size:14.0pt;\">A pregnant woman in her second trimester</span></p>"
        },
        {
          "id": 289235,
          "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old healthy individual receiving the flu vaccine</span></p>"
        },
        {
          "id": 289236,
          "text": "<p><span style=\"font-size:14.0pt;\">A 15-year-old girl receiving the MMR vaccine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following patients would be most at risk for complications due to receiving a live vaccine?&nbsp;</span></p>",
      "unique_key": "Q7151421",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A) A patient receiving chemotherapy for non-Hodgkin’s lymphoma</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Patients who are immunosuppressed, such as those receiving <strong>chemotherapy</strong>, are at high risk for complications from live vaccines due to their weakened immune systems.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Live vaccines can cause severe reactions in immunocompromised patients. Pregnant women are also at risk but the <strong>yellow fever vaccine</strong> is one exception, and vaccines such as <strong>MMR</strong> are generally contraindicated.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>A pregnant woman in her second trimester:</strong> Incorrect, as <strong>pregnant women</strong> are typically advised to avoid live vaccines, especially in the first trimester.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>A 60-year-old healthy individual receiving the flu vaccine:</strong> Incorrect, as the <strong>flu vaccine</strong> is inactivated and is safe for healthy individuals.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>A 15-year-old girl receiving the MMR vaccine:</strong> Incorrect, as the <strong>MMR</strong> vaccine is safe for healthy children and not contraindicated in this age group.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Immunocompromised patients (e.g., those on chemotherapy) are at high risk for complications from live vaccines.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Pregnant women should avoid live vaccines, with few exceptions.</span></li></ul>",
      "correct_choice_id": 289233,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72064,
      "choices": [
        {
          "id": 287257,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 3 only</span></p>"
        },
        {
          "id": 287258,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3 only</span></p>"
        },
        {
          "id": 287259,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3 and 4 only</span></p>"
        },
        {
          "id": 287260,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 4 only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements about AMTSL are correct?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Uterotonic agents should be given within 1 minute of delivery.</span></li><li><span style=\"font-size:14.0pt;\">Fundal massage is performed immediately after delivery of the baby.</span></li><li><span style=\"font-size:14.0pt;\">Controlled cord traction is an essential step.</span></li><li><span style=\"font-size:14.0pt;\">Routine fundal massage before placental delivery is mandatory.</span></li></ol>",
      "unique_key": "Q6402045",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A) 1 and 3 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Statement 1: Uterotonic agents should be given within 1 minute of delivery. (Correct)</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Explanation: Administration of uterotonic agents (e.g., oxytocin 10 IU IM or IV infusion) within 1 minute of delivery helps stimulate uterine contractions and reduce the risk of postpartum hemorrhage (PPH).</span></li><li><span style=\"font-size:14.0pt;\">Importance: Timely administration reduces the risk of uterine atony, which is the most common cause of PPH.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">&nbsp;Statement 3: Controlled cord traction is an essential step. (Correct)</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Explanation: Controlled cord traction (CCT) is an essential component of AMTSL to facilitate placental expulsion while preventing uterine inversion.</span></li><li><span style=\"font-size:14.0pt;\">Steps in CCT:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">One hand supports the uterus above the symphysis pubis.</span></li><li><span style=\"font-size:14.0pt;\">The cord is gently pulled downward with steady traction.</span></li><li><span style=\"font-size:14.0pt;\">If the placenta does not descend, no forceful pulling should be applied to avoid uterine inversion.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Statement 2: Fundal massage is performed immediately after delivery of the baby. (Incorrect)</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Explanation: Fundal massage should be performed after placental delivery, not immediately after the baby is born.</span></li><li><span style=\"font-size:14.0pt;\">Reason: If done before placental separation, it can lead to incomplete separation, increasing the risk of retained placenta and hemorrhage.</span></li><li><span style=\"font-size:14.0pt;\">Correct Practice: Fundal massage is done after placenta delivery to enhance uterine tone and prevent atony.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Statement 4: Routine fundal massage before placental delivery is mandatory. (Incorrect)</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Explanation: Fundal massage before placental delivery is not mandatory and is not part of the standard AMTSL protocol.</span></li><li><span style=\"font-size:14.0pt;\">Correct Approach:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Fundal massage should only be done after placental expulsion to promote uterine contraction and reduce blood loss.</span></li><li><span style=\"font-size:14.0pt;\">Routine pre-delivery fundal massage can cause premature placental separation, increasing complications.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective :</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">AMTSL is a key strategy to reduce postpartum hemorrhage and includes:</span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\">Timely administration of uterotonic agents within 1 minute of delivery.</span></li><li><span style=\"font-size:14.0pt;\">&nbsp;Controlled cord traction to aid placental expulsion while preventing uterine inversion.</span></li><li><span style=\"font-size:14.0pt;\">&nbsp;Fundal massage after placental delivery , not immediately after the baby is born to promote uterine contraction.</span></li></ol></li></ul>",
      "correct_choice_id": 287257,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72481,
      "choices": [
        {
          "id": 288913,
          "text": "<p><span style=\"font-size:14.0pt;\">Candida albicans</span></p>"
        },
        {
          "id": 288914,
          "text": "<p><span style=\"font-size:14.0pt;\">Aspergillus fumigatus</span></p>"
        },
        {
          "id": 288915,
          "text": "<p><span style=\"font-size:14.0pt;\">Trichosporon</span></p>"
        },
        {
          "id": 288916,
          "text": "<p><span style=\"font-size:14.0pt;\">Rhizopus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 34-year-old man with a history of diabetes mellitus presents with oral thrush. Microscopic findings is shown in the image below. Which of the following fungi is most likely responsible for this infection?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-21%20180624.jpg\" width=\"857\" height=\"449\"></span></p>",
      "unique_key": "Q9236711",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A)</strong> <strong>Candida albicans</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Candida albicans</strong> produces <strong>blastoconidia</strong> as part of its <strong>asexual reproduction</strong>, and it is the most common cause of <strong>oral thrush</strong> in immunocompromised individuals, such as those with <strong>diabetes mellitus</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Blastoconidia</strong> are a characteristic asexual spore type of <strong>Candida</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Aspergillus fumigatus</strong>: Produces <strong>conidiospores</strong>, not <strong>blastoconidia</strong>.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Trichosporon</strong>: It can also produce <strong>arthrospores</strong> but not <strong>blastoconidia</strong>.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option D. Rhizopus</strong>: It is a <strong>zygomycete</strong> that produces <strong>sporangia</strong> and not <strong>blastoconidia</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Candida albicans</strong> is characterized by the production of <strong>blastoconidia</strong> during its asexual reproduction and is a common cause of <strong>oral thrush</strong>.</span></p>",
      "correct_choice_id": 288913,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72214,
      "choices": [
        {
          "id": 287857,
          "text": "<p><span style=\"font-size:14.0pt;\">Renal and gastrointestinal blood flow increases to meet metabolic demands.</span></p>"
        },
        {
          "id": 287858,
          "text": "<p><span style=\"font-size:14.0pt;\">Coronary circulation decreases due to sympathetic vasoconstriction.</span></p>"
        },
        {
          "id": 287859,
          "text": "<p><span style=\"font-size:14.0pt;\">Cutaneous blood flow initially decreases and later increases to aid heat dissipation.</span></p>"
        },
        {
          "id": 287860,
          "text": "<p><span style=\"font-size:14.0pt;\">CNS blood flow significantly increases due to enhanced neural activity.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements about blood flow changes during exercise is correct?&nbsp;</span></p>",
      "unique_key": "Q6051605",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Cutaneous blood flow initially decreases and later increases to aid heat dissipation.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">During exercise, cutaneous blood flow is initially reduced due to sympathetic vasoconstriction as the body prioritizes blood flow to muscles. As exercise progresses and body temperature rises, cutaneous blood flow increases significantly to dissipate heat through sweat and evaporation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Renal and gastrointestinal blood flow increases to meet metabolic demands: </strong>Incorrect. Renal and gastrointestinal blood flow decreases during exercise due to sympathetic vasoconstriction as these organs are not prioritized for oxygen delivery during physical activity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Coronary circulation decreases due to sympathetic vasoconstriction: </strong>Incorrect. Coronary circulation actually increases during exercise to meet the heightened metabolic demands of the heart muscle. Sympathetic stimulation causes vasodilation in the coronary vessels.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. CNS blood flow significantly increases due to enhanced neural activity: </strong>Incorrect. CNS blood flow remains relatively constant during exercise due to autoregulation, ensuring the brain maintains its function regardless of systemic changes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Blood flow redistribution during exercise prioritizes muscles, heart, and heat dissipation while reducing flow to non-essential organs.</span></p>",
      "correct_choice_id": 287859,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72514,
      "choices": [
        {
          "id": 289045,
          "text": "<p><span style=\"font-size:14.0pt;\">Pulsatile to stimulate a natural rise and fall in gonadotropins.</span></p>"
        },
        {
          "id": 289046,
          "text": "<p><span style=\"font-size:14.0pt;\">Continuous to induce receptor desensitization and decrease gonadotropin release.</span></p>"
        },
        {
          "id": 289047,
          "text": "<p><span style=\"font-size:14.0pt;\">High-dose bolus once a month to maximize receptor stimulation.</span></p>"
        },
        {
          "id": 289048,
          "text": "<p><span style=\"font-size:14.0pt;\">Low-dose intermittent to gently suppress gonadotropin levels.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 7-year-old girl is diagnosed with central precocious puberty. The endocrinologist decides to initiate treatment with a GnRH agonist. Which administration strategy of GnRH agonist is most appropriate to achieve the therapeutic goal in this patient?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4395621",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Continuous to induce receptor desensitization and decrease gonadotropin release.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In central precocious puberty, the goal is to suppress premature gonadotropin secretion to halt early sexual maturation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Continuous administration of GnRH agonists leads to receptor desensitization on the pituitary gland, effectively decreasing the release of LH and FSH, thus preventing early puberty progression.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Pulsatile to stimulate a natural rise and fall in gonadotropins:</strong> Incorrect as pulsatile administration would mimic the natural secretion pattern and potentially exacerbate the condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>High-dose bolus once a month to maximize receptor stimulation:</strong> Incorrect because a high-dose bolus might initially stimulate gonadotropin release before achieving desensitization, potentially worsening symptoms temporarily.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Low-dose intermittent to gently suppress gonadotropin levels:</strong> Incorrect as intermittent low doses do not reliably induce the necessary receptor desensitization for therapeutic effect.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Apply knowledge of GnRH receptor pharmacodynamics to select appropriate therapy regimens for conditions like central precocious puberty, aiming for effective suppression of premature gonadotropin secretion.</span></li></ul>",
      "correct_choice_id": 289046,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72080,
      "choices": [
        {
          "id": 287321,
          "text": "<p><span style=\"font-size:14.0pt;\">Both Assertion and Reason are true, and Reason correctly explains the Assertion.</span></p>"
        },
        {
          "id": 287322,
          "text": "<p><span style=\"font-size:14.0pt;\">Both Assertion and Reason are true, but Reason does not explain the Assertion.</span></p>"
        },
        {
          "id": 287323,
          "text": "<p><span style=\"font-size:14.0pt;\">Assertion is true, but Reason is false.</span></p>"
        },
        {
          "id": 287324,
          "text": "<p><span style=\"font-size:14.0pt;\">Both Assertion and Reason are false.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Assertion: Periodic echocardiography is essential for monitoring patients with Duchenne muscular dystrophy (DMD).</span></p><p><br><span style=\"font-size:14.0pt;\">Reason: DMD patients are at increased risk of developing dilated cardiomyopathy due to dystrophin deficiency in myocardial tissue.</span></p>",
      "unique_key": "Q9610269",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) Both Assertion and Reason are true, and Reason correctly explains the Assertion.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">DMD-associated dystrophin deficiency leads to myocardial fibrosis and cardiomyopathy, necessitating echocardiographic surveillance.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">DMD-associated dystrophin deficiency leads to myocardial fibrosis and cardiomyopathy</span></p>",
      "correct_choice_id": 287321,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72092,
      "choices": [
        {
          "id": 287369,
          "text": "<p><span style=\"font-size:14.0pt;\">Lesser omentum</span></p>"
        },
        {
          "id": 287370,
          "text": "<p><span style=\"font-size:14.0pt;\">Inferior vena cava</span></p>"
        },
        {
          "id": 287371,
          "text": "<p><span style=\"font-size:14.0pt;\">Duodenum&nbsp;</span></p>"
        },
        {
          "id": 287372,
          "text": "<p><span style=\"font-size:14.0pt;\">Caudate lobe of liver</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">The following coronal section of the abdomen is showing the relations of epiploic foramen. What structure forms its superior boundary as indicated in the figure below?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-19%20181552.jpg\" width=\"442\" height=\"512\"></span></p>",
      "unique_key": "Q9964528",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D)&nbsp;Caudate lobe of liver</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>epiploic foramen</strong> (also known as the foramen of Winslow) connects the <strong>greater sac</strong> and the <strong>lesser sac</strong> of the abdominal cavity.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is bounded by critical structures that are essential for understanding abdominal anatomy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Boundaries of the Epiploic Foramen:</strong></span></p><p>&nbsp;</p><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\"><strong>Anterior</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Right free border of the lesser omentum containing:</span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:14.0pt;\">Bile duct</span></li><li><span style=\"font-size:14.0pt;\">Hepatic artery (vertical part)</span></li><li><span style=\"font-size:14.0pt;\">Portal vein (posterior to duct and artery)</span></li></ul></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Posterior</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Inferior vena cava (IVC)</span></li><li><span style=\"font-size:14.0pt;\">Right suprarenal gland</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Superior</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Caudate process of the caudate lobe of the liver</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Inferior</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">First part of the duodenum</span></li><li><span style=\"font-size:14.0pt;\">Horizontal part of the hepatic artery</span></li></ul></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Clinical Significance:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>epiploic foramen</strong> is of great importance in surgeries involving the liver or pancreas as it provides access to the lesser sac. Structures within its boundaries are prone to injury during abdominal surgeries.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Lesser omentum</strong>: Incorrect. The lesser omentum forms part of the anterior boundary, not the superior boundary of the epiploic foramen.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Inferior vena cava</strong>: Incorrect. The IVC forms the posterior boundary of the epiploic foramen, lying posterior to the portal vein.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Duodenum</strong>: Incorrect. The duodenum forms the inferior boundary of the epiploic foramen, specifically the first part of the duodenum.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Boundaries of the Epiploic Foramen</strong><i>:</i></span></p><p>&nbsp;</p><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\"><strong>Anterior</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Right free border of the lesser omentum containing:</span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:14.0pt;\">Bile duct</span></li><li><span style=\"font-size:14.0pt;\">Hepatic artery (vertical part)</span></li><li><span style=\"font-size:14.0pt;\">Portal vein (posterior to duct and artery)</span></li></ul></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Posterior</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Inferior vena cava (IVC)</span></li><li><span style=\"font-size:14.0pt;\">Right suprarenal gland</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Superior</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Caudate process of the caudate lobe of the liver</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Inferior</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">First part of the duodenum</span></li><li><span style=\"font-size:14.0pt;\">Horizontal part of the hepatic artery</span></li></ul></li></ol>",
      "correct_choice_id": 287372,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72536,
      "choices": [
        {
          "id": 289133,
          "text": "<p><span style=\"font-size:14.0pt;\">IV Regular insulin&nbsp;</span></p>"
        },
        {
          "id": 289134,
          "text": "<p><span style=\"font-size:14.0pt;\">Subcutaneous Regular insulin</span></p>"
        },
        {
          "id": 289135,
          "text": "<p><span style=\"font-size:14.0pt;\">IV NPH</span></p>"
        },
        {
          "id": 289136,
          "text": "<p><span style=\"font-size:14.0pt;\">IV Glargine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 19-year-old man, Rohan from Delhi, with a history of type 1 diabetes mellitus presents to the emergency department with abdominal pain, vomiting, and confusion. His capillary blood glucose is 520 mg/dL. Given the likely diagnosis, which of the following drugs should be used immediately to manage hyperglycemia in this patient?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3137400",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) IV Regular insulin</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient is likely experiencing diabetic ketoacidosis (DKA), a life-threatening complication of type 1 diabetes.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Immediate treatment involves fluid resuscitation and IV Regular insulin, which has a rapid onset and allows for precise titration to correct hyperglycemia and ketosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Subcutaneous Regular insulin:</strong> Not preferred in DKA due to delayed absorption and less predictable pharmacokinetics.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. IV NPH:</strong> NPH is an intermediate-acting insulin and is not suitable for acute management.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. IV Glargine:</strong> Glargine is long-acting and not administered IV; it is unsuitable for managing acute hyperglycemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In diabetic ketoacidosis, <strong>IV Regular insulin</strong> is the treatment of choice to rapidly lower blood glucose and correct acidosis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Early and appropriate insulin therapy is critical to prevent complications.</span></li></ul>",
      "correct_choice_id": 289133,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72207,
      "choices": [
        {
          "id": 287829,
          "text": "<p><span style=\"font-size:14.0pt;\">No further treatment</span></p>"
        },
        {
          "id": 287830,
          "text": "<p><span style=\"font-size:14.0pt;\">Perform extended cholecystectomy</span></p>"
        },
        {
          "id": 287831,
          "text": "<p><span style=\"font-size:14.0pt;\">Adjuvant chemotherapy</span></p>"
        },
        {
          "id": 287832,
          "text": "<p><span style=\"font-size:14.0pt;\">Radiation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 50-year-old female underwent a laparoscopic cholecystectomy for symptomatic cholelithiasis. The histopathology of the resected gallbladder revealed Stage T1a gallbladder carcinoma. What should be the next step in management?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5569093",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) No further treatment</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">T1a gallbladder carcinoma is defined as a tumor that invades the lamina propria but does not extend into the muscle layer.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Standard cholecystectomy is considered curative in such cases, provided that the surgical margins are clear, and there is no evidence of perineural, lymphatic, or vascular invasion.</span></li><li><span style=\"font-size:14.0pt;\"><strong>No further treatment</strong> is required for T1a lesions with negative margins, as the risk of recurrence is negligible.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Perform extended cholecystectomy:</strong> Extended cholecystectomy, which involves resection of the liver bed and lymphadenectomy, is recommended for T1b tumors or higher (tumor invades the muscular layer or beyond). It is not necessary for T1a tumors with negative margins.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Adjuvant chemotherapy:</strong> Chemotherapy is not indicated for T1a gallbladder carcinoma as it is an early-stage tumor with an excellent prognosis after curative cholecystectomy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Radiation:</strong> Radiation therapy has no role in the management of early-stage gallbladder cancer, including T1a lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">T1a gallbladder carcinoma is limited to the lamina propria and has an excellent prognosis following simple cholecystectomy, provided the margins are clear.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">No additional treatment is necessary in these cases.</span></li></ul>",
      "correct_choice_id": 287829,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72460,
      "choices": [
        {
          "id": 288829,
          "text": "<p><span style=\"font-size:14.0pt;\">Psammoma bodies</span></p>"
        },
        {
          "id": 288830,
          "text": "<p><span style=\"font-size:14.0pt;\">Solid sheets of undifferentiated cells</span></p>"
        },
        {
          "id": 288831,
          "text": "<p><span style=\"font-size:14.0pt;\">Presence of amyloid deposits</span></p>"
        },
        {
          "id": 288832,
          "text": "<p><span style=\"font-size:14.0pt;\">Follicular pattern with colloid-filled follicles</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 38-year-old female presents with a thyroid nodule and undergoes a fine-needle aspiration biopsy. The histology shows branching papillae with fibrovascular stalks and single-layered cuboidal cells with clear nuclei. The biopsy also shows concentric calcified spherules in the stroma. Which of the following features best differentiates this from other thyroid malignancies?</span></p>",
      "unique_key": "Q3530319",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) Psammoma bodies</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Psammoma bodies</strong>, which are small, concentric, calcified spherules, are characteristic of <strong>papillary carcinoma of the thyroid</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This feature helps differentiate papillary carcinoma from other thyroid malignancies.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Psammoma bodies are rarely found in other types of thyroid cancer.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-21%20173807.jpg\" width=\"781\" height=\"286\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other&nbsp;Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Solid sheets of undifferentiated cells</strong>: <strong>Solid sheets of undifferentiated cells</strong> are more characteristic of <strong>anaplastic carcinoma</strong>, not papillary carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Presence of amyloid deposits</strong>: <strong>Amyloid deposits</strong> are seen in <strong>medullary carcinoma</strong> due to C-cell hyperplasia, not in papillary carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Follicular pattern with colloid-filled follicles:</strong> <strong>Follicular pattern with colloid-filled follicles</strong> is characteristic of <strong>follicular carcinoma</strong>, not papillary carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Psammoma bodies are a hallmark feature of papillary carcinoma of the thyroid, helping to differentiate it from other thyroid malignancies.</span></p>",
      "correct_choice_id": 288829,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72544,
      "choices": [
        {
          "id": 289165,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 4&nbsp;</span></p>"
        },
        {
          "id": 289166,
          "text": "<p><span style=\"font-size:14.0pt;\">3, 4 and 5&nbsp;</span></p>"
        },
        {
          "id": 289167,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3 and 5</span></p>"
        },
        {
          "id": 289168,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 4 and 5&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following conditions can lead to Hyperphenylalaninemia?</span></p><p>&nbsp;</p><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\">Phenylalanine hydroxylase deficiency&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Phenylalanine hydroxylase overactivity&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Dihydrobiopterin reductase deficiency&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Tyrosine hydroxylase deficiency&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Defect in dihydrobiopterin biosynthesis&nbsp;</span></li></ol>",
      "unique_key": "Q7268081",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 1, 3 and 5</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Hyperphenylalaninemia can result from defects in the metabolic pathway of phenylalanine due to:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1. Phenylalanine hydroxylase deficiency</strong>: This enzyme is crucial for converting phenylalanine to tyrosine. Its deficiency leads to an accumulation of phenylalanine.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3. Dihydrobiopterin reductase deficiency</strong>: This enzyme is necessary for the recycling of tetrahydrobiopterin (BH4), a cofactor for phenylalanine hydroxylase. Its deficiency leads to a decrease in BH4, impairing phenylalanine hydroxylation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>5. Defect in dihydrobiopterin biosynthesis</strong>: Problems in the biosynthesis of BH4 also lead to reduced cofactor availability for phenylalanine hydroxylase, contributing to elevated phenylalanine levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2</strong>. <strong>Incorrect</strong>: <strong>Includes Phenylalanine hydroxylase overactivity</strong>, which would theoretically lower phenylalanine levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4.</strong> <strong>Incorrect: Includes Tyrosine hydroxylase deficiency,</strong> which affects dopamine synthesis but not directly phenylalanine levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The primary causes of hyperphenylalaninemia are defects in the metabolism of phenylalanine, which can be due to deficiencies in phenylalanine hydroxylase, dihydrobiopterin reductase, or defects in dihydrobiopterin biosynthesis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Understanding these deficiencies helps in diagnosing conditions such as phenylketonuria (PKU) and tetrahydrobiopterin (BH4)-deficiency disorders.</span></li></ul>",
      "correct_choice_id": 289167,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72456,
      "choices": [
        {
          "id": 288813,
          "text": "<p><span style=\"font-size:14.0pt;\">Typhus</span></p>"
        },
        {
          "id": 288814,
          "text": "<p><span style=\"font-size:14.0pt;\">Plague</span></p>"
        },
        {
          "id": 288815,
          "text": "<p><span style=\"font-size:14.0pt;\">Diarrhea</span></p>"
        },
        {
          "id": 288816,
          "text": "<p><span style=\"font-size:14.0pt;\">Typhoid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">During Napoleon’s ill-fated march to Moscow, the bulk of his army faced significant losses not due to battle, but from a different cause. Which of the following diseases was responsible for the maximum casualties among Napoleon’s troops?&nbsp;</span></p>",
      "unique_key": "Q3320646",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Typhus</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The maximum damage to Napoleon's army during the 1812 march to Moscow was caused by typhus, a highly contagious disease spread by lice.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The poor sanitary conditions, overcrowded camps, and harsh weather conditions facilitated the rapid spread of typhus among the soldiers, leading to widespread illness and death.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Typhus significantly weakened the army, contributing to its eventual defeat.</span></li><li><span style=\"font-size:14.0pt;\">While plague, diarrhea, and typhoid also affect military units, typhus was the primary cause of mass casualties during this campaign.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Plague:</strong> It is caused by the Yersinia pestis bacterium and can lead to widespread death, but there is no major historical record of the plague being the primary cause of death during Napoleon's campaign in Russia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Diarrhea:</strong> It is a common affliction in wartime due to poor sanitation, but it was typhus, not diarrhea, that caused the most significant casualties during Napoleon’s march.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Typhoid</strong>: It is caused by Salmonella typhi and leads to gastrointestinal symptoms, but it did not cause the massive death toll experienced from typhus during Napoleon's campaign.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">During Napoleon’s march to Moscow, typhus was the leading cause of casualties, resulting in significant losses due to its rapid transmission and high mortality rate in the poor conditions the soldiers endured.</span></li></ul>",
      "correct_choice_id": 288813,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72499,
      "choices": [
        {
          "id": 288985,
          "text": "<p><span style=\"font-size:14.0pt;\">Allopurinol</span></p>"
        },
        {
          "id": 288986,
          "text": "<p><span style=\"font-size:14.0pt;\">Febuxostat</span></p>"
        },
        {
          "id": 288987,
          "text": "<p><span style=\"font-size:14.0pt;\">Rasburicase</span></p>"
        },
        {
          "id": 288988,
          "text": "<p><span style=\"font-size:14.0pt;\">Furosemide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old man with acute myeloid leukemia is undergoing induction chemotherapy. Within 48 hours, he develops nausea, vomiting, oliguria, and severe flank pain. Laboratory results reveal hyperkalemia, hyperphosphatemia, hypocalcemia, and a markedly elevated uric acid level. The oncologist prescribes a medication that rapidly converts uric acid into allantoin for renal excretion. Which of the following drugs is the most appropriate treatment for this patient?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6453828",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Rasburicase</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient presents with <strong>tumor lysis syndrome (TLS),</strong> a condition characterized by the rapid release of intracellular contents, including potassium, phosphate, and uric acid, following chemotherapy.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">TLS leads to acute kidney injury due to uric acid crystal deposition in the renal tubules.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Rasburicase is the drug of choice because it <strong>catalyzes the enzymatic breakdown of uric acid into allantoin,</strong> a more water-soluble metabolite that is easily excreted by the kidneys, thereby preventing renal damage.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It acts much faster than xanthine oxidase inhibitors such as allopurinol.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Allopurinol:</strong> Incorrect. Allopurinol inhibits xanthine oxidase, preventing the formation of uric acid but does not degrade existing uric acid. It is used for long-term urate management but is ineffective for rapidly lowering uric acid levels in TLS.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Febuxostat:</strong> Incorrect. Febuxostat, like allopurinol, is a xanthine oxidase inhibitor that prevents uric acid formation but does not break down pre-existing uric acid. It has no immediate effect in acute TLS.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Furosemide:</strong> Incorrect. Furosemide is a loop diuretic that promotes diuresis but does not specifically lower uric acid levels. It is not the preferred treatment for TLS-associated hyperuricemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Rasburicase is the preferred treatment for tumor lysis syndrome because it directly degrades uric acid into allantoin, preventing renal complications.</span></li></ul>",
      "correct_choice_id": 288987,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72533,
      "choices": [
        {
          "id": 289121,
          "text": "<p><span style=\"font-size:14.0pt;\">Desaturation</span></p>"
        },
        {
          "id": 289122,
          "text": "<p><span style=\"font-size:14.0pt;\">Altered mental status</span></p>"
        },
        {
          "id": 289123,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased blood pressure</span></p>"
        },
        {
          "id": 289124,
          "text": "<p><span style=\"font-size:14.0pt;\">Retinal hemorrhage</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old man, Arjun from Bengaluru, experiences a sudden onset of severe headache, dizziness, and blurred vision while trekking at an altitude of 5000 meters in the Himalayas. Which of the following indicates the development of high-altitude cerebral edema (HACE)?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1818041",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Altered mental status</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>High-Altitude Cerebral Edema (HACE)</strong> is a severe form of <strong>acute mountain sickness (AMS)</strong> characterized by:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Altered mental status</strong> (confusion, disorientation, or coma).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Ataxia</strong> (difficulty walking or coordinating movements).</span></li></ul></li><li><span style=\"font-size:14.0pt;\">HACE occurs due to <strong>hypoxia-induced vasodilation and increased intracranial pressure (ICP)</strong> at altitudes &gt;2500 meters.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Progression from AMS to HACE often happens over 12 hours to 3 days. Immediate treatment includes:</span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\"><strong>Descent to lower altitude</strong></span></li><li><span style=\"font-size:14.0pt;\">Administration of <strong>dexamethasone</strong></span></li><li><span style=\"font-size:14.0pt;\">Supplemental oxygen or <strong>hyperbaric oxygen therapy (HBOT)</strong></span></li></ol></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Desaturation:</strong> Common at high altitudes but not specific to HACE.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Increased blood pressure:</strong> May occur as a physiological response to hypoxia but is not a diagnostic feature of HACE.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Retinal hemorrhage:</strong> Often seen at high altitudes but is not exclusive to HACE and occurs in asymptomatic individuals as well.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Altered mental status</strong> and <strong>ataxia</strong> are hallmarks of <strong>HACE</strong>, requiring immediate descent and medical intervention to prevent fatal complications.</span></li></ul>",
      "correct_choice_id": 289122,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72538,
      "choices": [
        {
          "id": 289141,
          "text": "<p><span style=\"font-size:14.0pt;\">Removal of catheter alone</span></p>"
        },
        {
          "id": 289142,
          "text": "<p><span style=\"font-size:14.0pt;\">Treatment with vancomycin and removal of catheter</span></p>"
        },
        {
          "id": 289143,
          "text": "<p><span style=\"font-size:14.0pt;\">Treatment with topical antibiotics at the catheter site</span></p>"
        },
        {
          "id": 289144,
          "text": "<p><span style=\"font-size:14.0pt;\">Treatment with vancomycin alone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 63-year-old man undergoing chemotherapy for lung cancer presents with a fever of 38.3°C (100.9°F) and erythema at the exit site of a tunnelled central venous catheter in his neck. The tunnel itself is neither tender nor red. Blood cultures are negative at 48 hours, and his neutrophil count is 1550/μL. What is the best approach to the management of this patient?</span></p>",
      "unique_key": "Q8554982",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;D) Treatment with vancomycin alone</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient has an <strong>exit site infection</strong> associated with his tunneled central venous catheter.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Exit site infections present with localized erythema, tenderness, or discharge at the catheter exit site, without signs of tunnel or systemic infection.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The absence of tunnel tenderness or systemic involvement (negative blood cultures) suggests a localized infection.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Vancomycin</strong> is recommended to cover <strong>gram-positive organisms</strong>, especially <strong>Staphylococcus aureus</strong>, which are the most common pathogens associated with catheter-related infections.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The catheter does not need to be removed unless the infection progresses, there are signs of tunnel or bloodstream infection, or symptoms do not improve with antibiotic therapy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Removal of catheter alone</strong>: Catheter removal is not necessary in the absence of systemic infection or tunnel involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Treatment with vancomycin and removal of catheter</strong>: This is excessive management in a patient with a localized infection without systemic involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Treatment with topical antibiotics at the catheter site</strong>: Topical antibiotics are insufficient for treating catheter-related infections, as systemic antibiotics are needed to address potential deep-seated infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Localized exit site infections in tunneled central venous catheters can often be managed with systemic antibiotics (e.g., vancomycin).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Catheter removal is reserved for refractory, systemic, or complicated infections.</span></li></ul>",
      "correct_choice_id": 289144,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72455,
      "choices": [
        {
          "id": 288809,
          "text": "<p><span style=\"font-size:14.0pt;\">Criterion validity</span></p>"
        },
        {
          "id": 288810,
          "text": "<p><span style=\"font-size:14.0pt;\">Internal consistency</span></p>"
        },
        {
          "id": 288811,
          "text": "<p><span style=\"font-size:14.0pt;\">Test-retest reliability</span></p>"
        },
        {
          "id": 288812,
          "text": "<p><span style=\"font-size:14.0pt;\">Construct validity</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A clinical psychologist is developing a new scale to assess patient satisfaction with healthcare services. After administering the scale to a large sample of patients, the psychologist calculates Cronbach’s alpha to determine the underlying concept. Which of the following describes the primary focus of Cronbach’s alpha in this context?&nbsp;</span></p>",
      "unique_key": "Q6726053",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Internal consistency</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Cronbach’s alpha is a measure of internal consistency, which assesses how well the individual items of a test or questionnaire measure the same underlying construct.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In this case, the psychologist is evaluating whether all items on the patient satisfaction scale are consistent in measuring patient satisfaction, which is the intended construct.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A high value of Cronbach’s alpha (usually above 0.7) indicates good internal consistency, meaning the items are reliably measuring the same concept.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Criterion validity:&nbsp;</strong>It<strong>&nbsp;</strong>measures how well a test or scale correlates with an external criterion or outcome, but it does not assess the internal consistency of a set of items.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option C. Test-retest reliability:&nbsp;</strong>It<strong>&nbsp;</strong>refers to the consistency of test results when administered at different times, not how well the items of a test measure the same construct.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option D. Construct validity</strong>: It assesses whether a test truly measures the concept it is intended to measure, but it focuses on the overall validity of the test, not internal consistency of the items.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Cronbach’s alpha is a measure of internal consistency, evaluating whether all items in a questionnaire or test reliably measure the same underlying construct.</span></li></ul>",
      "correct_choice_id": 288810,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}